Processing 00000000.tx.1: Mutant presenilins specifically elevate the levels of the 42 residue -amyloid peptide in vivo: evidence for augmentation of a 42-specific secretase Joanna L. 

Phrase: "Mutant presenilins specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "the levels of the 42 residue -amyloid peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: ":"

Phrase: "evidence for augmentation of a 42-specific secretase Joanna L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.2: Jankowsky1,, Daniel J. 

Phrase: "Jankowsky1,"

Phrase: ", Daniel J."
Processing 00000000.tx.3: Fadale3, Jeffrey Anderson4, Guilian M. 

Phrase: "Fadale3,"

Phrase: "Jeffrey Anderson4,"

Phrase: "Guilian M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Xu1, Victoria Gonzales1, Nancy A. 

Phrase: "Xu1,"

Phrase: "Victoria Gonzales1,"

Phrase: "Nancy A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.5: Jenkins5, Neal G. 

Phrase: "Jenkins5,"

Phrase: "Neal G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.6: Copeland5, Michael K. 

Phrase: "Copeland5,"

Phrase: "Michael K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.7: Lee1, Linda H. 

Phrase: "Lee1,"

Phrase: "Linda H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.8: Younkin3, Steven L. 

Phrase: "Younkin3,"

Phrase: "Steven L."
Processing 00000000.tx.9: Wagner4,6, Steven G. 

Phrase: "Wagner4,"

Phrase: "6,"

Phrase: "Steven G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.10: Younkin3 and David R. 

Phrase: "Younkin3"

Phrase: "and"

Phrase: "David R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.11: Borchelt1,2,* 1Department of Pathology and 2Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA, 3Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA, 4Merck Research Labs, San Diego, 505 Coast Boulevard South, La Jolla, CA 92037, USA, 5Mouse Cancer Genetics Program, NCI-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA and 6Neurogenetics Inc., 11085 North Torrey Pines Road, Suite 300, La Jolla, CA 92037, USA Received August 15, 2003; 

Phrase: "Borchelt1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* 1Department of Pathology"

Phrase: "and"

Phrase: "2Department of Neuroscience,"

Phrase: "The Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036375:School [Manufactured Object,Organization]
   748   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD 21205,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "3Mayo Clinic Jacksonville,"

Phrase: "4500 San Pablo Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "4Merck Research Labs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0587081:Labs [Finding]
   793 E C0022877:Lab [Manufactured Object,Organization]
   755 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "505 Coast Boulevard South,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710133:South [Spatial Concept]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92037,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "5Mouse Cancer Genetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0694768:cancer genetics [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]

Phrase: "Program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: ","

Phrase: "NCI-Frederick Cancer Research"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1516225:Cancer Research [Research Activity]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "Development Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "Frederick,"

Phrase: "MD 21702,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "6Neurogenetics Inc.,"

Phrase: "11085 North Torrey Pines Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442650:Road [Manufactured Object]

Phrase: "Suite 300,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553446:Suite [Intellectual Product]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92037,"

Phrase: "USA Received August 15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.12: Accepted November 11, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Amyloid precursor protein (APP) is endoproteolytically processed by BACE1 and -secretase to release amyloid peptides (A40 and 42) that aggregate to form senile plaques in the brains of patients with Alzheimer's disease (AD). 

Phrase: "Accepted November 11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "endoproteolytically"

Phrase: "processed by BACE1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1412727:BACE1 [Gene or Genome]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and -"

Phrase: "secretase to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A40"

Phrase: "and"

Phrase: "42"

Phrase: ")"

Phrase: "that"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "senile plaques in the brains of patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   748   C0392079:Senile [Finding]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.13: The C-terminus of A40/42 is generated by -secretase, whose activity is dependent upon presenilin (PS 1 or 2). 

Phrase: "The C-terminus of A40/42"

Phrase: "is"

Phrase: "generated by -secretase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C3146294:Generated [Activity]

Phrase: "whose activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "dependent upon presenilin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]

Phrase: "(PS 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Missense mutations in PS1 (and PS2) occur in patients with early-onset familial AD (FAD), and previous studies in transgenic mice and cultured cell models demonstrated that FAD-PS1 variants shift the ratio of A40:42 to favor A42. 

Phrase: "Missense mutations in PS1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "and"

Phrase: "PS2"

Phrase: ")"

Phrase: "occur in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "with early-onset familial AD (FAD),"

Phrase: "and"

Phrase: "previous studies in transgenic mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "cultured cell models"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C3161035:Models [Intellectual Product]
   734   C0007635:cultured cell [Cell]
   717 E C0007585:culture cell [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "that FAD-PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205419:variants [Qualitative Concept]

Phrase: "shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the ratio of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "42 to"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "A42."
Processing 00000000.tx.15: One hypothesis to explain this outcome is that mutant PS alters the specificity of -secretase to favor production of A42 at the expense of A40. 

Phrase: "One hypothesis to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "explain"

Phrase: "this outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "is"

Phrase: "that mutant PS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the specificity of -secretase to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "production of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "at the expense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680864:expense [Quantitative Concept]

Phrase: "of A40."
Processing 00000000.tx.16: To test this hypothesis in vivo, we studied A40 and 42 levels in a series of transgenic mice that co-express the Swedish mutation of APP (APPswe) with two FAD-PS1 variants that differentially accelerate amyloid pathology in the brain. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "A40"

Phrase: "and"

Phrase: "42 levels in a series of transgenic mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "co-express"

Phrase: "the Swedish mutation of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(APPswe"

Phrase: ")"

Phrase: "with two FAD-PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:variants [Qualitative Concept]

Phrase: "that differentially"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amyloid pathology in the brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0006119:Brain Pathology [Pathologic Function]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.17: We demonstrate a direct correlation between the concentration of A42 and the rate of amyloid deposition. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "a direct correlation between the concentration of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the rate of amyloid deposition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.18: We further show that the shift in A42:40 ratios associated with the expression of FAD-PS1 variants is due to a specific elevation in the steady-state levels of A42, while maintaining a constant level of A40. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the shift in A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]

Phrase: ":"

Phrase: "40 ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "associated with the expression of FAD-PS1 variants"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   739   C0015576:familial [Family Group]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205419:variants [Qualitative Concept]
   739   C0241888:Familial [Functional Concept]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is due to a specific elevation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0205369:Specific [Qualitative Concept]
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]
   753   C1552740:specific [Intellectual Product]
   753   C3146286:Due [Idea or Concept]

Phrase: "in the steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of A42,"

Phrase: "while"

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "a constant level of A40."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.19: These data suggest that PS1 variants do not simply alter the preferred cleavage site for -secretase, but rather that they have more complex effects on the regulation of -secretase and its access to substrates.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PS1 variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205419:variants [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "do"

Phrase: "not simply"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the preferred cleavage site for -secretase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "but"

Phrase: "rather"

Phrase: "that"

Phrase: "they"

Phrase: "have"

Phrase: "more complex effects on the regulation of -secretase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "its access to substrates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444454:Access [Spatial Concept]
   770   C1554204:access [Idea or Concept]
Processing 00000000.tx.20: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  The pathology of Alzheimer's disease (AD) is characterized by amyloid lesions formed by aggregated peptides (-amyloid, A), which are derived from the amyloid precursor protein (APP) through endoproteolytic cleavage by BACE1 and -secretase. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The pathology of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "(AD)"

Phrase: "is"

Phrase: "characterized by amyloid lesions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0221198:lesions [Finding]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1880022:Characterized [Activity]
   737 E C1546698:Lesion [Intellectual Product]

Phrase: "formed by aggregated peptides"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0205431:Formed [Functional Concept]
   770   C0332621:Aggregated [Functional Concept]
   737 E C0205418:Aggregate [Qualitative Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "(-amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "derived from the amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1441547:Derived [Qualitative Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "through endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "by BACE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]

Phrase: "and -"

Phrase: "secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.21: APP is also a substrate for other endoproteases (-secretase and BACE2), and collectively these cleavages generate a range of amyloid (A) peptides (for review see 1). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "a substrate for other endoproteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: "(-secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "BACE2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412728:BACE2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "collectively"

Phrase: "these cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0010813:cleavage [Cell Function]
   966   C0596311:Cleavage [Phenomenon or Process]
   966   C1330957:cleavage [Cell Function]

Phrase: "generate"

Phrase: "a range of amyloid (A) peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: The most pathogenic of these peptides, A40 and 42, share a common N-terminus (+1) and differ by two residues at their C-terminus (27). 

Phrase: "The most pathogenic of these peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0450254:Pathogenic [Organism]

Phrase: "A40"

Phrase: "and"

Phrase: "42,"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common N-terminus"

Phrase: "(+1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "differ by two residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "at their C-terminus"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.23: Mutations in APP identified from familial AD (FAD) kindreds alter the protein's normal processing, causing either increased production of both peptides or a specific elevation in A42 (811). 

Phrase: "Mutations in APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified from familial AD (FAD) kindreds"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0015576:familial [Family Group]
   748   C0205396:Identified [Qualitative Concept]
   748   C0241888:Familial [Functional Concept]
   748   C0598429:kindreds [Qualitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the protein's normal processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0033666:protein processing [Molecular Function]
   827   C1709694:Processing [Activity]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "either increased production of both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "or"

Phrase: "a specific elevation in A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "(811"

Phrase: ")."
Processing 00000000.tx.24: The longer A42 peptide is more prone than A40 to aggregate in vitro (12,13), and is the major species detected immunocytochemically in the brains of AD patients (14). 

Phrase: "The longer A42 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "more prone than A40 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033422:Prone [Spatial Concept]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "the major species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "immunocytochemically in the brains of AD patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0030705:Patients [Patient or Disabled Group]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.25: Mutations in two additional genes, presenilin 1 (PS1) and its homolog PS2, also cause early-onset FAD (1517). 

Phrase: "Mutations in two additional genes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "presenilin 1 (PS1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "its homolog PS2,"

Phrase: "also"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "early-onset FAD (1517"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C1833334:Early-onset [Finding]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   804   C0332162:Onset [Qualitative Concept]
   804   C1279919:Early [Temporal Concept]
   733 E C1704727:Family [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.26: Studies in both vertebrates and invertebrates suggest that PS1 and PS2 are components of a larger protein complex that contains nicastrin, Aph-1, and PEN-2 (1827). 

Phrase: "Studies in both vertebrates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "invertebrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021948:Invertebrates [Eukaryote]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"

Phrase: "are"

Phrase: "components of a larger protein complex"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   846   C1179436:Component of protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein complex component
   809   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "nicastrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "Aph-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "and"

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "(1827"

Phrase: ")."
Processing 00000000.tx.27: This complex is either a required cofactor for, or is itself, the -secretase activity that generates the C-termini of A40 and 42 (19,2224,2835). 

Phrase: "This complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "either"

Phrase: "a required cofactor for,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178555:Cofactor [Biologically Active Substance]

Phrase: "or"

Phrase: "is"

Phrase: "itself,"

Phrase: "the -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "generates"

Phrase: "the C-termini of A40"

Phrase: "and"

Phrase: "42"

Phrase: "(19,"

Phrase: "2224,"

Phrase: "2835"

Phrase: ")."
Processing 00000000.tx.28: Deletion of both PS1 and PS2 leads to a complete loss of -secretase activity (33). 

Phrase: "Deletion of both PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "PS2"

Phrase: "leads to a complete loss of -secretase activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0181586:leads [Medical Device]
   744   C0205177:Activity [Functional Concept]
   744   C0205197:Complete [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0725685:COMPLEAT [Food]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1517945:Loss [Quantitative Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.29: Cells deficient in PS1 also show abnormalities in the subcellular trafficking of integral membrane proteins, including APP (36,37). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "deficient in PS1 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011155:Deficient [Functional Concept]
   760   C1636779:% deficient [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "abnormalities in the subcellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "trafficking of integral membrane proteins,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   813   C1513112:Membrane Traffic, Protein [Molecular Function]
           Membrane Traffic
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0599895:Protein Trafficking [Cell Function]
   781   C1159772:Protein Trafficking [Cell Function]
   760   C0025255:Membrane [Tissue]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0443238:Integral [Quantitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0599896:trafficking [Cell Function]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.30: An interaction between the presenilins and APP was first suggested by the observation that the plasma of patients with mutations in PS1 had higher ratios of A42 relative to A40 than patients with sporadic AD (38). 

Phrase: "An interaction between the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "suggested by the observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the plasma of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032105:Plasma [Body Substance]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "had"

Phrase: "higher ratios of A42"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0456603:Ratios [Quantitative Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "relative to A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "than patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with sporadic AD (38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205422:Sporadic [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.31: Subsequent work in cell models demonstrated that co-expression of FAD-mutant PS1 with APP reproduced the rise in A42 relative to A40 that had been seen in patients with PS1-associated AD (3941). 

Phrase: "Subsequent work in cell models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Models [Intellectual Product]

Phrase: "demonstrated"

Phrase: "that co-expression of FAD-mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "reproduced"

Phrase: "the rise in A42"

Phrase: "relative to A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "seen in patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "with PS1-associated AD (3941"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1418985:PRESENILIN 1 [Gene or Genome]
   804   C0332281:Associated [Qualitative Concept]
   804   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.32: This shift in A40:A42 ratio was also found in the brains of transgenic mice co-expressing one of several FAD PS1 mutations (M146V, M146L, A246E or M286L) with the Swedish mutation of APP (39,4244). 

Phrase: "This shift in A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]

Phrase: ":"

Phrase: "A42 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "found in the brains of transgenic mice"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0025936:Mice, Transgenic [Mammal]
   748   C0003069:Transgenic [Animal]
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0150312:Found [Quantitative Concept]
   741   C1521713:Mouse Brain [Tissue]
   714 E C0243095:Find [Finding]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "co-expressing"

Phrase: "one of several FAD PS1 mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "(M146V,"

Phrase: "M146L,"

Phrase: "A246E"

Phrase: "or"

Phrase: "M286L"

Phrase: ")"

Phrase: "with the Swedish mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(39,"

Phrase: "4244"

Phrase: ")."
Processing 00000000.tx.33: Similar shifts in the steady-state ratios of mouse A40:A42 were also noted in mice expressing only FAD-variant PS1 (45) or PS2 (46). 

Phrase: "Similar shifts in the steady-state ratios of mouse A40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0333051:shifts [Functional Concept]
   706 E C2347509:Shift [Phenomenon or Process]

Phrase: ":"

Phrase: "A42"

Phrase: "were"

Phrase: "also"

Phrase: "noted in mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "expressing"

Phrase: "only FAD-variant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PRESENILIN 1 [Gene or Genome]
   799   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(45"

Phrase: ")"

Phrase: "or"

Phrase: "PS2"

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.34: Transgenic mice co-expressing mutated PS1 and APP developed amyloid pathology much earlier than mice expressing only APP; 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "co-expressing"

Phrase: "mutated PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "developed"

Phrase: "amyloid pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "much earlier than mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1279919:Early [Temporal Concept]

Phrase: "expressing"

Phrase: "only APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.35: the acceleration in amyloid formation directly correlated with the change in the A40:A42 ratios (42,47,48). 

Phrase: "the acceleration in amyloid formation directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0000894:Acceleration [Phenomenon or Process]

Phrase: "correlated with the change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in the A40"

Phrase: ":"

Phrase: "A42 ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "(42,"

Phrase: "47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.36: In contrast, co-expression of wild-type human PS1 with mutant human APP had no impact on the rate of amyloid formation (44). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "co-expression of wild-type human PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with mutant human APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   897   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "had"

Phrase: "no impact on the rate of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.37: Studies of dominant negative versions of PS1 and chemical inhibitors of -secretase have been interpreted as evidence that PS1 may comprise the active site of the -secretase complex (28,31,4952). 

Phrase: "Studies of dominant negative versions of PS1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "chemical inhibitors of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "been"

Phrase: "interpreted as evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence [Functional Concept]
   790   C1285553:interpreted [Functional Concept]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the active site of the -secretase complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0205681:Active Site [Functional Concept]
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(28,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "4952"

Phrase: ")."
Processing 00000000.tx.38: Moreover, because some of these inhibitors coordinately depress both A40 and A42 production, it has been assumed that one enzyme complex is responsible for the production of both peptides (50,51). 

Phrase: "Moreover,"

Phrase: "because"

Phrase: "some of these inhibitors coordinately"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205392:Some [Quantitative Concept]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C3540770:Some [Intellectual Product]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "depress"

Phrase: "both A40"

Phrase: "and"

Phrase: "A42 production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that one enzyme complex"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "responsible for the production of both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.39: In such a setting, FAD mutations in PS1 might alter the ratio of A peptides produced from APP simply by shifting the specificity of -secretase to favor cleavage at residue 42 over that at 40. 

Phrase: "In such"

Phrase: "a setting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]

Phrase: "FAD mutations in PS1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "might"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the ratio of A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "produced from APP simply"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "by shifting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333051:shifting [Functional Concept]

Phrase: "the specificity of -secretase to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "cleavage at residue 42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "over that"

Phrase: "at 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.40: In this scenario, mutations that increase the output of A42 should be accompanied by a decrease in the generation of A40. 

Phrase: "In this scenario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the output of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709366:Output [Conceptual Entity]

Phrase: "should"

Phrase: "be"

Phrase: "accompanied by a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of A40."
Processing 00000000.tx.41: In the current work, we took advantage of recent advances in ELISA methodology to examine A40 and A42 levels in several lines of APPswe mice co-expressing either of two FAD PS1 variants (A246E and dE9). 

Phrase: "In the current work,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of recent advances"

Phrase: "in ELISA methodology to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0969625:methodology [Intellectual Product]
   827   C3266812:Methodology [Idea or Concept]

Phrase: "examine"

Phrase: "A40"

Phrase: "and"

Phrase: "A42 levels in several lines of APPswe mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "co-expressing"

Phrase: "either of two FAD PS1 variants"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0015576:familial [Family Group]
   744   C0205419:variants [Qualitative Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0241888:Familial [Functional Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(A246E"

Phrase: "and"

Phrase: "dE9"

Phrase: ")."
Processing 00000000.tx.42: Each PS1 variant accelerated the rate of amyloid deposition to differing extents. 

Phrase: "Each PS1 variant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205419:Variant [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "the rate of amyloid deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "to differing extents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extents [Spatial Concept]
Processing 00000000.tx.43: After quantifying the levels of A40 and A42 in the brains of young, pre-symptomatic animals, we found that co-expression of either PS1A246E or PS1-dE9 in APPswe transgenic mice specifically increased A42 levels without altering A40. 

Phrase: "After"

Phrase: "quantifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709793:Quantify [Quantitative Concept]

Phrase: "the levels of A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A42 in the brains of young, pre-symptomatic animals,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that co-expression of either PS1A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "PS1-dE9 in APPswe transgenic mice specifically increased A42 levels"

Phrase: "without altering A40."
Processing 00000000.tx.44: From these data, we defined a direct correlation between the age of amyloid onset and A42 levels. 

Phrase: "From these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "a direct correlation between the age of amyloid onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "A42 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.45: Based on work from cultured cell models suggesting that mutant PS1 alters the production of A42 (3941), we conclude that changes in the steady-state level of this peptide in our transgenic mice were most likely due to alterations in the processing of APP. 

Phrase: "Based on work"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0043227:Work [Occupational Activity]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from cultured cell models"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C3161035:Models [Intellectual Product]
   734   C0007635:cultured cell [Cell]
   717 E C0007585:culture cell [Laboratory Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the production of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "(3941"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that changes in the steady-state level of this peptide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0443172:State changes [Quantitative Concept]
           changes
   739   C0392747:changes [Functional Concept]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "in our transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "most likely due to alterations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   806   C0750501:most likely [Idea or Concept]
   760   C0205393:Most [Quantitative Concept]
   760   C0332148:Likely [Qualitative Concept]
   760   C0750492:Likely [Idea or Concept]
   760   C3146286:Due [Idea or Concept]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "in the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.46: We suggest that FAD-PS1 variants may increase the accessibility of BACE1-cleaved C-terminal fragments of APP (-CTFs) to a -secretase that preferentially cleaves at residue 42.  

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that FAD-PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205419:variants [Qualitative Concept]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the accessibility of BACE1-cleaved C-terminal fragments of APP (APP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0814423:accessibility [Qualitative Concept]

Phrase: "to a -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that preferentially"

Phrase: "cleaves at residue 42."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.47: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Transgene-derived APPswe expression in lines Q2-2, 85 and C3-3 In this study, we used three different lines of mice that express Mo/HuAPP695swe under control of the mouse prion protein promoter (53). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Transgene-derived APPswe expression in lines Q2-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "85"

Phrase: "and"

Phrase: "C3-3 In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three different lines of mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "express"

Phrase: "Mo/HuAPP695swe under control of the mouse prion protein promoter"

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.48: The Mo/Hu APP695swe construct encodes mouse sequence throughout the extra- and intracellular regions, human sequence within the A domain, and Swedish mutations K594N/M595L just prior to the A N-terminus. 

Phrase: "The Mo/Hu APP695swe construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2827421:Construct [Classification]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "mouse sequence throughout the extra-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "intracellular regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "human sequence within the A domain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "Swedish mutations K594N/M595L just prior to the A N-terminus."
Processing 00000000.tx.49: Lines Q2-2 and C3-3 harbor only the APPswe construct and have been previously characterized (53). 

Phrase: "Lines Q2-2"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "C3-3 harbor only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475311:Harbor [Manufactured Object]

Phrase: "the APPswe construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.50: The third line of APPswe mice used for this study, line 85, expresses an identical Mo/Hu APPswe construct in conjunction with the exon-9-deleted variant of human presenilin 1 (PS1-dE9) (54). 

Phrase: "The third line of APPswe mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205132:Line [Spatial Concept]
   753   C0205437:Third [Quantitative Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "used for this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "line 85,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "expresses"

Phrase: "an identical Mo/Hu APPswe construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2827421:Construct [Classification]

Phrase: "in conjunction with the exon-9-deleted variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "of human presenilin 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: ")"

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.51: This line was produced by co-injection of the APPswe and PS1-dE9 vectors, each controlled by its own prion promoter element, following previously reported procedures (55). 

Phrase: "This line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "produced by co-injection of the APPswe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "PS1-dE9 vectors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]

Phrase: "each"

Phrase: "controlled by its own prion promoter element,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C0332298:Controlled by [Functional Concept]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0033164:Prion [Amino Acid, Peptide, or Protein]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1705248:Element [Conceptual Entity]
   748   C2587213:Controlled [Functional Concept]
   714 E C0243148:control [Qualitative Concept]
   714 E C1550141:Control [Substance]
   714 E C1882979:Control [Conceptual Entity]
   714 E C3274648:Control [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "previously reported procedures"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   867   C2937283:Report procedure [Health Care Activity]
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.52: Immunoblot analysis of brain protein separated by SDSPAGE demonstrated relatively high levels of APPswe expression in each of these lines (Fig.1). 

Phrase: "Immunoblot analysis of brain protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "separated by SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "demonstrated"

Phrase: "relatively high levels of APPswe expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in each"

Phrase: "of these lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.53: Blots probed with monoclonal antibody 22C11, which detects a shared epitope in the N-terminal region of mouse and human APP, showed that each of the transgenic lines expresses 2- to 4-fold more total APP than non-transgenic animals (Fig.1B). 

Phrase: "Blots"

Phrase: "probed with monoclonal antibody 22C11,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "which"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a shared epitope in the N-terminal region of mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0003316:Epitope [Immunologic Factor]

Phrase: "and"

Phrase: "human APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "each of the transgenic lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0003069:Transgenic [Animal]
   760   C0205132:lines [Spatial Concept]
   760   C1457900:Each [Quantitative Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "expresses"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 4-fold more total APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C0555903:Total protein [Laboratory Procedure]
   845   C1261360:total protein [Laboratory or Test Result]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "than non-transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003069:Animals, Transgenic [Animal]
   827   C0003062:Animals [Animal]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.54: Immunoblots probed with monoclonal antibody 6E10, which detects the humanized A domain of our transgene product, demonstrated that APPswe protein levels were highest in the brains of mice from line C3-3; 

Phrase: "Immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "probed with monoclonal antibody 6E10,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "which"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the humanized A domain of our transgene product,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "demonstrated"

Phrase: "that APPswe protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "highest in the brains of mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1522410:Highest [Qualitative Concept]
   719 E C0205250:High [Qualitative Concept]
   719 E C1299351:High [Qualitative Concept]
   719 E C2700149:HIGH [Intellectual Product]

Phrase: "from line C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.55: overall expression in the three lines ranked Q2-2<85<C3-3 (Fig.1A). 

Phrase: "overall expression in the three lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "ranked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699794:ranked [Intellectual Product]

Phrase: "Q2-2"

Phrase: "<85"

Phrase: "<C3-3"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.56: View larger version (66K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.57: Transgene-derived APPswe expression in the three mouse lines studied. 

Phrase: "Transgene-derived APPswe expression in the three mouse lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.58: (A) Human-A-specific antibody 6E10 was used to detect transgene-derived APP in brain homogenates from line Q2-2, 85 and C3-3 animals. 

Phrase: "(A"

Phrase: ")"

Phrase: "Human-A-specific antibody 6E10"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "transgene-derived APP in brain homogenates"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "from line Q2-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "85"

Phrase: "and"

Phrase: "C3-3 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.59: (B) Antibody 22C11 was used to detect endogenous mouse APP and amyloid precursor-like protein 2 (APLP-2) (80) in non-transgenic controls and both endogenous APP/APLP-2 and transgene-derived human APPswe in lines Q2-2, 85 and C3-3. 

Phrase: "(B) Antibody 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0368720:B Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "endogenous mouse APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "amyloid precursor-like protein 2 (APLP-2)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1412467:AMYLOID PRECURSOR-LIKE PROTEIN 2 [Gene or Genome]
   937   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   888   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   888   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   853   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(80"

Phrase: ")"

Phrase: "in non-transgenic controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "both endogenous APP/APLP-2"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   821   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   821   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   813   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205227:Endogenous [Functional Concept]
   790   C0238767:Both [Spatial Concept]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1706086:Both [Qualitative Concept]
   790   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "transgene-derived human APPswe in lines Q2-2,"

Phrase: "85"

Phrase: "and"

Phrase: "C3-3."
Processing 00000000.tx.60: Immunoblot analysis consistently revealed the highest APPswe expression in line C3-3, the lowest in line Q2-2, with Line 85 falling between the two lines.  

Phrase: "Immunoblot analysis consistently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the highest APPswe expression in line C3-3,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   795   C0205132:Line [Spatial Concept]
   795   C1522410:Highest [Qualitative Concept]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   762 E C0205250:High [Qualitative Concept]
   762 E C1299351:High [Qualitative Concept]
   762 E C2700149:HIGH [Intellectual Product]
   712 E C0489786:Height [Organism Attribute]

Phrase: "the lowest in line Q2-2,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1708760:Lowest [Qualitative Concept]
   771 E C0205251:low [Qualitative Concept]
   771 E C1299352:Low [Qualitative Concept]
   771 E C1550472:low [Idea or Concept]

Phrase: "with Line 85 falling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085639:FALLING [Finding]
   793 E C0238715:Fall [Temporal Concept]

Phrase: "between the two lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.61: PS1-A246E and PS1-dE9 possess different amyloidogenic potentials In previous studies we (44,47) and others (42,43,48) have shown that the co-expression mutant PS1 with APPswe can accelerate the rate of amyloid deposition. 

Phrase: "PS1-A246E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "different amyloidogenic potentials In previous studies we (44,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3245505:potentials [Qualitative Concept]

Phrase: "47"

Phrase: ")"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(42,"

Phrase: "43,"

Phrase: "48"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the co-expression mutant PS1 with APPswe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "can"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the rate of amyloid deposition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.62: By contrast, co-expression of wild-type human PS1, even at very high levels, has no effect on the rate of amyloid deposition (44). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "co-expression of wild-type human PS1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "even at very high levels,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0442804:Very high [Finding]
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "has"

Phrase: "no effect on the rate of amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.63: Here we extend this work to compare the effects of two FAD PS1 variants which hasten amyloid onset to differing degrees. 

Phrase: "Here"

Phrase: "we"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this work to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the effects of two FAD PS1 variants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   745   C1883473:Ad Effect [Qualitative Concept]
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "hasten"

Phrase: "amyloid onset to differing degrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.64: As shown previously (47), transgenic mice from line C3-3 do not develop amyloid deposits until well beyond 18 months of age (Fig.2AC). 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "transgenic mice from line C3-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "until"

Phrase: "well beyond 18 months of age (Fig.2AC"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C1510828:Age-Months [Organism Attribute]
   744   C0001779:Age [Organism Attribute]
   744   C0205170:Well [Qualitative Concept]
   744   C0349966:Fig [Food]
   744   C0439231:months [Temporal Concept]
   744   C1337208:FIG [Food]
   744   C3146287:Well [Manufactured Object]
   711 E C0439507:/month [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.65: Co-expression of PS1-A246E (line N-5) halves this time, with C3-3/N-5 mice developing amyloid deposits by 912 months (Fig.2DF) (47). 

Phrase: "Co-expression of PS1-A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(line N-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "halves"

Phrase: "this time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "with C3-3/N-5 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "developing"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits by 912 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0333562:Deposit [Functional Concept]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "(Fig.2DF"

Phrase: ")"

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.66: Plaque burden in the C3-3/N-5 mice worsens with age, and by 2024 months the hippocampus and cortex show high amyloid burdens. 

Phrase: "Plaque burden in the C3-3/N-5 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2828008:Burden [Idea or Concept]

Phrase: "worsens with age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0332271:worsen [Qualitative Concept]
   790   C1279889:worsen [Finding]

Phrase: "and by 2024 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439231:months [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "high amyloid burdens."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828008:Burden [Idea or Concept]
Processing 00000000.tx.67: A similar acceleration in amyloid deposition has been noted when mice from a different line of PS1-A246E (line I2-4) are crossed to C3-3 mice (44). 

Phrase: "A similar acceleration in amyloid deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0000894:Acceleration [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "when"

Phrase: "mice from a different line of PS1-A246E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C3657569:presenilin 1, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "(line I2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "crossed to C3-3 mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205203:Crossed [Spatial Concept]
   726 E C2828360:Cross [Conceptual Entity]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.68: When mice from line C3-3 are crossed with mice expressing the exon-9-deleted variant of PS1 (line S-9) (56), substantial amyloid deposition is visible by 6 months of age (Fig.2G) (57). 

Phrase: "When"

Phrase: "mice from line C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "crossed with mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0205203:Crossed [Spatial Concept]
   756 E C2828360:Cross [Conceptual Entity]

Phrase: "expressing"

Phrase: "the exon-9-deleted variant of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variant [Qualitative Concept]

Phrase: "(line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "S-"

Phrase: "9"

Phrase: ")"

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "substantial amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011560:Amyloid deposition [Pathologic Function]
   901   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]

Phrase: "is"

Phrase: "visible by 6 months of age (Fig.2G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205379:Visible [Qualitative Concept]

Phrase: ")"

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.69: As with PS1-A246E, amyloid burdens in the C3-3/PS1-dE9 mice increase throughout life (Fig.2H and I). 

Phrase: "As with PS1-A246E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "amyloid burdens in the C3-3/PS1-dE9 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C2828008:Burden [Idea or Concept]

Phrase: "increase throughout life"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   790   C0376558:Life [Idea or Concept]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C0595998:lives [Finding]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig.2H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292425:2H [Temporal Concept]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.70: The early appearance of amyloid deposits was observed in offspring of C3-3 mice mated with two different lines of PS1-dE9 mice (line S-9 shown here and line O-7, data not shown), confirming that the effect was due to the PS1-dE9 transgene and not to an artifact of integration site. 

Phrase: "The early appearance of amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "was"

Phrase: "observed in offspring of C3-3 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0680063:Offspring [Family Group]
   748   C1441672:Observed [Functional Concept]

Phrase: "mated with two different lines of PS1-dE9 mice"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   761   C3657569:presenilin 1, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0205132:lines [Spatial Concept]
   739   C0205448:Two [Quantitative Concept]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1254211:mated [Pharmacologic Substance]
   739   C1260875:Mated [Organism Function]
   739   C1705242:Different [Qualitative Concept]
   706 E C0682323:mate [Family Group]
   706 E C1550648:Line [Substance]
   706 E C1552960:Line [Quantitative Concept]

Phrase: "(line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "S-"

Phrase: "9"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "and"

Phrase: "line O-7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was due to the PS1-dE9 transgene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0678226:Due to [Functional Concept]
           due
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0043194:WAS [Disease or Syndrome]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0282641:Transgene [Gene or Genome]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1421478:WAS [Gene or Genome]
   744   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not to an artifact of integration site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C2945843:Site of [Qualitative Concept]
   748   C0085089:Artefact [Human-caused Phenomenon or Process]
   748   C0205145:Site [Spatial Concept]
   748   C1158478:Integration [Genetic Function]
   748   C1515974:Site [Body Location or Region]
   748   C1518422:Not [Functional Concept]
   748   C1705422:Integration [Machine Activity]
   748   C1879740:ARTIFACT [Phenomenon or Process]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.71: View larger version (100K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(100K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.72: Co-expression of PS1-dE9 dramatically accelerates amyloid pathology in APPswe transgenic mice. 

Phrase: "Co-expression of PS1-dE9 dramatically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amyloid pathology in APPswe transgenic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.73: (AC) Mice transgenic for only APPswe (line C3-3) develop hippocampal amyloid deposits at very late ages as shown by Hirano silver stain. 

Phrase: "(AC) Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "transgenic for only APPswe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003069:Transgenic [Animal]

Phrase: "(line C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "develop"

Phrase: "hippocampal amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits at very late ages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001779:Age [Organism Attribute]
   760   C0205087:Late [Temporal Concept]
   760   C0333562:Deposit [Functional Concept]
   760   C0442824:Very [Qualitative Concept]

Phrase: "as"

Phrase: "shown by Hirano silver stain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: Amyloid plaques are absent from young (A) and middle-aged (B) animals, appearing only in mice over 20 months of age (C). 

Phrase: "Amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "absent from young"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "middle-aged"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0205847:Middle Aged [Age Group]
   983 E C0026062:Middle Age [Temporal Concept]
   861   C0001779:Aged [Organism Attribute]
   861   C0001792:Aged [Population Group]
   861   C0444598:Middle [Spatial Concept]
   861   C0549183:middle [Spatial Concept]
   861   C1552826:middle [Idea or Concept]
   861   C1999167:aged [Population Group]
   805 E C0205098:Medial [Spatial Concept]

Phrase: "(B) animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "appearing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "only in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "over 20 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.75: (DF) Co-expression of PS1-A246E accelerates the appearance of amyloid plaques. 

Phrase: "(DF) Co-expression of PS1-A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the appearance of amyloid plaques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.76: Deposits are first observed in line C3-3 APPswe/PS1-A246E double transgenic mice at 1013 months of age (E) before plaque load worsens with age (F). 

Phrase: "Deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in line C3-3 APPswe/PS1-A246E"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic mice at 1013 months of age (E)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025936:Mice, Transgenic [Mammal]
   744   C0003069:Transgenic [Animal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "before"

Phrase: "plaque load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1550025:Load [Idea or Concept]
   861   C1704782:Load [Manufactured Object]
   861   C1708715:Load [Activity]

Phrase: "worsens with age (F)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001779:Age [Organism Attribute]
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0332271:worsen [Qualitative Concept]
   770   C0439133:(f) [Intellectual Product]
   770   C1279889:worsen [Finding]
   770   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.77: (GI) Co-expression of PS1-dE9 in line C3-3 APPswe mice further hastens the appearance of pathology. 

Phrase: "(GI) Co-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of PS1-dE9 in line C3-3 APPswe mice further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "hastens"

Phrase: "the appearance of pathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233426:Appearance [Organism Attribute]
   770   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.78: Double transgenic APPswe/PS1-dE9 mice have a substantial number of deposits by 6 months of age (G), and plaque burden increases progressively with time (H and I). 

Phrase: "Double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic APPswe/PS1-dE9 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0025936:Mice, Transgenic [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "a substantial number of deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "by 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age (G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "plaque burden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828008:Burden [Idea or Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "progressively with time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "(H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.79: The hippocampus is shown in all panels for ease of comparison; 

Phrase: "The hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "shown in all panels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]
   737   C1547282:Show [Intellectual Product]

Phrase: "for ease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1331418:Ease [Mental Process]
   928 E C0332219:Easy [Qualitative Concept]

Phrase: "of comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: ";"
Processing 00000000.tx.80: plaques are also observed in superficial layers of the anterior cortex concurrent with hippocampal onset.  

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "also"

Phrase: "observed in superficial layers of the anterior cortex"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0007776:Cortex [Body Part, Organ, or Organ Component]
   744   C0205094:Anterior [Spatial Concept]
   744   C0205124:Superficial [Spatial Concept]
   744   C0934502:layers [Body Part, Organ, or Organ Component]
   744   C1176472:Cortex [Body Part, Organ, or Organ Component]
   744   C1441672:Observed [Functional Concept]
   744   C2700441:Cortex [Plant]
   711 E C1522408:Layer [Qualitative Concept]
   711 E C1561599:Layer [Intellectual Product]

Phrase: "concurrent with hippocampal onset."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205420:Concurrent [Temporal Concept]
Processing 00000000.tx.81: Measurements of A levels by immunoprecipitation with antibodies to the N-terminus of A followed by immunoblotting with antibodies specific for the 40 or 42 termini demonstrated that the ratio of A40:A42 varied by genotype (Fig.3A). 

Phrase: "Measurements of A levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:measurements [Functional Concept]

Phrase: "by immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to the N-terminus"

Phrase: "of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for the 40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "42 termini"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the ratio of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "A42"

Phrase: "varied by genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017431:Genotype [Organism Attribute]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.82: In mice expressing only APPswe the ratio was 3:1; 

Phrase: "In mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "only APPswe"

Phrase: "the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.83: co-expressing PS1A246E decreased the ratio to 1.75:1, and co-expressing PS1dE9 dropped the ratio to 0.75:1. 

Phrase: "co-expressing"

Phrase: "PS1A246E"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the ratio to 1.75"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "co-expressing"

Phrase: "PS1dE9"

Phrase: "dropped"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1705648:Dropped [Activity]
   966 E C1321095:Drop [Quantitative Concept]
   966 E C2347093:Drop [Quantitative Concept]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "the ratio to 0.75"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.84: The degree of change in A40:A42 ratios was proportional to the acceleration in A deposition across genotypes (Fig.3B). 

Phrase: "The degree of change"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "in A40"

Phrase: ":"

Phrase: "A42 ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "proportional to the acceleration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205351:Proportional [Qualitative Concept]

Phrase: "in A deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "across genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.85: View larger version (15K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.86: Co-expressing mutant PS1 shifts the ratio of A40:42. 

Phrase: "Co-expressing"

Phrase: "mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "shifts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the ratio of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "42."
Processing 00000000.tx.87: (A) Quantitative immunoprecipitation and immunoblotting (see Methods) were used to measure A40:42 ratios in the brains of mice co-expressing APPswe with PS1A246E or PS1dE9. 

Phrase: "(A"

Phrase: ")"

Phrase: "Quantitative immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "A40"

Phrase: ":"

Phrase: "42 ratios in the brains of mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "co-expressing"

Phrase: "APPswe with PS1A246E"

Phrase: "or"

Phrase: "PS1dE9."
Processing 00000000.tx.88: In mice from line C3-3, the brains contains 2- to 3-fold more A40 than A42. 

Phrase: "In mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "from line C3-3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold more A40"

Phrase: "than A42."
Processing 00000000.tx.89: As reported in a previous work (39), co-expression of PS1A246E halves the A40:A42 ratio to 1.75. 

Phrase: "As"

Phrase: "reported in a previous work"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0043227:Work [Occupational Activity]
   760   C0205156:Previous [Temporal Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1552607:previous [Temporal Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "co-expression of PS1A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "halves"

Phrase: "the A40"

Phrase: ":"

Phrase: "A42 ratio to 1.75."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.90: Here we show that expressing PS1dE9 in the C3-3 APPswe mice alters A levels so dramatically that A42 becomes the dominant species. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that expressing PS1dE9 in the C3-3 APPswe mice"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "so"

Phrase: "dramatically"

Phrase: "that A42"

Phrase: "becomes"

Phrase: "the dominant species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.91: (B) Regression analysis reveals a direct correlation between the age of amyloid onset and the ratio of A40:42 in the C3-3 transgenic series. 

Phrase: "(B) Regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a direct correlation between the age of amyloid onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the ratio of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "42 in the C3-3 transgenic series."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0003069:Transgenic [Animal]
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]
Processing 00000000.tx.92: Statistical significance was determined by two-tailed Student's t-test.  

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined by two-tailed Student's t-test."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0022885:Test [Laboratory Procedure]
   748   C0038492:student [Professional or Occupational Group]
   748   C0039259:tailed [Body Part, Organ, or Organ Component]
   748   C0039593:Test [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0392366:test [Intellectual Product]
   748   C1551041:student [Idea or Concept]
   748   C1552573:student [Intellectual Product]
Processing 00000000.tx.93: Further evidence of the highly pathogenic activity of PS1-dE9 was seen when we extended our study to mice that express lower levels of APPswe. 

Phrase: "Further evidence of the highly pathogenic activity of PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "we"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "our study to mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "express"

Phrase: "lower levels of APPswe."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.94: Mice from line Q2-2 do not develop amyloid pathology until after 20 months of age (Fig.4A and E). 

Phrase: "Mice from line Q2-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "amyloid pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "until after 20 months of age (Fig.4A"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C1510828:Age-Months [Organism Attribute]
   744   C0001779:Age [Organism Attribute]
   744   C0349966:Fig [Food]
   744   C0439231:months [Temporal Concept]
   744   C0450373:4a [Intellectual Product]
   744   C1337208:FIG [Food]
   744   C1553636:4a [Medical Device]
   744   C1720302:Until [Intellectual Product]
   711 E C0439507:/month [Temporal Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.95: To test whether co-expression of mutant PS1 could induce plaques in this non-depositing line, we crossed Q2-2 APPswe mice with animals expressing either PS1-A246E (line I2-4) (44,56) or PS1-dE9 (line S-9) (56,57). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "co-expression of mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "plaques in this non-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0333463:plaques [Acquired Abnormality]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "depositing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333562:Deposit [Functional Concept]

Phrase: "line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "crossed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205203:Crossed [Spatial Concept]
   966 E C2828360:Cross [Conceptual Entity]

Phrase: "Q2-2 APPswe mice with animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "either PS1-A246E"

Phrase: "(line I2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "(44,"

Phrase: "56"

Phrase: ")"

Phrase: "or"

Phrase: "PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "(line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "S-"

Phrase: "9"

Phrase: ")"

Phrase: "(56,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.96: Despite its ability to accelerate amyloid deposition in line C3-3 mice (44), co-expression of PS1-A246E in line Q2-2 produced no amyloid pathology in any brain region through 20 months of age (Fig.4B and F). 

Phrase: "Despite its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amyloid deposition in line C3-3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "co-expression of PS1-A246E in line Q2-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "produced"

Phrase: "no amyloid pathology in any brain region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0006119:Brain Pathology [Pathologic Function]
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]

Phrase: "through 20 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age (Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450375:4b [Intellectual Product]

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.97: In contrast, double transgenic offspring from Q2-2xPS1-dE9 developed substantial amyloid pathology by mid-life (Fig.4C and G). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "double transgenic offspring from Q2-2xPS1-dE9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680063:Offspring [Family Group]

Phrase: "developed"

Phrase: "substantial amyloid pathology by mid-life"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.98: Deposits probably began at 1518 months; 

Phrase: "Deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "began at 1518 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]
   737   C0439659:Begin [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.99: by the time they were sacrificed at 20 months, animals had a considerable burden of both diffuse and compact plaques throughout the hippocampus and cortex. 

Phrase: "by the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "sacrificed at 20 months,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]
   737   C0681205:Sacrifice [Idea or Concept]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "a considerable burden of both diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "compact plaques throughout the hippocampus"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0333463:plaques [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]
Processing 00000000.tx.100: Thus, PS1-dE9 consistently induces earlier pathology in APPswe transgenic mice than PS1-A246E, and is pathogenic enough to cause amyloid formation even in a line of APPswe animals that would otherwise have remained free of deposits. 

Phrase: "Thus,"

Phrase: "PS1-dE9 consistently"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "earlier pathology in APPswe transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "than PS1-A246E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "pathogenic enough to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0450254:Pathogenic [Organism]
   755 E C0030657:pathogenicity [Qualitative Concept]
   755 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "amyloid formation even in a line of APPswe animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "that"

Phrase: "would"

Phrase: "otherwise"

Phrase: "have"

Phrase: "remained free of deposits."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.101: View larger version (69K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(69K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.102: Co-expression of PS1-dE9 can induce plaque formation in a non-depositing line of APPswe transgenic mice. 

Phrase: "Co-expression of PS1-dE9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "plaque formation in a non-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "depositing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333562:Deposit [Functional Concept]

Phrase: "line of APPswe transgenic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205132:Line [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.103: (A and E) Unlike previously published lines of APPswe transgenic mice, animals from line Q2-2 never develop amyloid deposits even at very late ages. 

Phrase: "(A"

Phrase: "and"

Phrase: "E) Unlike previously published lines of APPswe transgenic mice,"

Phrase: "animals from line Q2-2 never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003062:Animals [Animal]

Phrase: "develop"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "even at very late ages."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0205087:Late [Temporal Concept]
   760   C0442824:Very [Qualitative Concept]
Processing 00000000.tx.104: Shown here are Hirano silver stained sections from the hippocampus (A) and cortex (E) of 20-month-old animals. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "Hirano silver stained sections from the hippocampus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "(E) of 20-month-old animals."
Processing 00000000.tx.105: (B and F) Co-expression of PS1-A246E is not sufficient too induce amyloidosis in mice from line Q2-2 before 20 months of age. 

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "F) Co-expression of PS1-A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not sufficient too"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "amyloidosis in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "from line Q2-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "before 20 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.106: (C and G) Co-expression of the more pathogenic PS1-dE9 leads to the formation of amyloid plaques in Q2-2 mice by 20 months of age. 

Phrase: "(C"

Phrase: "and"

Phrase: "G) Co-expression of the more pathogenic PS1-dE9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to the formation of amyloid plaques"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "in Q2-2 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "by 20 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.107: Diffuse and dense core deposits are found in both the hippocampus (C) and cortex (G) at this age. 

Phrase: "Diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "and"

Phrase: "dense core deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "found in both"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "(G) at this age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.108: (D and H) Line 85 mice in which the APPswe and PS1-dE9 transgenes have been co-injected are shown for comparison. 

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "H) Line 85 mice in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "the APPswe"

Phrase: "and"

Phrase: "PS1-dE9 transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282641:Transgenes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "co-injected"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C1720154:Inject [Functional Concept]
   789 E C0021485:injection [Therapeutic or Preventive Procedure]
   789 E C1272883:Injection [Biomedical or Dental Material]
   789 E C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   789 E C1828121:Injection [Functional Concept]

Phrase: "are"

Phrase: "shown for comparison."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Comparison [Activity]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.109: These animals express slightly higher levels of APPswe than line Q2-2 mice, leading to an earlier onset of pathology than Q2-2xPS1dE9. 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "express"

Phrase: "slightly higher levels of APPswe"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "than line Q2-2 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "leading to an earlier onset of pathology"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   762   C1833334:Early-onset [Finding]
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C0677042:pathology [Pathologic Function]
   748   C1522538:Leading [Functional Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714   C1279919:Early [Temporal Concept]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "than Q2-2xPS1dE9."
Processing 00000000.tx.110: Plaques are abundant in the hippocampus (D) and cortex (H) of line 85 mice by 9 months of age.  

Phrase: "Plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "abundant in the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "(H) of line 85 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0648345:H 85 [Organic Chemical]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "by 9 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.111: Analysis of the double-transgenic mice, created by co-injecting Mo/Hu APPswe and PS1-dE9 constructs, again confirmed the amyloidogenic potential of the PS1-dE9 variant. 

Phrase: "Analysis of the double-transgenic mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "created by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1707531:Created By [Qualitative Concept]
   833   C1706214:Created [Activity]
   799 E C3244320:create [Functional Concept]

Phrase: "co-injecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1720154:Inject [Functional Concept]

Phrase: "Mo/Hu APPswe"

Phrase: "and"

Phrase: "PS1-dE9 constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "again"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the amyloidogenic potential of the PS1-dE9 variant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.112: Animals from line 85 express levels of APPswe intermediate to lines C3-3 and Q2-2 (Fig.1); 

Phrase: "Animals from line 85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003062:Animals [Animal]

Phrase: "express"

Phrase: "levels of APPswe"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "intermediate to lines C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205103:Intermediate [Spatial Concept]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "Q2-2"

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.113: however, because they invariably co-express PS1dE9, line 85 mice develop amyloid deposits far earlier than either single transgenic APPswe line (Fig.4D and H). 

Phrase: "however,"

Phrase: "because"

Phrase: "they invariably"

Phrase: "co-express"

Phrase: "PS1dE9,"

Phrase: "line 85 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "develop"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "far earlier than either single transgenic APPswe line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1279919:Early [Temporal Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.114: Occasional deposits can be found in line 85 mice as young as 6 months of age, and by 9 months most animals have a significant plaque burden in the cortex and hippocampus (Fig.4D and H). 

Phrase: "Occasional deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "in line 85 mice as young"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "as 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and by 9 months most animals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0003062:Animals [Animal]
   753   C0439231:months [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   719 E C0439507:/month [Temporal Concept]

Phrase: "have"

Phrase: "a significant plaque burden in the cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.115: Thus the dE9 variant appears to be a highly pathogenic mutation, with profound effects on the deposition of amyloid peptides. 

Phrase: "Thus"

Phrase: "the dE9 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a highly pathogenic mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "with profound effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "on the deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "of amyloid peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.116: Despite its highly pathogenic activity, expression of PS1-dE9 alone in mice is not sufficient to induce amyloid deposits from endogenous mouse APP (not shown), consistent with previous reports of other FAD variant PS1 transgenic mice (48). 

Phrase: "Despite its highly pathogenic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "expression of PS1-dE9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Alone [Quantitative Concept]
   790   C0439044:alone [Finding]
   790   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits from endogenous mouse APP"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C2936349:Amyloid Deposits [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205227:Endogenous [Functional Concept]
   748   C0333562:Deposit [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "consistent with previous reports of other FAD variant PS1 transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.117: Mutant PS1 specifically increases the steady-state levels of A42 By two independent approaches, we have demonstrated that the earlier appearance of amyloid in mice co-expressing APPswe (line C3-3) with PS1-A246E (line N-5) or PS1-dE9 (line S-9) is associated with a change in the ratio of A40:A42 to favor A42 (Fig.3) (39). 

Phrase: "Mutant PS1 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the steady-state levels of A42"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0678587:steady state [Natural Phenomenon or Process]
   773   C0683927:state level [Spatial Concept]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "By two independent approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the earlier appearance of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "co-expressing"

Phrase: "APPswe"

Phrase: "(line C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "with PS1-A246E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "(line N-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "(line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "S-"

Phrase: "9"

Phrase: ")"

Phrase: "is"

Phrase: "associated with a change"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of A40"

Phrase: ":"

Phrase: "A42 to"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "A42"

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.118: In both of these studies, however, variance in the efficiency of A peptide captured by either immunoprecipitation or ELISA made it difficult to distinguish whether A42 levels were increased at the expense of A40, or whether the level of A42 increased independently while A40 remained unchanged. 

Phrase: "In both"

Phrase: "of these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "variance in the efficiency of A peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]

Phrase: "captured by either immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "or"

Phrase: "ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "distinguish"

Phrase: "whether"

Phrase: "A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased at the expense of A40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0680864:expense [Quantitative Concept]

Phrase: "or"

Phrase: "whether"

Phrase: "the level of A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "independently"

Phrase: "while"

Phrase: "A40"

Phrase: "remained"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.119: In the course of our study, a refined ELISA approach (58) was developed that allowed us to address this issue. 

Phrase: "In the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a refined ELISA approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "(58"

Phrase: ")"

Phrase: "was"

Phrase: "developed"

Phrase: "that allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.120: Using the refined ELISA assay, we studied the levels of A peptides in the brains of young, pre-deposit animals from each of the double transgenic lines described above (Fig.5). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the refined ELISA assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0014441:ELISA assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the levels of A peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of young, pre-deposit animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   886   C0598744:young animal [Animal]
   812   C0003062:Animals [Animal]

Phrase: "from each"

Phrase: "of the double transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0003069:Transgenic [Animal]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.121: Tissue was processed using a two-step extraction method: following sonication in 0.2% diethylamine (DEA) and high-speed centrifugation, soluble A was recovered in the supernatant, and the pellet was then re-extracted with 70% formic acid (FA) to recover all remaining insoluble species. 

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-step extraction method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449341:extraction method [Intellectual Product]
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "sonication in 0.2% diethylamine (DEA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037680:Sonication [Research Activity]

Phrase: "and"

Phrase: "high-speed centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "soluble A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "recovered in the supernatant,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521108:recovered [Qualitative Concept]
   770   C1550101:Supernatant [Body Substance]
   737 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "re-extracted with 70% formic acid (FA) to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0885348:formic acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C0202406:Acid [Laboratory Procedure]
   748   C2986904:RE [Idea or Concept]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: "all remaining insoluble species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.122: The two fractions were assayed separately; 

Phrase: "The two fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "separately"

Phrase: ";"
Processing 00000000.tx.123: data for total A were calculated by addition of the DEA and FA fraction values obtained for each animal. 

Phrase: "data for total A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "calculated by addition of the DEA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0057938:diethylamine [Organic Chemical]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "FA fraction values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "obtained for each animal."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003062:Animal [Animal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.124: We noted that approximately 50% of A40 was extracted by DEA, while a lower, and more variable, percentage of A42 was extracted by this solvent (Table 1). 

Phrase: "We"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that approximately 50% of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332232:Approximately [Qualitative Concept]

Phrase: "was"

Phrase: "extracted by DEA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0057938:diethylamine [Organic Chemical]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "while"

Phrase: "a lower,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "and"

Phrase: "more variable, percentage of A42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "extracted by this solvent"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: Because all of the samples were prepared from young, pre-deposit animals, especially in the case of the mice transgenic for only APPswe, we do not believe that the relative insolubility of A42 was due to oligomerization of this peptide, but rather to an inherent difference in the solubility of the two peptides in DEA. 

Phrase: "Because"

Phrase: "all of the samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared from young, pre-deposit animals,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0598744:young animal [Animal]
   753   C0003062:Animals [Animal]
   753   C0332152:Pre [Temporal Concept]
   753   C0332239:Young [Temporal Concept]
   753   C0333562:Deposit [Functional Concept]
   753   C0740175:Pre [Qualitative Concept]
   753   C2257086:PRE [Genetic Function]
   719   C1521827:Prepare [Functional Concept]

Phrase: "especially in the case of the mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]

Phrase: "transgenic for only APPswe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003069:Transgenic [Animal]

Phrase: "we"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "believe"

Phrase: "that"

Phrase: "the relative insolubility of A42"

Phrase: "was due to oligomerization of this peptide,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1421478:WAS [Gene or Genome]
   748   C3146286:Due [Idea or Concept]

Phrase: "but"

Phrase: "rather to an inherent difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in the solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037628:Solubility [Qualitative Concept]
   928 E C1749467:soluble [Cell Component]
   928 E C1948047:Soluble [Qualitative Concept]

Phrase: "of the two peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "in DEA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057938:diethylamine [Organic Chemical]
Processing 00000000.tx.126: Our comparisons across genotypes in each transgenic series therefore focus on total A values rather than DEA- or FA-soluble fractions to accommodate the differential solubility of the two peptides. 

Phrase: "Our comparisons across genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707455:Comparison [Activity]

Phrase: "in each transgenic series therefore focus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205234:Focus [Spatial Concept]
   812   C1285542:focus [Functional Concept]

Phrase: "on total A values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "rather than"

Phrase: "DEA-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057938:diethylamine [Organic Chemical]

Phrase: "or"

Phrase: "FA-soluble fractions to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "accommodate"

Phrase: "the differential solubility of the two peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0037628:Solubility [Qualitative Concept]
Processing 00000000.tx.127: View larger version (30K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.128: Mutant PS1 specifically elevates the levels of A42 and proportionately decreases the age at which deposits first appear in APPswe transgenic mice. 

Phrase: "Mutant PS1 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "elevates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "the levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "proportionately"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the age at which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "appear in APPswe transgenic mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0025936:Mice, Transgenic [Mammal]
   760   C0003069:Transgenic [Animal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0700364:APPEAR [Qualitative Concept]
Processing 00000000.tx.129: (A) The levels of A40 and 42 were measured in the brains of mice from five distinct genotypes (noted below graph) by ELISA as described in Materials and Methods. 

Phrase: "(A"

Phrase: ")"

Phrase: "The levels of A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "42"

Phrase: "were"

Phrase: "measured in the brains of mice"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0444706:Measured [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   750   C1521713:Mouse Brain [Tissue]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from five distinct genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "("

Phrase: "noted below graph"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0681493:Graph [Intellectual Product]
   790   C2698021:Graph [Conceptual Entity]
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: ")"

Phrase: "by ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.130: Values for A40 and 42 in each genotype were normalized to the levels in C3-3 single transgenic mice, so that the value of each peptide in the C3-3 mice is set to 1, and the values for A40 and 42 in other genotypes are related to C3-3 mice (see Table 1). 

Phrase: "Values for A40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "42 in each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotype [Organism Attribute]

Phrase: "were"

Phrase: "normalized to the levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C1882115:Normalized [Research Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in C3-3 single transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the value of each peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]

Phrase: "in the C3-3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "set to 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "the values for A40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "42 in other genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "are"

Phrase: "related to C3-3 mice"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: Statistical significance among genotypes was calculated pair-wise using a two-tailed Student's t-test (pairs noted by brackets on figure). 

Phrase: "Statistical significance among genotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   833   C1709380:Statistical Significance [Quantitative Concept]
   770   C0038215:Statistical [Occupation or Discipline]
   770   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "pair-wise"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1427738:WISE [Gene or Genome]
   861   C1709450:Pair [Qualitative Concept]
   789 E C0871611:wisdom [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-tailed Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0022885:Test [Laboratory Procedure]
   804   C0038492:student [Professional or Occupational Group]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C1551041:student [Idea or Concept]
   804   C1552573:student [Intellectual Product]

Phrase: "(pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "noted by brackets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0179407:brackets [Medical Device]
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "on figure"

Phrase: ")."
Processing 00000000.tx.132: The asterisk denotes a significant difference in A40 levels between C3-3xPS1-A246E and C3-3xPS1-dE9 (P<0.0015). 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "denotes"

Phrase: "a significant difference in A40 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between C3-3xPS1-A246E"

Phrase: "and"

Phrase: "C3-3xPS1-dE9"

Phrase: "(P<0.0015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.133: There were no statistical differences in A40 levels within the remaining C3-3 pairs. 

Phrase: "There"

Phrase: "were"

Phrase: "no statistical differences in A40 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "within the remaining C3-3 pairs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.134: By contrast, levels of A42 were significantly increased in mice co-expressing mutant PS1. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in mice"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "co-expressing"

Phrase: "mutant PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.135: (B) The relationship between brain concentration of A42 and the age of amyloid onset for the genotypes analyzed in (A). 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The relationship between brain concentration of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "the age of amyloid onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "for the genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "in (A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.136: As in (A), all A42 values are normalized to the levels measured in C3-3 single transgenic animals. 

Phrase: "As"

Phrase: "in (A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "all A42 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "normalized to the levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C1882115:Normalized [Research Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "measured in C3-3 single transgenic animals."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0003069:Animals, Transgenic [Animal]
           Transgenic
   748   C0003062:Animals [Animal]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.137: Co-expression of Hu PS1dE9 induces the greatest relative increase in A42 and the largest decrease in age of amyloid onset. 

Phrase: "Co-expression of Hu PS1dE9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the greatest relative increase in A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "the largest decrease in age of amyloid onset."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.138: Note that the onset of amyloid lesions for line Q2-2 is estimated from the age at which plaques appear in Q2-2xPS1dE9 animals, and would be difficult to observe in the normal mouse lifespan. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the onset of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332162:Onset [Qualitative Concept]

Phrase: "lesions for line Q2-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205132:Line [Spatial Concept]
   760   C0221198:Lesion [Finding]
   760   C1546698:Lesion [Intellectual Product]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "estimated from the age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0804404:Age estimated [Clinical Attribute]
   770   C0001779:Age [Organism Attribute]
   770   C0750572:Estimated [Quantitative Concept]

Phrase: "at which plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "appear in Q2-2xPS1dE9 animals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003062:Animals [Animal]
   760   C0700364:APPEAR [Qualitative Concept]

Phrase: "and"

Phrase: "would"

Phrase: "be"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "observe in the normal mouse lifespan."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0870809:life span [Group Attribute]
   753   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.139: (C) The levels of A40 and 42 in the brains of Q2-2 APPswe mice crossed to PS1 mice were measured in a separate ELISA assay. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The levels of A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "42 in the brains of Q2-2 APPswe mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   745   C1310510:Brain-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0006104:Brains [Body Part, Organ, or Organ Component]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   728   C1521713:Mouse Brain [Tissue]
   708 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "crossed to PS1 mice"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   827   C3657569:presenilin 1, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205203:Crossed [Spatial Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   726 E C2828360:Cross [Conceptual Entity]

Phrase: "were"

Phrase: "measured in a separate ELISA assay."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0443299:Separate [Spatial Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.140: The concentration of each peptide was normalized to the value measured in Q2-2 single transgenic mice (set to 1). 

Phrase: "The concentration of each peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "normalized to the value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522609:Value [Quantitative Concept]
   770   C1882115:Normalized [Research Activity]

Phrase: "measured in Q2-2 single transgenic mice"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0025936:Mice, Transgenic [Mammal]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(set to 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.141: As in the C3-3 series, the co-expression of PS1A246E and PS1dE9 in the Q2-2 mice significantly elevated the level of A42 without decreasing that of A40. 

Phrase: "As in the C3-3 series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "the co-expression of PS1A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PS1dE9 in the Q2-2 mice significantly"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "the level of A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "without decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "that of A40."
Processing 00000000.tx.142: The asterisk denotes a small but significant difference in A40 found between Q2-2xPS1-A246E and Q2-2. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "denotes"

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "significant difference in A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "found between Q2-2xPS1-A246E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "Q2-2."
Processing 00000000.tx.143: None of the remaining pairs showed significant differences in A40.  

Phrase: "None of the remaining pairs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C1527428:Remaining [Qualitative Concept]
   760   C1709450:Pair [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant differences in A40."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.144: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.145: Normalized fractions of brain A extracted into DEA and formic acid  Two separate series of experiments were performed. 

Phrase: "Normalized fractions of brain A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1264633:Fraction of [Quantitative Concept]
           Fractions
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "extracted into DEA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0057938:diethylamine [Organic Chemical]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "formic acid  Two separate series of experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.146: In one series we compared A40 and A42 levels in the brains of C3-3 APPswe mice with the levels in C3-3xPS1-A246E, C3-3xPS1-dE9, APPswe/PS1dE9 line 85 and Q2-2 mice (Fig.5A and Table 1). 

Phrase: "In one series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "A40"

Phrase: "and"

Phrase: "A42 levels in the brains of C3-3 APPswe mice"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0446413:c3 levels [Body Location or Region]
   741   C0456949:Level 3 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "with the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "in C3-3xPS1-A246E,"

Phrase: "C3-3xPS1-dE9,"

Phrase: "APPswe/PS1dE9 line 85"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "Q2-2 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: In the first series, all values were normalized to A levels in the C3-3 mice. 

Phrase: "In the first series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "all values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized to A levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0441889:Levels [Qualitative Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1882115:Normalized [Research Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the C3-3 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.148: Graphing the relative levels of each peptide in these animals revealed that the addition of mutant PS1 increases the concentration of A42 without causing a proportionate decrease in A40. 

Phrase: "Graphing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0681493:Graph [Intellectual Product]
   966   C2698021:Graph [Conceptual Entity]

Phrase: "the relative levels of each peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the addition of mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the concentration of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "without causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a proportionate decrease in A40."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.149: The case for this conclusion is stronger in the second series of mice described below, but even in the C3-3 series our measurements show that, compared with APPswe single transgenic mice, co-expression of PS1A246E caused a 50% increase, and PS1-dE9 a 150% increase, in the concentration of A42 without consistently lowering the level of A40. 

Phrase: "The case for this conclusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "is"

Phrase: "stronger in the second series of mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0442821:Strong [Qualitative Concept]

Phrase: "described below,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "but"

Phrase: "even in the C3-3 series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "our measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "compared with APPswe single transgenic mice,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "co-expression of PS1A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 50% increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "a 150% increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of A42"

Phrase: "without consistently"

Phrase: "lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the level of A40."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.150: In mice co-expressing the PS1dE9 variant with APPswe, the levels of A42 exceeded that of A40 (Fig.3), hence it is difficult to argue that the lack of change in A40 levels might be due to a far greater abundance of A40 relative to A42. 

Phrase: "In mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "co-expressing"

Phrase: "the PS1dE9 variant with APPswe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "the levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "exceeded"

Phrase: "that of A40"

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "hence"

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "argue"

Phrase: "that"

Phrase: "the lack of change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in A40 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "might"

Phrase: "be due to a far greater abundance of A40"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0205108:far [Spatial Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C1704243:Greater [Quantitative Concept]
   742   C2346714:Abundance [Qualitative Concept]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]
   708 E C0549177:Great [Quantitative Concept]

Phrase: "relative to A42."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.151: Comparison of these values with the ages at which amyloid deposits first appear in each genotype suggests an immediate relationship (Fig.5B). 

Phrase: "Comparison of these values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "with the ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "at which amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "appear in each genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017431:Genotype [Organism Attribute]
   770   C0700364:APPEAR [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an immediate relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.152: The age of onset in each cross directly correlates with the concentration of A42 in the brain. 

Phrase: "The age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "in each"

Phrase: "cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "correlates with the concentration of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.153: This correlation extends beyond the C3-3 series. 

Phrase: "This correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "extends beyond the C3-3 series."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205549:Series [Quantitative Concept]
   753   C0231448:Extend [Functional Concept]
   753   C0439792:extend [Spatial Concept]
   753   C2348044:Series [Intellectual Product]
Processing 00000000.tx.154: Line 85 mice, made by co-injecting APPswe and PS1dE9 vectors, were very similar to C3-3xPS1-dE9 mice in both their peptide levels and in their age of amyloid onset (Fig.5A and B). 

Phrase: "Line 85 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "made by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1881534:Make [Functional Concept]

Phrase: "co-injecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1720154:Inject [Functional Concept]

Phrase: "APPswe"

Phrase: "and"

Phrase: "PS1dE9 vectors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "very similar to C3-3xPS1-dE9 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "in both"

Phrase: "their peptide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and in their age of amyloid onset"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   748   C0001779:Age [Organism Attribute]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0332162:Onset [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1515981:And [Idea or Concept]

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: At the other end of this spectrum, Q2-2 single transgenic mice accumulate even less A42 than C3-3 single transgenic mice, and show no sign of amyloid pathology at ages when deposits have already begun in C3-3 animals (Fig.5A and B). 

Phrase: "At the"

Phrase: "other end of this spectrum,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "Q2-2 single transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "accumulate"

Phrase: "even less A42 than C3-3 single transgenic mice,"

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no sign of amyloid pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0311392:Sign [Finding]
   760   C1547188:Sign [Idea or Concept]

Phrase: "at ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "when"

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "have"

Phrase: "already"

Phrase: "begun in C3-3 animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003062:Animals [Animal]
   726   C0439659:Begin [Temporal Concept]

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.156: In the second ELISA experiment, we measured A levels across the Q2-2 APPswe series (Q2-2; Q2-2xPS1-A246E; and Q2-2xPS1-dE9). 

Phrase: "In the second ELISA experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "A levels across the Q2-2 APPswe series"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456948:Level 2 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Q2-2"

Phrase: "; Q2-2xPS1-A246E"

Phrase: ";"

Phrase: "and"

Phrase: "Q2-2xPS1-dE9"

Phrase: ")."
Processing 00000000.tx.157: The concentrations of A values for each genotype were normalized to levels in the Q2-2 single transgenic animals. 

Phrase: "The concentrations of A values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "for each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "were"

Phrase: "normalized to levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0441889:Levels [Qualitative Concept]
   790   C1882115:Normalized [Research Activity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the Q2-2 single transgenic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0003069:Animals, Transgenic [Animal]
   804   C0003062:Animals [Animal]
Processing 00000000.tx.158: Again, we found that the addition of mutant PS1 specifically elevates A42 levels without lowering A40 levels (Fig.5C and Table 1). 

Phrase: "Again,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the addition of mutant PS1 specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "elevates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A42 levels without lowering A40 levels"

Phrase: "(Fig.5C"

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: Collectively these data demonstrate that when mutant PS1 is present, then there is a specific increase in A42 without a proportionate decrease in A40. 

Phrase: "Collectively"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "when"

Phrase: "mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "present, then there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
   827   C1883708:Then [Temporal Concept]

Phrase: "is"

Phrase: "a specific increase in A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "without a proportionate decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in A40."
Processing 00000000.tx.160: These data also demonstrate that the concentration of A42 is the driving force behind changes in the rate of amyloid deposition that occur in the double transgenic mice. 

Phrase: "These data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the concentration of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "the driving force behind changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "that"

Phrase: "occur in the double transgenic mice."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.161: Transgenic mice expressing PS1-dE9 do not develop cotton wool plaques In FAD patients, the dE9 mutation is associated with pathology and motor symptoms atypical for AD. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "cotton wool plaques In FAD patients,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0333463:plaques [Acquired Abnormality]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "the dE9 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "associated with pathology"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0030664:Pathology [Biomedical Occupation or Discipline]
   790   C0205469:pathology [Functional Concept]
   790   C0677042:pathology [Pathologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "motor symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0426980:Motor symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "atypical for AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205182:Atypical [Qualitative Concept]
   790   C0741302:Atypical [Finding]
Processing 00000000.tx.162: Neuropathological examination of several patients carrying this mutation have revealed large, loose, cotton wool amyloid aggregates in the cortex, and a relative absence of compact dense core deposits (5963). 

Phrase: "Neuropathological examination of several patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0031809:Examination of patient [Health Care Activity]
           patient examination

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "revealed large, loose, cotton wool amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregates in the cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0205418:Aggregate [Qualitative Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "a relative absence of compact dense core deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "(5963"

Phrase: ")."
Processing 00000000.tx.163: Such atypical pathology has not been found in all PS1-dE9 kindreds (62,64), and indeed, was not observed in mice expressing the dE9 transgene. 

Phrase: "Such atypical pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "found in all PS1-dE9 kindreds"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0150312:Found [Quantitative Concept]
   748   C0598429:kindreds [Qualitative Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   714 E C0243095:Find [Finding]

Phrase: "(62,"

Phrase: "64"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "indeed,"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1441672:Observed [Functional Concept]

Phrase: "expressing"

Phrase: "the dE9 transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.164: Instead, APPswe/PS1-dE9 double transgenic animals displayed characteristic compact, dense-cored, deposits throughout the cortex and hippocampus which could be stained with Congo Red and were birefringent under polarized light (Fig.6). 

Phrase: "Instead,"

Phrase: "APPswe/PS1-dE9"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "characteristic compact, dense-cored,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0444669:Core [Spatial Concept]
   779   C1167518:core [Cell Component]
   779   C1706352:Core [Medical Device]
   779   C1882467:Core [Manufactured Object]
   779   C3274653:Core [Body Substance]

Phrase: "deposits throughout the cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0333562:Deposit [Functional Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "stained with Congo Red"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   865   C0009742:Congo red stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   770   C0009738:Congo [Geographic Area]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "were"

Phrase: "birefringent under polarized light"

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.165: View larger version (151K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(151K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.166: Congophilic amyloid deposits are found in mice co-expressing PS1-dE9 and APPswe. 

Phrase: "Congophilic amyloid deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1836162:Congophilic deposits [Finding]
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "found in mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "co-expressing"

Phrase: "PS1-dE9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "APPswe."
Processing 00000000.tx.167: (AH) Mice expressing the dE9 mutation of PS1 in conjunction with Mo/Hu APPswe develop typical diffuse and compact, birefringent, deposits. 

Phrase: "(AH) Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the dE9 mutation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in conjunction with Mo/Hu APPswe"

Phrase: "develop"

Phrase: "typical diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205219:Diffuse [Qualitative Concept]

Phrase: "and"

Phrase: "compact, birefringent, deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.168: This panel shows Congo Red-stained plaques under bright-field (A, C, E and G) and under polarized light (B, D, F and H). 

Phrase: "This panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "Congo Red-stained plaques under bright-field"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0333463:plaques [Acquired Abnormality]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C,"

Phrase: "E"

Phrase: "and"

Phrase: "G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and under polarized light"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599025:polarized light [Human-caused Phenomenon or Process]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1881376:Light [Qualitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.169: The plaques appear qualitatively identical in mice from both high-expressing, early onset C3-3 and low-expressing, late-onset Q2-2 lines. 

Phrase: "The plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "qualitatively identical in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]

Phrase: "from both high-expressing, early onset C3-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1833334:Early-onset [Finding]
   799   C0205250:High [Qualitative Concept]
   799   C0332162:Onset [Qualitative Concept]
   799   C1279919:Early [Temporal Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "low-expressing, late-onset Q2-2 lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.170: Shown are sections from 6-month old C3-3xPS1-dE9 mice (A, B, E and F) and 20-month-old Q2-2xPS1-dE9 mice (C, D, G and H). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "sections from 6-month old C3-3xPS1-dE9 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "E"

Phrase: "and"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "20-month-old Q2-2xPS1-dE9 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.171: Congophilic deposits are found both in the cortex (AD) and in the hippocampus (EH).   

Phrase: "Congophilic deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836162:Congophilic deposits [Finding]
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "both in the cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0238767:Both [Spatial Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1706086:Both [Qualitative Concept]
   770   C2700441:Cortex [Plant]

Phrase: "(AD)"

Phrase: "and in the hippocampus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]

Phrase: "(EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: ")."
Processing 00000000.tx.172: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  We have studied how the FAD variants of PS1 elevate A levels and accelerate amyloid deposition to different extents in transgenic mice that co-express Mo/Hu APPswe. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "how"

Phrase: "the FAD variants of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amyloid deposition to different extents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "co-express"

Phrase: "Mo/Hu APPswe."
Processing 00000000.tx.173: By comparing A measurements in APPswe/PS1-dE9 double transgenic mice to animals expressing APPswe, alone or with the less pathogenic PS1-A246E mutation, we have gained insight into the mechanisms by which mutations in PS1 cause early-onset AD. 

Phrase: "By comparing A measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "in APPswe/PS1-dE9"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic mice to animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   819   C0003069:Animals, Transgenic [Animal]
           Transgenic
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "APPswe,"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with the less pathogenic PS1-A246E mutation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0026882:Mutation [Genetic Function]
   742   C0450254:Pathogenic [Organism]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "have"

Phrase: "gained insight into the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:Insight [Mental Process]

Phrase: "by which mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PS1 cause early-onset AD."
Processing 00000000.tx.174: Our data show that FAD variants of PS1 selectively increase the levels of A42 without affecting A40 levels. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that FAD variants of PS1 selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "without affecting A40 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.175: Thus, co-expression of PS1 variants increases the amount of total A derived from a constant level of APPswe protein, suggesting that mutant PS1, either directly or indirectly, makes more substrate available for -processing, and that this additional substrate is specifically cleaved at residue 42. 

Phrase: "Thus,"

Phrase: "co-expression of PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of total A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "derived from a constant level of APPswe protein,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0428479:Protein level [Laboratory or Test Result]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1441547:Derived [Qualitative Concept]
   744   C1547014:*Constant [Quantitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C1948059:Constant [Qualitative Concept]
   744   C2946261:Level [Pharmacologic Substance]
   744   C3245521:derived [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mutant PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "either directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly,"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "more substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "available for -processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this additional substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "is"

Phrase: "specifically"

Phrase: "cleaved at residue 42."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.176: We further demonstrate that small changes in the levels of A42 can have considerable impact on the rate of amyloid deposition, highlighting the potential therapeutic benefit that might be gained by lowering A42 levels, even partially, early in the clinical course of AD. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "demonstrate"

Phrase: "that small changes in the levels of A42"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   744   C0700321:Small [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "have"

Phrase: "considerable impact on the rate of amyloid deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "highlighting"

Phrase: "the potential therapeutic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   861   C0302350:Therapeutic [Functional Concept]

Phrase: "benefit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814225:Benefit [Quantitative Concept]

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "gained by lowering A42 levels,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0441889:Levels [Qualitative Concept]
   760   C0441994:lowering [Spatial Concept]
   760   C2003888:Lowering [Activity]
   726 E C0456079:Level [Classification]
   726   C1517378:Gain [Quantitative Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C1548802:Lower [Body Location or Region]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "even partially,"

Phrase: "early in the clinical course of AD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0449259:Clinical course [Temporal Concept]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0750729:Course [Temporal Concept]
   748   C1279919:Early [Temporal Concept]
Processing 00000000.tx.177: Amyloid onset is determined by the level of A42 In previous studies, we (44,47) and others (42,43,48) have demonstrated that the co-expression of FAD-associated PS1 variants in APP transgenic mice shifts the ratio of A40:A42, and that this shift correlates with a more rapid appearance of amyloid deposits. 

Phrase: "Amyloid onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "determined by the level of A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "In previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we (44,"

Phrase: "47"

Phrase: ")"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(42,"

Phrase: "43,"

Phrase: "48"

Phrase: ")"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the co-expression of FAD-associated PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in APP transgenic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "shifts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the ratio of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "A42,"

Phrase: "and"

Phrase: "that"

Phrase: "this shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "correlates with a more rapid appearance of amyloid deposits."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C2936349:Amyloid Deposits [Acquired Abnormality]
   762   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0233426:Appearance [Organism Attribute]
   742   C0333562:Deposits [Functional Concept]
   742   C0439831:Rapid [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.178: In contrast, the co-expression of wild-type human PS1 has no impact on the rate of amyloid formation (44). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the co-expression of wild-type human PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "no impact on the rate of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.179: All previous studies have been two-point comparisons between one line of mice expressing mutant APP mice and mice expressing one FAD-PS1 variant. 

Phrase: "All previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "two-point comparisons between one line of mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1707455:Comparison [Activity]

Phrase: "expressing"

Phrase: "mutant APP mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "one FAD-PS1 variant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.180: The present study is the first to analyze different combinations of APP and PS1 variants that show distinct courses of amyloid pathology. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "analyze"

Phrase: "different combinations of APP"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0453882:Combinations [Manufactured Object]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "PS1 variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205419:variants [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "that"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "distinct courses of amyloid pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750729:Courses [Temporal Concept]
Processing 00000000.tx.181: Our data demonstrate that the age at which amyloid deposits first appear correlates directly with the concentration of A42 in the brain. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the age at which amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001779:Age [Organism Attribute]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "correlates directly with the concentration of A42"

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.182: As demonstrated in mice from line Q2-2, not all animals over-expressing APP, nor even those co-expressing PS1, will form amyloid deposits in their 2-year lifetime. 

Phrase: "As"

Phrase: "demonstrated in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "from line Q2-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "nor"

Phrase: "even"

Phrase: "those"

Phrase: "co-expressing"

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "will"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in their 2-year lifetime."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0333562:Deposit [Functional Concept]
   753   C0439234:year [Temporal Concept]
   753   C0439508:/year [Temporal Concept]
Processing 00000000.tx.183: While co-expression of PS1-A246E was able to dramatically accelerate the appearance of plaques in C3-3 APPswe transgenic mice, its effect was not strong enough to induce plaques by 20 months of age in the lower-expressing Q2-2 APPswe mice. 

Phrase: "While"

Phrase: "co-expression of PS1-A246E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "able to dramatically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the appearance of plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233426:Appearance [Organism Attribute]
   770   C0700364:Appearance [Qualitative Concept]

Phrase: "in C3-3 APPswe transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "its effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not strong enough to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0442821:Strong [Qualitative Concept]
   812   C1518422:Not [Functional Concept]
   741 E C0237897:Strength [Quantitative Concept]
   741 E C0808080:Strength [Idea or Concept]
   741 E C1705922:Strength [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "plaques by 20 months of age"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0333463:plaques [Acquired Abnormality]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "in the lower-expressing Q2-2 APPswe mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.184: Instead, plaques were only observed in mice from line Q2-2 when the highly pathogenic PS1-dE9 variant was introduced. 

Phrase: "Instead,"

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1441672:Observed [Functional Concept]

Phrase: "from line Q2-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "when"

Phrase: "the highly pathogenic PS1-dE9 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "introduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]
Processing 00000000.tx.185: Quantitative ELISA analysis in mice from each genotype revealed that both PS1 variants altered the concentration of A42 in the brain: animals expressing either PS1 variant contained more A42 than Q2-2 single transgenic mice. 

Phrase: "Quantitative ELISA analysis in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "both PS1 variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205419:variants [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the concentration of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "expressing"

Phrase: "either PS1 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "more A42 than Q2-2 single transgenic mice."
Processing 00000000.tx.186: However, co-expression of PS1-dE9 led to substantially higher A42 levels than did PS1-A246E, consistent with its ability to induce amyloid formation earlier than PS1-A246E. 

Phrase: "However,"

Phrase: "co-expression of PS1-dE9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to substantially higher A42 levels than"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "PS1-A246E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "consistent with its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "earlier than PS1-A246E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1279919:Early [Temporal Concept]
Processing 00000000.tx.187: Studies of A40 and A42 fibrilization in vitro have demonstrated that the formation of congophilic fibrils follows second-order kinetics, where there is a long lag phase (the nucleation and seeding phase) followed by an exponential phase of fibril formation until extinction of the substrate (12,13,65,66). 

Phrase: "Studies of A40"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "A42 fibrilization"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the formation of congophilic fibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "second-order kinetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022702:Kinetics [Natural Phenomenon or Process]
   827   C0220865:kinetics [Functional Concept]
   827   C2825046:Kinetics [Occupation or Discipline]

Phrase: "where there"

Phrase: "is"

Phrase: "a long lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205390:Phase [Temporal Concept]
   812   C1416797:Lag [Gene or Genome]

Phrase: "("

Phrase: "the nucleation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1979936:Nucleated [Qualitative Concept]

Phrase: "and"

Phrase: "seeding phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: ")"

Phrase: "followed by an exponential phase of fibril formation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0205390:Phase [Temporal Concept]
   744   C0220781:formation [Biologic Function]
   744   C0225328:Fibril [Cell Component]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1552645:exponential [Qualitative Concept]
   744   C1948066:Fibril [Physical Object]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "until extinction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015347:extinction [Mental Process]

Phrase: "of the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "(12,"

Phrase: "13,"

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")."
Processing 00000000.tx.188: Since the length of the lag phase is proportional to the concentration of A peptides (12,13,65,66), we believe that the different rates of A deposition observed in each genotype represent changes in the rate of nucleation and seeding of A42 fibrils in vivo. 

Phrase: "Since"

Phrase: "the length of the lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "is"

Phrase: "proportional to the concentration of A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205351:Proportional [Qualitative Concept]

Phrase: "(12,"

Phrase: "13,"

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "believe"

Phrase: "that"

Phrase: "the different rates of A deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "observed in each genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017431:Genotype [Organism Attribute]
   770   C1441672:Observed [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "changes in the rate of nucleation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "seeding of A42 fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705192:Seeding [Laboratory Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.189: Congophilic neuritic amyloid pathology in Mo/Hu APPswexPS1dE9 mice Neuropathological studies of brains from FAD patients with the PS1-dE9 mutation have reported a number of cases that contain senile plaques atypical for AD. 

Phrase: "Congophilic neuritic amyloid pathology in Mo/Hu APPswexPS1dE9 mice Neuropathological studies of brains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   749   C0919386:Pathology studies [Laboratory Procedure]
   749   C1512513:Human Pathology [Biomedical Occupation or Discipline]
   735   C0030664:Pathology [Biomedical Occupation or Discipline]
   735   C0205469:pathology [Functional Concept]
   735   C0677042:pathology [Pathologic Function]
   732   C0006119:Brain Pathology [Pathologic Function]
   732 E C0551718:Pathology study [Clinical Attribute]

Phrase: "from FAD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "with the PS1-dE9 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "atypical for AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205182:Atypical [Qualitative Concept]
   790   C0741302:Atypical [Finding]
Processing 00000000.tx.190: In these unusual cases, A aggregates have been described as cotton wool deposits because they lack compact dense cores and do not show birefringence when stained with Congo Red (5963). 

Phrase: "In these unusual cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "A aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described as cotton wool deposits"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0440207:Cotton wool [Biomedical or Dental Material]
   760   C0010196:Cotton [Plant]
   760   C0043220:Wool [Substance]
   760   C0330523:cotton [Plant]
   760   C0330524:cotton [Plant]
   760   C0333562:Deposits [Functional Concept]
   760   C1095832:Cotton [Substance]
   760   C1552738:described [Idea or Concept]
   760   C1561494:Wool [Intellectual Product]

Phrase: "because"

Phrase: "they"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "compact dense cores"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0444669:Core [Spatial Concept]
   793   C1167518:core [Cell Component]
   793   C1706352:Core [Medical Device]
   793   C1882467:Core [Manufactured Object]
   793   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "birefringence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005597:Birefringence [Natural Phenomenon or Process]

Phrase: "when"

Phrase: "stained with Congo Red"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   865   C0009742:Congo red stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   770   C0009738:Congo [Geographic Area]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(5963"

Phrase: ")."
Processing 00000000.tx.191: However such atypical pathology has not been found in all PS1-dE9 kindreds (62,64). 

Phrase: "However"

Phrase: "such atypical pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "found in all PS1-dE9 kindreds"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0150312:Found [Quantitative Concept]
   748   C0598429:kindreds [Qualitative Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   714 E C0243095:Find [Finding]

Phrase: "(62,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.192: Indeed, mice carrying the PS1dE9 mutation do not recapitulate the cotton wool plaques of the dE9 FAD patients. 

Phrase: "Indeed,"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the PS1dE9 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recapitulate"

Phrase: "the cotton wool plaques of the dE9 FAD patients."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0333463:plaques [Acquired Abnormality]
   706 E C0011389:Plaque [Disease or Syndrome]
   706 E C0332461:Plaque [Finding]
Processing 00000000.tx.193: Instead, all lines of APPswe/PS1dE9 mice examined in this study develop congophilic, neuritic, senile plaques (Fig.6). 

Phrase: "Instead,"

Phrase: "all lines of APPswe/PS1dE9 mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "examined in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "develop"

Phrase: "congophilic, neuritic, senile plaques"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   875   C0333463:Neuritic Plaques [Acquired Abnormality]
           Senile Plaques
           plaques
   812   C0392079:Senile [Finding]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]
   756 E C0231337:Old age [Finding]
   756 E C1999167:Old age [Population Group]

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.194: Perhaps the extreme concentrations of A needed to observe amyloid formation within the mouse lifespan artificially drive plaques into the compact form. 

Phrase: "Perhaps"

Phrase: "the extreme concentrations of A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "amyloid formation within the mouse lifespan artificially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "plaques into the compact form."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0333463:plaques [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
Processing 00000000.tx.195: The second atypical feature of FAD caused by the PS1-dE9 mutation is the frequent appearance of spastic paraparesis (59,61,67). 

Phrase: "The second atypical feature of FAD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "caused by the PS1-dE9 mutation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0026882:Mutation [Genetic Function]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "the frequent appearance of spastic paraparesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "(59,"

Phrase: "61,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.196: Affected patients exhibit abnormal gait with hyper-reflexive lower extremities. 

Phrase: "Affected patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522476:affected patients [Qualitative Concept]
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "abnormal gait with hyper-reflexive lower extremities."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0575081:Abnormal gait [Sign or Symptom]
   748   C0016928:Gait [Finding]
Processing 00000000.tx.197: However, not all kindreds carrying PS1-dE9 show motor involvement (62). 

Phrase: "However,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all kindreds carrying PS1-dE9"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "motor involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1314939:Involvement [Functional Concept]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.198: We have yet to observe any evidence of diminished motor function in any line mice expressing PS1-dE9, either alone or in conjunction with APPswe (A. Savonenko et al., submitted). 

Phrase: "We"

Phrase: "have"

Phrase: "yet to"

Phrase: "observe"

Phrase: "any evidence of diminished motor function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in any line mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "PS1-dE9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or in conjunction with APPswe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2699427:Conjunction [Idea or Concept]

Phrase: "(A. Savonenko et al.,"

Phrase: "submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.199: The incomplete penetrance of atypical pathology and motor dysfunction in the PS1-dE9 kindreds, and the lack of such features in the transgenic models, suggests that a modifier locus may influence the expression of these phenotypes in humans. 

Phrase: "The incomplete penetrance of atypical pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1836598:Incomplete penetrance [Finding]
   753   C0524899:Penetrance [Quantitative Concept]

Phrase: "and"

Phrase: "motor dysfunction in the PS1-dE9 kindreds,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234131:Motor dysfunction [Sign or Symptom]
   744   C0031847:dysfunction [Functional Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "and"

Phrase: "the lack of such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "features in the transgenic models,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1519606:Transgenic Model [Experimental Model of Disease]
   760   C0003069:Transgenic [Animal]
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]
   760   C3161035:Models [Intellectual Product]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a modifier locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "influence"

Phrase: "the expression of these phenotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.200: Mutant presenilins may recruit new pools of substrate to the -secretase pathway to elevate production of A42 Studies of presenilin biology suggest that PS1 and PS2 compete for inclusion into a larger protein complex that contains nicastrin, Aph-1 and PEN-2 (1827). 

Phrase: "Mutant presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "recruit"

Phrase: "new pools of substrate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0337051:pools [Geographic Area]
   737 E C1509144:pool [Clinical Attribute]
   737 E C2349200:Pool [Functional Concept]

Phrase: "to the -secretase pathway to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "production of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "Studies of presenilin biology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005532:Biology [Biomedical Occupation or Discipline]
   770   C0557651:Study [Manufactured Object]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"

Phrase: "compete for inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1512693:Inclusion [Qualitative Concept]

Phrase: "into a larger protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "nicastrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "Aph-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "and"

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "(1827"

Phrase: ")."
Processing 00000000.tx.201: This complex is required for active -secretase, which is responsible for proteolytic processing of APP to generate the C-termini of A peptides (28,33). 

Phrase: "This complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "required for active -secretase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Active [Functional Concept]
   770   C1514873:Required [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "responsible for proteolytic processing of APP to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1273518:Responsible to [Finding]
           Responsible

Phrase: "generate"

Phrase: "the C-termini of A peptides"

Phrase: "(28,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.202: Studies with chemical inhibitors of -secretase have shown that the cleavage of APP at the 40 site and 42 sites are coordinately suppressed, suggesting a single activity is responsible for both cleavages (50,51,6870). 

Phrase: "Studies with chemical inhibitors of -secretase"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "at the 40 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "42 sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "coordinately"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a single activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "responsible for both cleavages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "(50,"

Phrase: "51,"

Phrase: "6870"

Phrase: ")."
Processing 00000000.tx.203: In this setting, the simplest explanation for the elevation of A42 relative to A40 in the presence of mutant PS1 was a simple shift in the enzyme specificity to favor cleavage at residue 42 with no net change in the amount of total A. 

Phrase: "In this setting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]

Phrase: "the simplest explanation for the elevation of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]

Phrase: "relative to A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "a simple shift in the enzyme specificity to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0333051:Shift [Functional Concept]
   744   C2347509:Shift [Phenomenon or Process]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "cleavage at residue 42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "with no net change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of total A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.204: However, our results indicate that the expression of FAD PS1 variants specified increases in the steady-state levels of A42 without altering A 40 levels. 

Phrase: "However,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the expression of FAD PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "specified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]

Phrase: "increases in the steady-state levels of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "without altering A 40 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.205: Expression of mutant PS1 thus leads to a net increase in total A. 

Phrase: "Expression of mutant PS1 thus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to a net increase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0442805:Increase [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704   C0439739:Reticular [Spatial Concept]

Phrase: "in total A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.206: A similar finding was reported by Oyama and colleagues in their study of mice transgenic for PS2-N141I, which also show a specific increase in A42 levels (46). 

Phrase: "A similar finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037088:Finding [Sign or Symptom]
   827   C0243095:Finding [Finding]
   827   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "reported by Oyama"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "colleagues in their study of mice"

Phrase: "transgenic for PS2-N141I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003069:Transgenic [Animal]

Phrase: "which also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a specific increase in A42 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.207: Experiments in cell cultures have shown that co-expression of FAD PS1 variants with APP alters the ratio of A40:42 in the medium in favor of A42 (3941). 

Phrase: "Experiments in cell cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007585:Cell Cultures [Laboratory Procedure]
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that co-expression of FAD PS1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the ratio of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "42 in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "in favor of A42"

Phrase: "(3941"

Phrase: ")."
Processing 00000000.tx.208: In these cell culture experiments, it is assumed that the PS1 variants alter the production and secretion of A42 rather than altering its clearance or catabolism. 

Phrase: "In these cell culture experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "it"

Phrase: "is"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that"

Phrase: "the PS1 variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205419:variants [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "secretion of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "rather than"

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "its clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "catabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]
Processing 00000000.tx.209: However, the cell culture paradigms cannot replicate the complex architecture and signaling patterns of neurons the brain. 

Phrase: "However,"

Phrase: "the cell culture paradigms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681797:paradigms [Research Activity]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "cannot"

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "the complex architecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003737:Architecture [Occupation or Discipline]

Phrase: "and"

Phrase: "signaling patterns of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.210: In hippocampal slice cultures, Kamenetz et al. 

Phrase: "In hippocampal slice cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "Kamenetz et al."
Processing 00000000.tx.211: (71) recently demonstrated that neuronal activity can influence the secretion of A into the extracellular space. 

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that neuronal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "influence"

Phrase: "the secretion of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "into the extracellular space."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015352:Extracellular Space [Body Space or Junction]
   861   C1883067:Space [Spatial Concept]
Processing 00000000.tx.212: In vivo, such as with the animal models used for our studies, it is difficult to separate changes in the production of A from changes in its catabolism. 

Phrase: "In vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "such as"

Phrase: "with the animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "used for our studies,"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "changes in the production of A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "from changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in its catabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]
Processing 00000000.tx.213: However, based on the cell culture studies of APP processing, we believe it likely that the increase in steady-state levels of A42 measured in brain tissue from our mice reflects enhanced production of A42, rather than changes in its stability or clearance. 

Phrase: "However,"

Phrase: "based on the cell culture studies of APP processing,"
Meta Candidates (Total=31; Excluded=5; Pruned=0; Remaining=26)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   759   C0681854:culture cell study [Research Activity]
   756   C0007585:Cell Culture [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0033666:protein processing [Molecular Function]
   754   C0018956:precursor cell [Cell]
   754   C0230625:cell processing [Cell Component]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0007634:Cell [Cell]
   738   C0010453:Culture [Idea or Concept]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0220814:culture [Functional Concept]
   738   C0430400:Culture [Laboratory Procedure]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0947630:studies [Laboratory Procedure]
   738   C1269647:Cell [Cell]
   738   C1527178:Based [Functional Concept]
   738   C1704653:Cell [Medical Device]
   738   C1705938:Based [Idea or Concept]
   738   C1709634:Precursor [Idea or Concept]
   738   C1709694:Processing [Activity]
   738   C1948049:Cell [Spatial Concept]
   738   C2242979:Culture [Laboratory Procedure]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C0557651:Study [Manufactured Object]
   704 E C1880279:Base [Biomedical or Dental Material]
   704 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "believe"

Phrase: "it likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the increase in steady-state levels of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "measured in brain tissue"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0440746:Brain tissue [Tissue]
   833   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C0444706:Measured [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1547928:Tissue [Intellectual Product]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "from our mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "enhanced production of A42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "rather than"

Phrase: "changes in its stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.214: Studies demonstrating the absolute requirement of PS1 or PS2 function for an active -secretase (28,33) are consistent with this interpretation. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrating"

Phrase: "the absolute requirement of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]

Phrase: "or"

Phrase: "PS2 function for an active -secretase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "(28,"

Phrase: "33"

Phrase: ")"

Phrase: "are"

Phrase: "consistent with this interpretation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.215: Recent reports indicate that PS1 is required for the translocation of APP from the plasma membrane into endosomes where the -secretase cleavage that produces extracellular A is thought to occur (72), and that specific mutations in PS1 alter this movement (7375). 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "indicate"

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "required for the translocation of APP"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0599893:Protein translocation [Cell Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040715:Translocation [Cell or Molecular Dysfunction]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514873:Required [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]
   744   C2987521:Translocation [Activity]

Phrase: "from the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "into endosomes where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "the -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "that"

Phrase: "produces"

Phrase: "extracellular A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "(72"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that specific mutations in PS1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "this movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026649:Movement [Organism Function]

Phrase: "(7375"

Phrase: ")."
Processing 00000000.tx.216: Moreover, others have demonstrated that cells deficient in PS1 show alterations in the subcellular trafficking of specific membrane proteins (36,37). 

Phrase: "Moreover,"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "deficient in PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011155:Deficient [Functional Concept]
   770   C1636779:% deficient [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "alterations in the subcellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "trafficking of specific membrane proteins"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   813   C1513112:Membrane Traffic, Protein [Molecular Function]
           Membrane Traffic
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0599895:Protein Trafficking [Cell Function]
   781   C1159772:Protein Trafficking [Cell Function]
   760   C0025255:Membrane [Tissue]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0599896:trafficking [Cell Function]
   760   C1552740:specific [Intellectual Product]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.217: However, studies in cultured cells have suggested that full-length APP is not the preferred substrate for -secretase. 

Phrase: "However,"

Phrase: "studies in cultured cells"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   859   C0681854:culture cell study [Research Activity]
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the preferred substrate for -secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.218: Instead, it appears that the direct substrates of -secretase are C-terminal fragments of APP generated by - or -secretase. 

Phrase: "Instead,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the direct substrates of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "C-terminal fragments of APP"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   774   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1168438:Protein C [Laboratory Procedure]
   774   C1418943:PROTEIN C [Gene or Genome]
   774   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated by - or -secretase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.219: These fragments, not the full-length protein, accumulate to high levels when -secretase is inhibited (28,30,31,33,4952). 

Phrase: "These fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the full-length protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulate to high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "when -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "(28,"

Phrase: "30,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "4952"

Phrase: ")."
Processing 00000000.tx.220: Whether the effects we have detected are due to changes in APP trafficking is unclear. 

Phrase: "Whether"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "are due to changes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.221: We note that an analysis of the levels of sAPP-, the soluble ectodomain of APP generated by BACE1, failed to detect obvious alterations due to co-expression of mutant PS1 (Supplementaly Material, Fig. S1). 

Phrase: "We"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "an analysis of the levels of sAPP-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "the soluble ectodomain of APP"

Phrase: "generated by BACE1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1412727:BACE1 [Gene or Genome]
   790   C3146294:Generated [Activity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "obvious alterations due to co-expression of mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1515926:Alteration [Idea or Concept]

Phrase: "(Supplementaly Material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "Fig. S1"

Phrase: ")."
Processing 00000000.tx.222: In light of foregoing data, we favor the notion that PS1-A246E and PS1-dE9, with differing efficiencies, place a greater amount of APP-CTF substrate in contact with a -secretase that preferentially cleaves at residue 42. 

Phrase: "In light of foregoing data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the notion"

Phrase: "that PS1-A246E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "PS1-dE9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "with differing efficiencies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:efficiencies [Quantitative Concept]
   777 E C0442799:Efficient [Qualitative Concept]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "a greater amount of APP-CTF substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "in contact with a -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that preferentially"

Phrase: "cleaves at residue 42."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.223: This mechanism would explain the specific elevation in A42 levels and the absence of change in A40 levels. 

Phrase: "This mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "would"

Phrase: "explain"

Phrase: "the specific elevation in A42 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "and"

Phrase: "the absence of change"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in A40 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.224: Moreover, this scenario could also explain how certain natural and experimental variants of PS1 differentially affect the cleavage of APP-CTFs and Notch, another important substrate of -secretase (32). 

Phrase: "Moreover,"

Phrase: "this scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "could"

Phrase: "also"

Phrase: "explain"

Phrase: "how certain natural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205296:Natural [Functional Concept]

Phrase: "and"

Phrase: "experimental variants of PS1 differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the cleavage of APP-CTFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0597304:Protein Cleavage [Molecular Function]
   736   C0010813:cleavage [Cell Function]
   736   C0596311:Cleavage [Phenomenon or Process]
   736   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Notch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "another important substrate of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.225: We note that if the PS1/Nicastrin/PEN-2/Aph-1 protein complex were responsible for the delivery of substrates to -secretase but not their proteolysis, inhibition of the PS1 complex, either genetically or pharmacologically, would diminish -secretase activity in a manner indistinguishable from inhibiting -secretase itself. 

Phrase: "We"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "if"

Phrase: "the PS1/Nicastrin/PEN-2/Aph-1 protein complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   854   C0960914:nicastrin protein [Amino Acid, Peptide, or Protein]
   817   C0207890:APH Protein [Amino Acid, Peptide, or Protein,Enzyme]
   807   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C1523872:protein complex [Cell Component]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0439855:Complex [Qualitative Concept]
   791   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "responsible for the delivery of substrates to -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1273518:Responsible to [Finding]
           Responsible

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "their proteolysis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "inhibition of the PS1 complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "either genetically"

Phrase: "or"

Phrase: "pharmacologically,"

Phrase: "would"

Phrase: "diminish -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "secretase activity in a manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "indistinguishable from inhibiting -secretase"

Phrase: "itself."
Processing 00000000.tx.226: Thus, we think it possible that one of the effects of mutant PS1 is to augment the amount of substrate presented to a 42-specific -secretase.  

Phrase: "Thus,"

Phrase: "we"

Phrase: "think"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:think [Mental Process]

Phrase: "it possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that one of the effects of mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "the amount of substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "presented to a 42-specific -secretase."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205369:Specific [Qualitative Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1552740:specific [Intellectual Product]
   719 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.227: CONCLUSIONS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  These studies have highlighted how small changes in the production of A42 can modulate the rate of amyloid deposition. 

Phrase: "CONCLUSIONS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "highlighted"

Phrase: "how small changes in the production of A42"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   744   C0700321:Small [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the rate of amyloid deposition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.228: Within the limits imposed by the mouse lifespan, these small changes in A42 levels can make the difference between the appearance and absence of amyloid pathology. 

Phrase: "Within the limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439801:limits [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
   916 E C3542948:Limited [Intellectual Product]

Phrase: "imposed by the mouse lifespan,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0870809:life span [Group Attribute]

Phrase: "these small changes in A42 levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0700321:Small [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the difference between the appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "absence of amyloid pathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.229: We show here that this dichotomy is determined by a threshold concentration of A42, and that once this minimum is surpassed further elevations in A42 act to hasten the onset of amyloid aggregation. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "this dichotomy"

Phrase: "is"

Phrase: "determined by a threshold concentration of A42,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0086045:Concentration [Mental Process]
   748   C0449864:Threshold [Qualitative Concept]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "once"

Phrase: "this minimum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1524031:Minimum [Qualitative Concept]
  1000   C1552614:minimum [Idea or Concept]
  1000   C2826545:MINIMUM [Quantitative Concept]
   928 E C0547040:Minimal [Qualitative Concept]
   928 E C2945599:Minimal [Qualitative Concept]

Phrase: "is"

Phrase: "surpassed"

Phrase: "further elevations in A42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0702240:elevations [Spatial Concept]
   737 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hasten"

Phrase: "the onset of amyloid aggregation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.230: These findings suggest that even partial reductions of A42 levels by pharmacological agents may substantially delay the onset of amyloid lesions in patients at risk for AD. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that even partial reductions of A42 levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0301630:reductions [Natural Phenomenon or Process]
   748   C0441610:reductions [Therapeutic or Preventive Procedure]
   714 E C0392756:Reduction [Qualitative Concept]

Phrase: "by pharmacological agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   933   C1254351:Pharmacologic Agent [Pharmacologic Substance]
           Agent
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1521826:Agent [Intellectual Product]

Phrase: "may"

Phrase: "substantially"

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "the onset of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332162:Onset [Qualitative Concept]

Phrase: "lesions in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0221198:Lesion [Finding]
   790   C1546698:Lesion [Intellectual Product]

Phrase: "at risk for AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1444641:At risk [Qualitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C1516077:At [Spatial Concept]
Processing 00000000.tx.231: Our study is also the first to demonstrate that the presence of mutant PS1 results in more A42 by specifically increasing the concentration of this peptide without altering that of A40. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "also"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the presence of mutant PS1 results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in more A42"

Phrase: "by specifically"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the concentration of this peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "without altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "that of A40."
Processing 00000000.tx.232: We suggest that mutant PS1 may act to recruit new pools of APP -CTF substrate to a -secretase that favors cleavage at residue 42. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recruit"

Phrase: "new pools of APP -CTF substrate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0337051:pools [Geographic Area]
   711 E C1509144:pool [Clinical Attribute]
   711 E C2349200:Pool [Functional Concept]

Phrase: "to a -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that favors cleavage at residue 42."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
Processing 00000000.tx.233: Altering the subcellular trafficking of APP substrates could therefore be another therapeutic approach to diminish the concentration of A42 the brains of patients with AD.  

Phrase: "Altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the subcellular"

Phrase: "trafficking of APP substrates"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0599895:Protein Trafficking [Cell Function]
   783   C1159772:Protein Trafficking [Cell Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0599896:trafficking [Cell Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "could"

Phrase: "therefore"

Phrase: "be"

Phrase: "another therapeutic approach to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "the concentration of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "the brains of patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with AD."
Processing 00000000.tx.234: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Generation of transgenic mice With the exception of line 85, all transgenic mice used in this study have been described and fully characterized in earlier publications. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of line 85,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "all transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "fully"

Phrase: "characterized in earlier publications."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0034036:Publications [Intellectual Product,Manufactured Object]
   770   C1880022:Characterized [Activity]
   737 E C0034037:Publication [Occupational Activity]
   737   C1279919:Early [Temporal Concept]
   737 E C1704324:Publication [Intellectual Product]
Processing 00000000.tx.235: All transgenes were expressed under control of the mouse prion protein promoter (MoPrP.Xho), which drives high protein expression in neurons and astrocytes of the CNS (53,57). 

Phrase: "All transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgenes [Gene or Genome]

Phrase: "were"

Phrase: "expressed under control of the mouse prion protein promoter"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C1568447:prion protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   764   C1418941:PRION PROTEIN [Gene or Genome]
   762   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "(MoPrP.Xho"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "high protein expression in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1171362:protein expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "astrocytes of the CNS (53,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004112:Astrocytes [Cell]

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.236: Lines C3-3 and Q2-2 expressing mouse/human (Mo/Hu) chimeric APP695 (humanized A domain) harboring the Swedish (K594M/N595L) mutation are described in Borchelt et al. 

Phrase: "Lines C3-3"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "Q2-2 expressing mouse/human (Mo/Hu) chimeric APP695"

Phrase: "(humanized A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "the Swedish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710263:Swedish [Population Group]

Phrase: "(K594M/N595L"

Phrase: ")"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "described in Borchelt et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.237: (53). 

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.238: Line I2-4, which expresses human PS1-A246E, is described in Lee et al. 

Phrase: "Line I2-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "which"

Phrase: "expresses"

Phrase: "human PS1-A246E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "described in Lee et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.239: (56) and Borchelt et al. 

Phrase: "(56"

Phrase: ")"

Phrase: "and"

Phrase: "Borchelt et al."
Processing 00000000.tx.240: (44). 

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.241: Lines S-9 and O-7, expressing human PS1-dE9, are described in Lee et al. 

Phrase: "Lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "S-"

Phrase: "9"

Phrase: "and"

Phrase: "O-7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "expressing"

Phrase: "human PS1-dE9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "described in Lee et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.242: (56). 

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.243: The Mo/HuAPPswe (line C3-3) and PS1A246E (line N-5) mice have been deposited in the Jackson Laboratories. 

Phrase: "The Mo/HuAPPswe"

Phrase: "(line C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PS1A246E"

Phrase: "(line N-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "been"

Phrase: "deposited in the Jackson Laboratories."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0333562:deposited [Functional Concept]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.244: Line 85 is a companion to lines 7, 26, 56, and 57 that were described in Jankowsky et al. 

Phrase: "Line 85"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "a companion to lines 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0335343:Companion [Population Group]
   760   C0682323:Companion [Family Group]

Phrase: "26,"

Phrase: "56,"

Phrase: "and"

Phrase: "57"

Phrase: "that"

Phrase: "were"

Phrase: "described in Jankowsky et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.245: (55). 

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.246: All five lines were created by co-injection of chimeric mouse/human APPswe and human PS1-dE9 vectors controlled by independent mouse prion protein promoter elements. 

Phrase: "All five lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "created by co-injection of chimeric mouse/human APPswe"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C1707531:Created By [Qualitative Concept]
   742   C0008109:chimeric [Organism]
   742   C0021485:injection [Therapeutic or Preventive Procedure]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0086418:Human [Human]
   742   C1272883:Injection [Biomedical or Dental Material]
   742   C1533685:Injection [Therapeutic or Preventive Procedure]
   742   C1706214:Created [Activity]
   742   C1828121:Injection [Functional Concept]
   708 E C3244320:create [Functional Concept]

Phrase: "and"

Phrase: "human PS1-dE9 vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]
   717   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controlled by independent mouse prion protein promoter elements."
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   800   C1568447:prion protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   770   C0332298:Controlled by [Functional Concept]
   770   C1418941:PRION PROTEIN [Gene or Genome]
   767   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0013879:Elements [Element, Ion, or Isotope]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0085862:Independent [Idea or Concept]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1299583:Independent [Finding]
   744   C2587213:Controlled [Functional Concept]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1705248:Element [Conceptual Entity]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.247: The two transgenes co-integrated and co-segregate as a single locus (55). 

Phrase: "The two transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgenes [Gene or Genome]

Phrase: "co-integrated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C1158478:Integration [Genetic Function]
   789   C1705422:Integration [Machine Activity]

Phrase: "and"

Phrase: "co-segregate as a single locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1708726:Locus [Gene or Genome]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.248: Protein expression of transgenic APPswe in line 85 is comparable to that previously described for line 57 (55). 

Phrase: "Protein expression of transgenic APPswe in line 85"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1171362:protein expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "comparable to"

Phrase: "that previously"

Phrase: "described for line 57"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552738:described [Idea or Concept]
   770   C1552960:Line [Quantitative Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.249: Line 85 mice have been deposited in the Jackson Laboratories. 

Phrase: "Line 85 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "been"

Phrase: "deposited in the Jackson Laboratories."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0333562:deposited [Functional Concept]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.250: All animals used in this study were maintained in a hybrid background by back-crossing to C3HeJxC57BL/6J F1 mice obtained from Jackson Laboratories (Bar Harbor, ME, USA). 

Phrase: "All animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "maintained in a hybrid background"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0020205:Hybrid [Organism]
   760   C1314677:Maintained [Functional Concept]
   760   C1706907:Background [Conceptual Entity]
   726 E C0024501:Maintain [Activity]

Phrase: "by"

Phrase: "back-crossing to C3HeJxC57BL/6J F1 mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0004600:Back [Body Location or Region]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205095:Back [Spatial Concept]
   748   C0460009:Back [Body Location or Region]
   748   C1995000:Back [Body Location or Region]
   714   C2828360:Cross [Conceptual Entity]

Phrase: "obtained from Jackson Laboratories"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1301820:Obtained [Functional Concept]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C1706701:Obtain [Activity]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.251: Offspring were genotyped for the presence of the transgene by PCR amplification of genomic DNA extracted from 1cm tail clippings, as described in Jankowsky et al. 

Phrase: "Offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "genotyped for the presence of the transgene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0282641:Transgene [Gene or Genome]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714   C0017431:Genotype [Organism Attribute]

Phrase: "by PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "extracted from 1cm tail clippings,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1546575:Clippings [Intellectual Product]
   760   C3541890:EXTRACTED [Finding]
   726 E C0185010:Clipping [Therapeutic or Preventive Procedure]
   726 E C1283066:Clipping [Therapeutic or Preventive Procedure]
   726 E C2828366:Extract [Substance]

Phrase: "as"

Phrase: "described in Jankowsky et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.252: (55). 

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.253: Reactions contained three primers, one antisense primer matching sequence within the vector that is also present in mouse genomic PrP (5'-GTG GAT ACC CCC TCC CCC AGC CTA GAC C), one sense primer specific for the transgene cDNA (PS1: 5'-CAG GTG GTG GAG CAA GAT G; 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "three primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "one antisense primer matching sequence within the vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "also"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "in mouse genomic PrP (5'-GTG GAT ACC CCC TCC CCC AGC CTA GAC C), one sense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   784   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for the transgene cDNA (PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: ":"

Phrase: "5'-CAG GTG GTG GAG CAA GAT G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0439267:g% [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.254: APP: 5'-CCG AGA TCT CTG AAG TGA AGA TGG ATG), and a second sense primer specific for the genomic PrP coding region (which was removed from the MoPrP vector); 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ":"

Phrase: "5'-CCG AGA TCT CTG AAG TGA AGA TGG ATG"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a second sense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for the genomic PrP coding region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "("

Phrase: "which"

Phrase: "was"

Phrase: "removed from the MoPrP vector"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C0849355:Removed [Qualitative Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.255: (5'-CCT CTT TGT GAC TAT GTG GAC TGA TGT CGG). 

Phrase: "(5'-CCT CTT TGT GAC TAT GTG GAC TGA TGT CGG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C1864172:CGG [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.256: All reactions give a 750bp product from the endogenous PrP gene as a control for DNA integrity and successful amplification; 

Phrase: "All reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a 750bp product from the endogenous PrP gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]

Phrase: "as a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "for DNA integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "successful amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.257: transgene-positive samples have an additional band at 400bp (APP) or 1.3kb (PS1). 

Phrase: "transgene-positive samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "have"

Phrase: "an additional band at 400bp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "1.3kb"

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")."
Processing 00000000.tx.258: Animals were housed in microisolator cages with unlimited access to food and water. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "housed in microisolator cages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0020056:Housed [Manufactured Object]
   770   C0337189:cages [Manufactured Object]
   737 E C0441239:Cage [Medical Device]
   737 E C0442519:house [Conceptual Entity]
   737 E C2003847:House [Manufactured Object]

Phrase: "with unlimited access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0444454:Access [Spatial Concept]
   861   C1554204:access [Idea or Concept]

Phrase: "to food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "and"

Phrase: "water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.259: All procedures involving animals were approved by the JHU Institutional Animal Care and Use Committee. 

Phrase: "All procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "approved by the JHU Institutional Animal Care"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0178478:animal care [Occupation or Discipline]
   774   C0868975:Institutional care [Health Care Activity]
   748   C0003062:Animal [Animal]
   748   C0205540:Approved [Qualitative Concept]
   748   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.260: A peptide analysis by quantitative immunoblot Quantitation of A levels in transgenic mouse brain tissue was performed as described in Lesuisse et al. 

Phrase: "A peptide analysis by quantitative immunoblot Quantitation of A levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0020985:Immunoblot Analysis [Laboratory Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "in transgenic mouse brain tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0440746:Brain tissue [Tissue]
   861   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C1521713:Mouse Brain [Tissue]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0040300:Tissue [Tissue]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Lesuisse et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.261: (57). 

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.262: Briefly, hemibrain samples from line C3-3 mice were homogenized with a Dounce tissue grinder in 24 vols of PBS containing 1% CHAPS, 1mM PMSF, 5g/ml leupeptin, 30g/ml aprotinin, and 1M pepstatin. 

Phrase: "Briefly,"

Phrase: "hemibrain samples from line C3-3 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "homogenized with a Dounce tissue grinder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0493160:GRINDER, TISSUE [Medical Device]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "in 24 vols"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449468:VOL [Quantitative Concept]
   827   C0560268:vol% [Quantitative Concept]
   827   C1690016:% vol [Qualitative Concept]

Phrase: "of PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036082:Saline [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   827 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "1mM PMSF,"

Phrase: "5g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "30g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "1M pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.263: Homogenates were mixed for 30min at 4C, and then centrifuged for 1h at 100000g. 

Phrase: "Homogenates"

Phrase: "were"

Phrase: "mixed for 30min"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205430:Mixed [Functional Concept]
   790   C3160715:Mixed [Finding]
   756 E C1421951:MIX [Gene or Genome]
   756 E C1720722:Mix [Qualitative Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1442450:1H [Temporal Concept]
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 100000g."
Processing 00000000.tx.264: Supernatants were immunoprecipitated with monoclonal antibody 26D6 (specific for A1-12), and recovered peptides were separated by bicine/urea SDSPAGE. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "immunoprecipitated with monoclonal antibody 26D6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(specific for A1-12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "recovered peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "separated by bicine/urea SDSPAGE."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0067332:BICINE [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   704 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.265: Proteins were transferred to PVDF membrane and blotted with 26D6 conjugated to horseradish peroxidase. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred to PVDF membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0071710:PVDF [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "blotted with 26D6"

Phrase: "conjugated to horseradish peroxidase."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.266: Antibody binding was visualized with ECL reagent exposed to film, and quantified using scanning laser densitometry to compare band densities for each sample to synthetic A standards run in parallel. 

Phrase: "Antibody binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "visualized with ECL reagent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0234621:Visualized [Functional Concept]
   770   C1332684:ECL [Gene or Genome]

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]

Phrase: ","

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "scanning laser densitometry to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011321:Densitometry [Laboratory Procedure]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "band densities for each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178587:densities [Quantitative Concept]

Phrase: "to synthetic A standards run in parallel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C2348042:Parallel [Qualitative Concept]
   799   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.267: Statistics were performed by one-way ANOVA with least-square difference (LSD) post-test using the Statistica analysis program (StatSoft, Tulsa, OK, USA). 

Phrase: "Statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "were"

Phrase: "performed by one-way ANOVA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   862   C1709320:One-way ANOVA [Quantitative Concept]
   806   C1550369:Performed By [Qualitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with least-square difference (LSD)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]
   734   C0023189:Least Square [Quantitative Concept]

Phrase: "post-test"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Statistica analysis program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "(StatSoft,"

Phrase: "Tulsa,"

Phrase: "OK,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.268: A peptide quantitation by ELISA Frozen mouse hemi-brains (n=45 per genotype) were extracted by sonication in 0.2% diethylamine (DEA)/50mM NaCl to a concentration of 100mg/ml. 

Phrase: "A peptide quantitation by ELISA Frozen mouse hemi-brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709793:Quantitation [Quantitative Concept]

Phrase: "(n=45 per genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "extracted by sonication"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0037680:Sonication [Research Activity]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "in 0.2% diethylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0057938:diethylamine [Organic Chemical]

Phrase: "(DEA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057938:diethylamine [Organic Chemical]

Phrase: ")"

Phrase: "/50mM NaCl to a concentration of 100mg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.269: After centrifugation at 100000g for 1h at 4C, the supernatant was removed and saved as the DEA extract. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 100000g"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "saved as the DEA extract."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0057938:diethylamine [Organic Chemical]
   760   C2828366:Extract [Substance]
   726   C2347840:Save [Machine Activity]
Processing 00000000.tx.270: The pellet was then sonicated in 70% formic acid (FA) diluted in water, using a volume equal to the original volume of DEA. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sonicated in 70% formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "(FA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "diluted in water,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "equal to the original volume of DEA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0205163:Equal To [Qualitative Concept]
           Equal
   748   C1549782:Equal [Idea or Concept]
Processing 00000000.tx.271: After centrifugation at 100000g for 1h at 4C, the supernatant was removed and saved as the FA extract. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 100000g"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "saved as the FA extract."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0885348:formic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C2828366:Extract [Substance]
   719   C2347840:Save [Machine Activity]
Processing 00000000.tx.272: Brain extracts were measured by sandwich ELISA as described previously (11,58,76). 

Phrase: "Brain extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "measured by sandwich ELISA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0014441:ELISA [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11,"

Phrase: "58,"

Phrase: "76"

Phrase: ")."
Processing 00000000.tx.273: The DEA extracts were neutralized by adding 1/10vol of 0.5M TrisHCl, pH 6.8. 

Phrase: "The DEA extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "neutralized by adding 1/10vol of 0.5M TrisHCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0945818:Add 1 [Quantitative Concept]
   708   C1883712:Add [Functional Concept]

Phrase: "pH 6.8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.274: After vortexing briefly, neutralized samples were prepared for ELISA by 1:10 dilution in EC buffer (0.02M phosphate buffer, pH 7, 0.4M NaCl, 2mM EDTA, 0.4% Block Ace (Dainipponseiyaku, Suita, Osaka, Japan), 0.2% bovine serum albumin, 0.05% CHAPS, and 0.05% sodium azide. 

Phrase: "After"

Phrase: "vortexing briefly,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0439648:vortexing [Spatial Concept]
   861   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   827 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "neutralized samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared for ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "by 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10 dilution in EC buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]

Phrase: "(0.02M phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "0.4M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "2mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.4% Block Ace (Dainipponseiyaku,"

Phrase: "Suita,"

Phrase: "Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "0.2% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "0.05% CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   793 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "0.05% sodium azide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0004492:azide [Chemical Viewed Structurally]
Processing 00000000.tx.275: The standard curve used to calculate A concentration of DEA extracts was also performed in EC buffer. 

Phrase: "The standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "A concentration of DEA extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   745   C1720005:Concentrated extract [Biomedical or Dental Material]

Phrase: "was"

Phrase: "also"

Phrase: "performed in EC buffer."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.276: The FA extracts were neutralized and prepared for ELISA by diluting 1:20 in 1M Trisphosphate buffer (TPB), pH 11. 

Phrase: "The FA extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "were"

Phrase: "neutralized"

Phrase: "and"

Phrase: "prepared for ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "by diluting 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720119:Dilute [Functional Concept]
   827   C1948037:Dilute [Functional Concept]

Phrase: ":"

Phrase: "20 in 1M Trisphosphate buffer (TPB),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0470296:1M [Quantitative Concept]

Phrase: "pH 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.277: The standard curve for FA extracts was performed in the same mixture of FA and TPB. 

Phrase: "The standard curve for FA extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "performed in the same mixture of FA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0885348:formic acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439962:Mixture [Substance]
   744   C0445247:Same [Qualitative Concept]
   744   C0884358:Performed [Functional Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "TPB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.278: All samples were assayed with a human-A-specific ELISA system, which uses the BAN50 monoclonal antibody (mAb; epitope A1-16) for capture and the BA27 and BC05 mAbs for detection of A40 and A42, respectively. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "assayed with a human-A-specific ELISA system,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   767   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0086418:Human [Human]
   744   C0205369:Specific [Qualitative Concept]
   744   C0449913:System [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1552740:specific [Intellectual Product]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "which"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the BAN50 monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "(mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "; epitope A1-16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitope [Immunologic Factor]

Phrase: ")"

Phrase: "for capture"

Phrase: "and"

Phrase: "the BA27"

Phrase: "and"

Phrase: "BC05 mAbs for detection of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "A42,"

Phrase: "respectively."
Processing 00000000.tx.279: Final A concentrations were expressed as picomoles per gram tissue, calculated from the original brain weight measurement prior to homogenization. 

Phrase: "Final A concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "expressed as picomoles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   756   C0439192:picomole [Quantitative Concept]
   706 E C0439284:picomolar [Quantitative Concept]

Phrase: "per gram tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "calculated from the original brain weight measurement"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0043101:weight measurement [Quantitative Concept]
   778   C0870228:brain weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0043100:Weight [Quantitative Concept]
   748   C0205313:Original [Idea or Concept]
   748   C0242485:Measurement [Functional Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1705104:Weight [Idea or Concept]
   748   C2347409:Original [Occupational Activity]

Phrase: "prior to homogenization."
Processing 00000000.tx.280: Statistics were performed by one-way ANOVA with (LSD) post-test using the Statistica analysis program (StatSoft, Tulsa, OK, USA). 

Phrase: "Statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "were"

Phrase: "performed by one-way ANOVA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   862   C1709320:One-way ANOVA [Quantitative Concept]
   806   C1550369:Performed By [Qualitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with"

Phrase: "(LSD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]
   734   C0023189:Least Square [Quantitative Concept]

Phrase: ")"

Phrase: "post-test"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Statistica analysis program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "(StatSoft,"

Phrase: "Tulsa,"

Phrase: "OK,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.281: Histology Mice were euthanized by ether inhalation and the brain removed for immersion in 4% paraformaldehyde/1xbuffered saline (PBS). 

Phrase: "Histology Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "euthanized by ether inhalation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004048:Inhalation [Organism Function]
   770   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
   770   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
   770   C0205535:Inhalation [Functional Concept]
   770   C1161324:ether [Organic Chemical,Pharmacologic Substance]
   770   C1705211:Inhalation [Quantitative Concept]

Phrase: "and"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "removed for immersion"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0020940:Immersion [Therapeutic or Preventive Procedure]
   790   C0038561:Immersion [Injury or Poisoning]
   790   C0849355:Removed [Qualitative Concept]
   790   C2827727:Immersion [Functional Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "in 4% paraformaldehyde/1xbuffered saline (PBS)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036082:Saline [Substance]
Processing 00000000.tx.282: After fixation for 48h at 4C, brains were transferred to PBS, dehydrated in an alcohol series, treated with cedarwood oil and methylsalicylate, and embedded in paraffin for sectioning. 

Phrase: "After fixation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185023:Fixation [Therapeutic or Preventive Procedure]
  1000   C0728733:fixation [Mental Process]
  1000   C1522662:Fixation [Laboratory Procedure]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to PBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036082:Saline [Substance]

Phrase: "dehydrated in an alcohol series,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C2825044:Dehydrated Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C0001962:ALCOHOL [Organic Chemical]
   760   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   760   C0011175:Dehydrated [Disease or Syndrome]
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "treated with cedarwood oil"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0208034:cedarwood oil [Lipid,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0028908:Oil [Lipid]
   770   C0330153:cedarwood [Plant]
   770   C1517288:Oil [Food,Lipid]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
   715 E C0996956:Olea [Plant]

Phrase: "and"

Phrase: "methylsalicylate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066282:methyl salicylate [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "embedded in paraffin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "for sectioning."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0700320:sectioning [Laboratory Procedure]
   966 E C0205155:Section [Spatial Concept]
   966 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966 E C1522472:Section [Substance]
   966 E C1552923:Section [Quantitative Concept]
   966 E C1705191:Section [Physical Object]
Processing 00000000.tx.283: Hirano silver stain Silver impregnation histology was performed on 10m paraffin-embedded sections by Hirano's modification of the Bielschowsky method (77,78). 

Phrase: "Hirano silver stain Silver impregnation histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0019638:Histology [Biomedical Occupation or Discipline]
   799   C0205462:histology [Functional Concept]
   799   C0344441:Histology [Laboratory Procedure]

Phrase: "was"

Phrase: "performed on 10m paraffin-embedded sections"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   783   C0085185:embedded paraffin [Laboratory Procedure]
   753   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   753   C0884358:Performed [Functional Concept]
   753   C1442446:10M [Temporal Concept]
   753   C1707903:Embedded [Laboratory Procedure]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "by Hirano's modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "of the Bielschowsky method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(77,"

Phrase: "78"

Phrase: ")."
Processing 00000000.tx.284: Briefly, sections were deparaffinized through xylene and alcohols into tap water before being placed into fresh 20% silver nitrate solution for 20min. 

Phrase: "Briefly,"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "deparaffinized through xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "alcohols into tap water"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0001975:Alcohols [Organic Chemical,Pharmacologic Substance]
   737 E C0001962:ALCOHOL [Organic Chemical]

Phrase: "before"

Phrase: "being"

Phrase: "placed into fresh 20% silver nitrate solution"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   831   C0361850:Silver nitrate 20% solution [Clinical Drug]
   778   C0037129:Silver Nitrate [Inorganic Chemical,Pharmacologic Substance]
   778   C1161347:silver nitrate [Pharmacologic Substance]
   778   C1321600:Silver nitrate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   748   C0028125:Nitrate [Chemical Viewed Structurally]
   748   C0037125:Silver [Element, Ion, or Isotope]
   748   C0037633:Solution [Substance]
   748   C0443224:Fresh [Qualitative Concept]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C0699857:Nitrate [Inorganic Chemical]
   748   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   748   C1305285:Silver [Qualitative Concept]
   748   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   748   C2827486:Fresh [Body Substance]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "for 20min."
Processing 00000000.tx.285: After washing thoroughly with distilled water, slides were immersed in 20% silver nitrate solution titrated with fresh ammonium hydroxide. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "thoroughly with distilled water,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "immersed in 20% silver nitrate solution"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   851   C0361850:Silver nitrate 20% solution [Clinical Drug]
   790   C0037129:Silver Nitrate [Inorganic Chemical,Pharmacologic Substance]
   790   C1161347:silver nitrate [Pharmacologic Substance]
   790   C1321600:Silver nitrate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   753   C0028125:Nitrate [Chemical Viewed Structurally]
   753   C0037125:Silver [Element, Ion, or Isotope]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0699857:Nitrate [Inorganic Chemical]
   753   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   753   C1305285:Silver [Qualitative Concept]
   753   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]

Phrase: "titrated with fresh ammonium hydroxide."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0051719:ammonium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   760   C0002611:Ammonium [Inorganic Chemical]
   760   C0220853:hydroxide [Element, Ion, or Isotope]
   760   C0443224:Fresh [Qualitative Concept]
   760   C2827486:Fresh [Body Substance]
   726   C1883350:Titrate [Health Care Activity]
Processing 00000000.tx.286: After 20min, slides were washed with ammonia water before being individually developed with 100l of developer (20ml of 37% formaldehyde, 100ml distilled water, 50l concentrated nitric acid and 0.5g citric acid) added to 50ml of titrated silver nitrate solution. 

Phrase: "After 20min,"

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "washed with ammonia water"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0051719:Ammonia water [Inorganic Chemical,Pharmacologic Substance]
   770   C0002607:Ammonia [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1095824:Ammonia [Eukaryote]
   770   C1548982:Washed [Idea or Concept]
   770   C1550678:Water [Inorganic Chemical]
   737 E C0441648:Wash [Activity]

Phrase: "before"

Phrase: "being"

Phrase: "individually"

Phrase: "developed with 100l of developer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2363670:developer [Medical Device]

Phrase: "(20ml of 37% formaldehyde,"

Phrase: "100ml distilled water,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C0681549:distilled [Occupational Activity]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "50l"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "nitric acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0068808:Nitric Acid [Hazardous or Poisonous Substance,Inorganic Chemical]
  1000   C1556065:Nitric Acid [Intellectual Product]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "0.5g citric acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0055819:Citric Acid [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
           citric
   861   C1171556:citric acid [Organic Chemical,Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "added to 50ml of titrated silver nitrate solution."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   770   C0037129:Silver Nitrate [Inorganic Chemical,Pharmacologic Substance]
   770   C1161347:silver nitrate [Pharmacologic Substance]
   770   C1321600:Silver nitrate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   744   C0028125:Nitrate [Chemical Viewed Structurally]
   744   C0037125:Silver [Element, Ion, or Isotope]
   744   C0037633:Solution [Substance]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0699857:Nitrate [Inorganic Chemical]
   744   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   744   C1305285:Silver [Qualitative Concept]
   744   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   744   C1524062:Added [Functional Concept]
   711   C1883350:Titrate [Health Care Activity]
   711 E C1883712:Add [Functional Concept]
Processing 00000000.tx.287: Slides were then rinsed in tap water, fixed in 5% sodium thiosulfate, and dehydrated through alcohols and xylene. 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed in tap water,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]
   770   C0034115:Tap [Health Care Activity]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "fixed in 5% sodium thiosulfate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0074774:Sodium thiosulphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0039950:Thiosulfate [Inorganic Chemical]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "dehydrated through alcohols"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   841   C2825044:Dehydrated Alcohol [Organic Chemical,Pharmacologic Substance]
   790   C0001975:Alcohols [Organic Chemical,Pharmacologic Substance]
   790   C0011175:Dehydrated [Disease or Syndrome]
   756 E C0001962:ALCOHOL [Organic Chemical]
   706 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "and"

Phrase: "xylene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.288: Congo Red stain Congo Red staining was performed according to standard techniques. 

Phrase: "Congo Red stain Congo Red staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   904   C0009742:congo red staining [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   904   C1293958:congo red staining [Laboratory Procedure]
   799   C0487602:Staining [Laboratory Procedure]
   799   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed according to standard techniques."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025664:techniques [Intellectual Product]
   760   C0449851:Techniques [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.289: Deparaffinized slides with 10m brain sections were counterstained in hematoxylin, rinsed well, then immersed in congo red solution 20g sodium chloride in 100ml distilled water mixed with 5g Congo Red (Sigma, St Louis, MO, USA) dissolved in 400ml 95% ethanol for 30min. 

Phrase: "Deparaffinized slides with 10m brain sections"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0444330:slides [Research Device]
   719 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "counterstained in hematoxylin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "well,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immersed in congo red solution 20g sodium chloride"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C0036082:Sodium chloride solution [Substance]
   770   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0008203:Chloride, NOS [Inorganic Chemical]
   744   C0009738:Congo [Geographic Area]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0037633:Solution [Substance]
   744   C0332575:Red [Finding]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0596019:Chloride [Element, Ion, or Isotope]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1260956:Red [Qualitative Concept]

Phrase: "in 100ml distilled water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C0681549:distilled [Occupational Activity]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "mixed with 5g Congo Red"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0009738:Congo [Geographic Area]
   760   C0205430:Mixed [Functional Concept]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "dissolved in 400ml 95% ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001962:Ethanol [Organic Chemical]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "for 30min."
Processing 00000000.tx.290: Without rinsing, slides were moved into aniline blue (7.5g aniline blue, 5ml glacial acetic acid, and 250ml distilled water), then dehydrated in ethanol and xylene. 

Phrase: "Without rinsing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882955:Rinsing [Activity]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "moved into aniline blue"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1321796:aniline blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0003036:Aniline [Hazardous or Poisonous Substance,Organic Chemical]
   770   C1260957:Blue [Qualitative Concept]
   770   C1269909:moved [Functional Concept]
   770   C1299988:moved [Functional Concept]
   770   C2699029:Moved [Activity]
   737 E C0560560:move [Organism Function]
   737 E C0578671:move [Finding]

Phrase: "(7.5g aniline blue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1321796:aniline blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0003036:Aniline [Hazardous or Poisonous Substance,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: "5ml glacial acetic acid,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0000983:Glacial Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Acetic Acid
   861   C0000985:Acetic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   756 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "250ml distilled water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C0681549:distilled [Occupational Activity]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dehydrated in ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   790   C0011175:Dehydrated [Disease or Syndrome]

Phrase: "and"

Phrase: "xylene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.291: Western blotting Western blotting to assess transgenic APP expression in the Q2-2, 85 and C3-3 lines was performed as described in Jankowsky et al. 

Phrase: "Western blotting Western blotting to"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "transgenic APP expression in the Q2-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1171362:protein expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "85"

Phrase: "and"

Phrase: "C3-3 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Jankowsky et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.292: (55). 

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.293: Briefly, 5 or 50g of brain homogenate (when probed by 22C11 or 6E10 and antiSEVNL, respectively) were loaded per lane onto a 10% Trisglycine SDSPAGE gel (Invitrogen, Carlsbad, CA, USA) and electrophoresed for several hours in 1xTGSDS buffer (Amresco, Solon, OH, USA). 

Phrase: "Briefly,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "50g of brain homogenate"

Phrase: "("

Phrase: "when"

Phrase: "probed by 22C11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "6E10"

Phrase: "and"

Phrase: "antiSEVNL,"

Phrase: "respectively"

Phrase: ")"

Phrase: "were"

Phrase: "loaded per lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "onto a 10% Trisglycine SDSPAGE gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "electrophoresed for several hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439227:hours [Temporal Concept]
   737   C0013855:electrophorese [Laboratory Procedure]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "in 1xTGSDS buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Amresco,"

Phrase: "Solon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0142991:Solon [Organic Chemical,Pharmacologic Substance]

Phrase: "OH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.294: Proteins were transferred overnight to 0.45m Optitran nitrocellulose (Schleicher and Schuell, Keene, NH, USA) in 1xTG buffer (Amresco). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "overnight to 0.45m Optitran nitrocellulose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439583:Overnight [Temporal Concept]
   753   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   753   C1442463:45M [Temporal Concept]

Phrase: "(Schleicher"

Phrase: "and"

Phrase: "Schuell,"

Phrase: "Keene,"

Phrase: "NH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "in 1xTG buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Amresco"

Phrase: ")."
Processing 00000000.tx.295: Blots were blocked in PBS containing 5% non-fat dry milk powder, and incubated for 3h at room temperature with either antibody 22C11 (kind gift of Drs Konrad Beyreuther and Andreas Weidemann) diluted 1:2000 in blocking solution, antibody 6E10 Signet Laboratories (Dedham, MA, USA) diluted 1:2500 in blocking solution, or -SEVNL (79) diluted 1:2000 in blocking solution. 

Phrase: "Blots"

Phrase: "were"

Phrase: "blocked in PBS"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0028778:Blocked [Pathologic Function]
   760   C0036082:Saline [Substance]
   760   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C0332206:Blocked [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% non-fat dry milk powder,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   839   C0991850:fat milk [Lipid,Pharmacologic Substance]
   827   C1440965:Milk powder [Immunologic Factor]
   799   C0026131:Milk [Body Substance]
   799   C0032861:Powder [Biomedical or Dental Material]
   799   C0349374:Milk [Food]
   799   C0444318:Milk [Substance]
   799   C1382110:Powder [Substance]
   799   C2825079:Milk [Food]
   743 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   743 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   727 E C0443260:Milky [Finding]

Phrase: "and"

Phrase: "incubated for 3h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442460:3H [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with either antibody 22C11"

Phrase: "(kind gift of Drs Konrad Beyreuther"

Phrase: "and"

Phrase: "Andreas Weidemann"

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 in blocking solution,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "antibody 6E10 Signet Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022877:Laboratories [Manufactured Object,Organization]
   812   C1619828:Laboratories [Intellectual Product]
   779 E C3244292:laboratory [Functional Concept]

Phrase: "(Dedham,"

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2500 in blocking solution,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "or -SEVNL"

Phrase: "(79"

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 in blocking solution."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.296: The blots were washed several times with PBS containing 0.1% Tween-20, and then incubated either in peroxidase-conjugated protein A (Sigma, St Louis, MO, USA) diluted 1:2000 in blocking solution or (for 6E10) in a mixture of peroxidase-protein A diluted 1:1000 and rabbit anti-mouse IgG (Chemicon, Temecula, CA, USA) diluted 1:2000 in blocking solution. 

Phrase: "The blots"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "several times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween-20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "either in peroxidase-conjugated protein A"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0522529:Conjugated [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   719 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 in blocking solution"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "or (for 6E10"

Phrase: ")"

Phrase: "in a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of peroxidase-protein A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "and"

Phrase: "rabbit anti-mouse IgG (Chemicon,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 in blocking solution."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.297: After washing several times in PBS with 0.1% Tween-20, blots were developed with enhanced chemiluminescence reagent (New England Nuclear, Boston, MA, USA) and exposed to film. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "several times in PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "with 0.1% Tween-20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "blots"

Phrase: "were"

Phrase: "developed with enhanced chemiluminescence reagent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   760   C2349975:Enhanced [Activity]

Phrase: "(New England Nuclear, Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.298: The levels of PS1 transgene products in the mice used here have been previously described (39,44,56). 

Phrase: "The levels of PS1 transgene products"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(39,"

Phrase: "44,"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.299: The steady-state levels of human PS1 protein in the various mice used here accumulate to similar levels (44,56).  

Phrase: "The steady-state levels of human PS1 protein"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0678587:steady state [Natural Phenomenon or Process]
   748   C0683927:state level [Spatial Concept]
   745   C0428479:Protein level [Laboratory or Test Result]
   745   C0456947:Level 1 [Intellectual Product]
   742   C0205361:Steady [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the various mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "accumulate to similar levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(44,"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.300: SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Supplementary Material is available at HMG Online.  

Phrase: "SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "is"

Phrase: "available at HMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "Online."
Processing 00000000.tx.301: ACKNOWLEDGEMENTS  We thank Debbie Swing for assistance with the production of transgenic mice, and David Fromholt and Alvin George for help with mouse genotyping. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Debbie Swing for assistance"

Phrase: "with the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "David Fromholt"

Phrase: "and"

Phrase: "Alvin George for"

Phrase: "help with mouse genotyping."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0018896:Help [Social Behavior]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1285573:Genotyping [Laboratory Procedure]
   770   C1552861:help [Idea or Concept]
Processing 00000000.tx.302: Data on crosses of Mo/Hu APPswe line C3-3 to PS1-dE9 line O-7 were kindly provided by Drs. 

Phrase: "Data on crosses of Mo/Hu APPswe line C3-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0596723:data human [Intellectual Product,Research Activity]
   739   C1511726:Data [Idea or Concept]
   739   C3245479:data [Medical Device]

Phrase: "to PS1-dE9 line O-7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PRESENILIN 1 [Gene or Genome]
   799   C0205132:Line [Spatial Concept]
   799   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   799   C1550648:Line [Substance]
   799   C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by Drs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.303: Shadid Zaman, Flavio Kamenetz, and Roberto Malinow (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA). 

Phrase: "Shadid Zaman,"

Phrase: "Flavio Kamenetz,"

Phrase: "and"

Phrase: "Roberto Malinow"

Phrase: "(Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.304: We are grateful to Drs Konrad Beyreuther and Andreas Weidemann for sharing the 22C11 antibody, and to Dr Robert Siman (University of Pennsylvania Medical School) for sharing the anti-SEVNL antibody. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Drs Konrad Beyreuther"

Phrase: "and"

Phrase: "Andreas Weidemann for sharing"

Phrase: "the 22C11 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and to Dr Robert Siman"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1515981:And [Idea or Concept]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "(University of Pennsylvania Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   804   C0036375:School [Manufactured Object,Organization]

Phrase: ")"

Phrase: "for sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "the anti-SEVNL antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.305: This work was funded by grants from the National Institute of Aging (D.R.B.; NIA 1 P50 AG 14248 and NIA 1 P01 AG-98-003), the National Cancer Institute (N.A.J. and N.G.C.), and the Alzheimer's Association (D.R.B.). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded by grants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016820:funded [Quantitative Concept]
   790   C0018173:Grants [Quantitative Concept]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "(D.R.B."

Phrase: "; NIA 1 P50 AG 14248"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1074110:Nia [Fungus]
   804   C1955974:NIA [Health Care Related Organization]

Phrase: "and"

Phrase: "NIA 1 P01 AG-98-003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1074110:Nia [Fungus]
   799   C1548698:P01 [Intellectual Product]
   799   C1955974:NIA [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "the National Cancer Institute"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1513882:National Cancer Institute [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0021622:institute [Organization]
   827   C0998265:Cancer [Eukaryote]
   827   C1272753:Institute [Idea or Concept]
   827   C1306459:Cancer [Finding]
   827   C3245503:national [Intellectual Product]

Phrase: "(N.A.J."

Phrase: "and"

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "C."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Alzheimer's Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "(D.R.B."

Phrase: ")."
Processing 00000000.tx.306: J.L.J. was supported by a training grant (NIH 1 T32 NS 07435), and by funding from the John Douglas French Alzheimer's Foundation and the American Health Assistance Foundation.  

Phrase: "J."

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "was"

Phrase: "supported by a training grant"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0555633:Training grant [Intellectual Product]
   781   C0040608:Training Support [Educational Activity]
   760   C0018173:Grant [Quantitative Concept]
   760   C0040607:Training [Educational Activity]
   760   C0220931:Training [Educational Activity]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   760   C2673163:training [Qualitative Concept]
   726 E C0183683:Support [Medical Device]
   726 E C0336809:Train [Manufactured Object]
   726 E C1552514:Train [Manufactured Object]

Phrase: "(NIH 1 T32 NS 07435"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0027468:NIH [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "and by funding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243098:Funding [Quantitative Concept]
   790   C0376244:funding [Quantitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "from the John Douglas French Alzheimer's Foundation"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   804   C0016617:Foundation [Organization]
   721 E C0002055:base [Inorganic Chemical]
   721 E C0178499:Base [Chemical Viewed Functionally]
   721 E C1626935:Bases [Quantitative Concept]
   721 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the American Health Assistance Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.307: FOOTNOTES  * To whom correspondence should be addressed at: Department of Pathology, The Johns Hopkins University School of Medicine, 558 Ross Research Building, 720 Rutland Ave, Baltimore, MD 21205, USA. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "The Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036375:School [Manufactured Object,Organization]
   748   C0041740:University [Manufactured Object,Organization]

Phrase: "558 Ross"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331968:Ross [Health Care Related Organization]
   861   C2699100:Ross [Bird]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547706:Building [Functional Concept]
  1000   C1999269:Building [Manufactured Object]

Phrase: "720 Rutland Ave,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD 21205,"

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.308: Tel: +1 4105025174; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 4105025174"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.309: Fax: +1 4109559777; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 4109559777"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.310: Email: drbor{at}jhmi.edu Present address:Division of Biology, MC 156-29 California Institute of Technology, Pasadena, CA 91125, USA.  

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "drbor{at}jhmi.edu Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Division of Biology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "MC 156-29 California"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006754:California [Geographic Area]
   812   C3146274:California [Plant]

Phrase: "Institute of Technology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021622:institute [Organization]
   790   C0039421:Technology [Occupation or Discipline]
   790   C1272753:Institute [Idea or Concept]

Phrase: "Pasadena,"

Phrase: "CA 91125,"

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.311: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Jankowsky, J.L., Savonenko, A., Schilling, G., Wang, J., Xu, G. and Borchelt, D.R. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION CONCLUSIONS MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Jankowsky,"

Phrase: "J.L., Savonenko,"

Phrase: "A.,"

Phrase: "Schilling,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Xu,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Borchelt,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.312: (2002) Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "models of neurodegenerative disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   819   C0683033:disease model [Intellectual Product]
   819   C0684309:Disease model [Experimental Model of Disease]
   770   C0012634:Disease [Disease or Syndrome]
   770   C3161035:Model [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "opportunities for therapeutic development."
Processing 00000000.tx.313: Curr. 

Phrase: "Curr."
Processing 00000000.tx.314: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.315: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.316: Rep., 2, 457464.[Medline] Glenner, G.G. and Wong, C.W. 

Phrase: "Rep., 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413395:REP-2 [Gene or Genome]
   861   C1744664:REP [Molecular Function]

Phrase: "457464."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Glenner,"

Phrase: "G.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C.W."
Processing 00000000.tx.317: (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ":"

Phrase: "sharing of a unique cerebrovascular amyloid fibril protein."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   789   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0225328:Fibril [Cell Component]
   744   C0237876:Sharing [Social Behavior]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1710548:Unique [Qualitative Concept]
   744   C1880018:Cerebrovascular [Qualitative Concept]
   744   C1948066:Fibril [Physical Object]
Processing 00000000.tx.318: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.319: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.320: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.321: Commun., 122, 11311135.[ISI][Medline] Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K. 

Phrase: "Commun.,"

Phrase: "122,"

Phrase: "11311135."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Simms,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Weinman,"

Phrase: "N.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McDonald,"

Phrase: "B.L."

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.322: (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Amyloid plaque core protein in Alzheimer disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.323: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.324: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.325: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.326: USA, 82, 42454249.[Abstract] Roher, A., Wolfe, D., Palutke, M. and KuKurga, D. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "82,"

Phrase: "42454249."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roher,"

Phrase: "A.,"

Phrase: "Wolfe,"

Phrase: "D."

Phrase: ","

Phrase: "Palutke,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "KuKurga,"

Phrase: "D."
Processing 00000000.tx.327: (1986) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "ultrastructure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041623:Ultrastructure [Idea or Concept]

Phrase: "and"

Phrase: "chemical analysis of Alzheimer disease amyloid plaque core protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0243074:chemical analysis [Functional Concept]
   764   C3495389:Chemical analysis [Laboratory Procedure]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.328: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.329: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.330: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.331: USA, 83, 26622666.[Abstract] Shoji, M., Golde, T.E., Ghiso, J., Cheung, T.T., Estus, S., Shaffer, L.M., Cai, X.-D., McKay, D.M., Tintner, R., Frangione, B. and Younkin, S.G. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "83,"

Phrase: "26622666."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Golde,"

Phrase: "T.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "T.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Shaffer,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "McKay,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Tintner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.332: (1992) Production of the Alzheimer amyloid  protein by normal proteolytic processing. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Production of the Alzheimer amyloid  protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "by normal proteolytic processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1514570:Proteolytic Processing [Molecular Function]
   827   C1709694:Processing [Activity]
Processing 00000000.tx.333: Science, 258, 126129.[ISI][Medline] Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B. and Selkoe, D.J. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "258,"

Phrase: "126129."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A.Y.,"

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mellon,"

Phrase: "A.,"

Phrase: "Ostaszewski,"

Phrase: "B.L., Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Koo,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.334: (1992) Amyloid -peptide is produced by cultured cells during normal metabolism. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "produced by cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "during normal metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.335: Nature, 359, 322325.[CrossRef][ISI][Medline] Roher, A.E., Lowenson, J.D., Clarke, S., Woods, A.S., Cotter, R.J., Gowing, E. and Ball, M.J. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "359,"

Phrase: "322325."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roher,"

Phrase: "A.E.,"

Phrase: "Lowenson,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Clarke,"

Phrase: "S."

Phrase: ","

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "A."

Phrase: "S."

Phrase: ","

Phrase: "Cotter,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gowing,"

Phrase: "E."

Phrase: "and"

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.336: (1993) beta-Amyloid-(142) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "beta-Amyloid-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(142"

Phrase: ")"

Phrase: "is"

Phrase: "a major component of cerebrovascular amyloid deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1440087:Amyloid A component [Immunologic Factor]
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: ":"

Phrase: "implications for the pathology of Alzheimer disease."
Processing 00000000.tx.337: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.338: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.339: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.340: USA, 90, 1083610840.[Abstract] Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D.J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1083610840."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A.Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.341: (1992) Mutation of the -amyloid precursor protein in familial Alzheimer's disease increases -protein production. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mutation of the -amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in familial Alzheimer's disease increases -protein production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]
Processing 00000000.tx.342: Nature, 360, 672674.[CrossRef][ISI][Medline] Cai, X.-D., Golde, T.E. and Younkin, S.G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "360,"

Phrase: "672674."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.343: (1993) Release of excess amyloid  protein from a mutant amyloid  protein precursor. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Release of excess amyloid  protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030685:Release [Health Care Activity]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   760   C1979886:Excess [Qualitative Concept]

Phrase: "from a mutant amyloid  protein precursor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]
   708   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.344: Science, 259, 514516.[ISI][Medline] Haass, C., Hung, A.Y., Selkoe, D.J. and Teplow, D.B. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "259,"

Phrase: "514516."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A.Y.,"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.345: (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid -protein precursor. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with a locus"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1708726:Locus [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for familial Alzheimer's disease result"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C1274040:Result [Functional Concept]
   812   C1546471:Result [Idea or Concept]
   812   C2825142:Result [Finding]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "in alternative processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of amyloid -protein precursor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: Biol. 

Phrase: "Biol."
Processing 00000000.tx.348: Chem., 269, 1774117748.[Abstract/Free FullText] Suzuki, N., Cheung, T.T., Cai, X.-D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T.E. and Younkin, S.G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "1774117748."

Phrase: "[Abstract/Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: (1994) An increased percentage of long amyloid  protein secreted by familial amyloid  protein precursor (APP717) mutants. 

Phrase: "(1994"

Phrase: ")"

Phrase: "An increased percentage of long amyloid  protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "secreted by familial amyloid  protein precursor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0015576:familial [Family Group]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0241888:Familial [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1327616:Secreted [Cell Function]
   753   C1709634:Precursor [Idea or Concept]
   748   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APP717"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0299605:APP717 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.350: Science, 264, 13361340.[ISI][Medline] Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C. and Glabe, C. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "264,"

Phrase: "13361340."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Soreghan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "M."

Phrase: ","

Phrase: "Kosmoski,"

Phrase: "J.,"

Phrase: "Knauer,"

Phrase: "M."

Phrase: ","

Phrase: "Henschen,"

Phrase: "A.,"

Phrase: "Yates,"

Phrase: "J.,"

Phrase: "Cotman,"

Phrase: "C."

Phrase: "and"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.351: (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/ amyloid peptide analogs. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "aggregation properties of synthetic Alzheimer's A4/ amyloid peptide analogs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0871161:properties [Qualitative Concept]
   742   C1292721:properties [Functional Concept]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]
Processing 00000000.tx.352: J. 

Phrase: "J."
Processing 00000000.tx.353: Biol. 

Phrase: "Biol."
Processing 00000000.tx.354: Chem., 267, 546554.[Abstract/Free FullText] Jarrett, J.T., Lansbury, P.T., Jr. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "267,"

Phrase: "546554."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jarrett,"

Phrase: "J.T.,"

Phrase: "Lansbury,"

Phrase: "P.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.355: (1993) Seeding one-dimensional crystallization of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? 

Phrase: "(1993"

Phrase: ")"

Phrase: "Seeding one-dimensional crystallization of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010423:Crystallization [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "a pathogenic mechanism in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "scrapie?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036457:Scrapie [Disease or Syndrome]
Processing 00000000.tx.356: Cell, 73, 10551058.[ISI][Medline] Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N. and Ihara, Y. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "73,"

Phrase: "10551058."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizusawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.357: (1994) Visualization of A42(43)-positive and A40-positive senile plaques with end-specific A-monoclonal antibodies: evidence that an initially deposited A species is A1-42(43). 

Phrase: "(1994"

Phrase: ")"

Phrase: "Visualization of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0175631:Visualization [Mental Process]
   790   C2827662:Visualization [Occupation or Discipline]

Phrase: "(43"

Phrase: ")-"

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "A40-positive senile plaques with end-specific A-monoclonal antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0333463:Senile Plaques [Acquired Abnormality]
           amyloid plaques
           plaques
   757   C2936349:Plaques, Amyloid [Acquired Abnormality]
   739   C0392079:Senile [Finding]
   706 E C0011389:Plaque [Disease or Syndrome]
   706 E C0332461:Plaque [Finding]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "an initially deposited A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "A1-42"

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.358: Neuron, 13, 4553.[ISI][Medline] Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T. et al. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "13,"

Phrase: "4553."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T. et al."
Processing 00000000.tx.359: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.360: Nature, 376, 775778.[CrossRef][ISI][Medline] Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775778."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G. et al."
Processing 00000000.tx.361: (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning of a gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0009015:Cloning [Research Activity]

Phrase: "in early-onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.362: Nature, 375, 754760.[CrossRef][ISI][Medline] Sherrington, R., Froelich, S., Sorbi, S., Campion, D., Chi, H., Rogaeva, E.A., Levesque, G., Rogaev, E.I., Lin, C. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754760."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rogaeva,"

Phrase: "E.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C. et al."
Processing 00000000.tx.363: (1996) Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "and"

Phrase: "variably penetrant."
Processing 00000000.tx.364: Hum. 

Phrase: "Hum."
Processing 00000000.tx.365: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.366: Genet., 5, 985988.[Abstract/Free FullText] Thinakaran, G., Harris, C.L., Ratovitski, T., Davenport, F., Slunt, H.H., Price, D.L., Borchelt, D.R. and Sisodia, S.S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "985988."

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Harris,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H.H.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L., Borchelt,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.367: (1997) Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that levels of presenilins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"

Phrase: ")"

Phrase: "are"

Phrase: "coordinately"

Phrase: "regulated by competition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0679932:competition [Social Behavior]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "for limiting cellular factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.368: J. 

Phrase: "J."
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: Chem., 272, 2841528422.[Abstract/Free FullText] Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.Q., Rogaeva, E., Chen, F., Kawaral, T. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "272,"

Phrase: "2841528422."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Arawaka,"

Phrase: "S."

Phrase: ","

Phrase: "Levitan,"

Phrase: "D."

Phrase: ","

Phrase: "Zhang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tandon,"

Phrase: "A.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "Y.Q., Rogaeva,"

Phrase: "E.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kawaral,"

Phrase: "T. et al."
Processing 00000000.tx.371: (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and beta-APP processing. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "presenilin-mediated notch/glp-1 signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0037083:Signal Transduction [Cell Function]
   795   C1160185:transduction [Organism Function]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "beta-APP processing."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   771   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   722   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1750295:beta protein [Genetic Function]
   708   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.372: Nature, 407, 4854.[CrossRef][ISI][Medline] Chung, H.M. and Struhl, G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "407,"

Phrase: "4854."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "H.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348952:H/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Struhl,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.373: (2001) Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "is"

Phrase: "required for Presenilin-mediated transmembrane cleavage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0010813:cleavage [Cell Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1167322:transmembrane [Cell Component]
   753   C1330957:cleavage [Cell Function]
   753   C1514873:Required [Functional Concept]
   753   C2752508:transmembrane [Cell Component]

Phrase: "in Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]
Processing 00000000.tx.374: Nat. 

Phrase: "Nat."
Processing 00000000.tx.375: Cell Biol., 3, 11291132.[CrossRef][ISI][Medline] Edbauer, D., Winkler, E., Haass, C. and Steiner, H. 

Phrase: "Cell Biol.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "11291132."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Winkler,"

Phrase: "E.,"

Phrase: "Haass,"

Phrase: "C."

Phrase: "and"

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.376: (2002) Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "regulate"

Phrase: "each other"

Phrase: "and"

Phrase: "determine"

Phrase: "amyloid beta-peptide production via complex formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]
Processing 00000000.tx.377: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.378: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.379: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.380: USA, 99, 86668671.[Abstract/Free FullText] Hu, Y., Ye, Y. and Fortini, M.E. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "99,"

Phrase: "86668671."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hu,"

Phrase: "Y.,"

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Y."

Phrase: "and"

Phrase: "Fortini,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.381: (2002) Nicastrin is required for -secretase cleavage of the Drosophila notch receptor. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "is"

Phrase: "required for -secretase cleavage of the Drosophila notch receptor."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1143933:notch receptor, Drosophila [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0013138:Drosophila [Eukaryote]
   742   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1028876:Drosophila [Fungus]
   742   C1235660:Notch [Body Space or Junction]
   742   C1330957:cleavage [Cell Function]
   742   C1504613:Drosophila [Eukaryote]
   742   C1514873:Required [Functional Concept]
Processing 00000000.tx.382: Dev. 

Phrase: "Dev."
Processing 00000000.tx.383: Cell, 2, 6978.[ISI][Medline] Lee, S.F., Shah, S., Li, H., Yu, C., Han, W. and Yu, G. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6978."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Shah,"

Phrase: "S."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "W."

Phrase: "and"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.384: (2002) Mammalian APH-1 interacts with presenilin and nicastrin, and is required for intramembrane proteolysis of APP and Notch. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mammalian APH-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024660:Mammalian [Mammal]
   827   C1332101:APH [Gene or Genome]
   827   C1705550:APH [Gene or Genome]

Phrase: "interacts with presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "nicastrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "required for intramembrane proteolysis of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987018:Intramembrane Proteolysis [Phenomenon or Process]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0597304:Proteolysis [Molecular Function]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514873:Required [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Notch."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]
Processing 00000000.tx.385: J. 

Phrase: "J."
Processing 00000000.tx.386: Biol. 

Phrase: "Biol."
Processing 00000000.tx.387: Chem., 277, 4501345019.[Abstract/Free FullText] Lopez-Schier, H. and St Johnston, D. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "4501345019."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lopez-Schier,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "St Johnston,"

Phrase: "D."
Processing 00000000.tx.388: (2002) Drosophila nicastrin is essential for the intramembranous cleavage of notch. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Drosophila nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538050:NICASTRIN [Gene or Genome]

Phrase: "is"

Phrase: "essential for the intramembranous cleavage of notch."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.389: Dev. 

Phrase: "Dev."
Processing 00000000.tx.390: Cell, 2, 7989.[ISI][Medline] Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "7989."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Winkler,"

Phrase: "E.,"

Phrase: "Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Prokop,"

Phrase: "S."

Phrase: ","

Phrase: "Basset,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yamasaki,"

Phrase: "A.,"

Phrase: "Kostka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.391: (2002) PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. 

Phrase: "(2002"

Phrase: ")"

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "is"

Phrase: "an integral component of the gamma-secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "required for coordinated expression of presenilin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0427184:Coordinated [Finding]
   753   C0700114:Coordinated [Functional Concept]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1514873:Required [Functional Concept]
   719 E C1707511:Coordinate [Spatial Concept]

Phrase: "and"

Phrase: "nicastrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]
Processing 00000000.tx.392: J. 

Phrase: "J."
Processing 00000000.tx.393: Biol. 

Phrase: "Biol."
Processing 00000000.tx.394: Chem., 277, 3906239065.[Abstract/Free FullText] Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G. and Iwatsubo, T. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "3906239065."

Phrase: "[Abstract/Free FullText"

Phrase: "] Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hayashi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsuruoka,"

Phrase: "M."

Phrase: ","

Phrase: "Niimura,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.395: (2003) The role of presenilin cofactors in the gamma-secretase complex. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The role of presenilin cofactors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the gamma-secretase complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2753842:gamma-secretase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.396: Nature, 422, 438441.[CrossRef][ISI][Medline] Luo, W.J., Wang, H., Li, H., Kim, B.S., Shah, S., Lee, H.J., Thinakaran, G., Kim, T.W., Yu, G. and Xu, H. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "422,"

Phrase: "438441."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "W.J.,"

Phrase: "Wang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Shah,"

Phrase: "S."

Phrase: ","

Phrase: "Lee,"

Phrase: "H.J.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kim,"

Phrase: "T.W., Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1006780:yu [Plant]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Xu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.397: (2003) PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. 

Phrase: "(2003"

Phrase: ")"

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "and"

Phrase: "APH-1 coordinately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1332101:APH [Gene or Genome]
   827   C1705550:APH [Gene or Genome]

Phrase: "regulate"

Phrase: "proteolytic processing of presenilin 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1514570:Proteolytic Processing [Molecular Function]
   760   C1709694:Processing [Activity]
Processing 00000000.tx.398: J. 

Phrase: "J."
Processing 00000000.tx.399: Biol. 

Phrase: "Biol."
Processing 00000000.tx.400: Chem., 278, 78507854.[Abstract/Free FullText] De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K. and Van Leuven, F. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "78507854."

Phrase: "[Abstract/Free FullText"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.401: (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Deficiency of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the normal cleavage of amyloid precursor protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
Processing 00000000.tx.402: Nature, 391, 387390.[CrossRef][ISI][Medline] Ray, W.J., Yao, M., Mumm, J., Schroeter, E.H., Saftig, P., Wolfe, M., Selkoe, D.J., Kopan, R. and Goate, A.M. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "391,"

Phrase: "387390."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W.J.,"

Phrase: "Yao,"

Phrase: "M."

Phrase: ","

Phrase: "Mumm,"

Phrase: "J.,"

Phrase: "Schroeter,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kopan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goate,"

Phrase: "A.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: (1999) Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell surface presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "participates in the gamma-secretase-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017011:Gamma [Natural Phenomenon or Process]
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1552644:Gamma [Intellectual Product]
   760   C2349976:Gamma [Quantitative Concept]

Phrase: "like proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "of Notch."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]
Processing 00000000.tx.404: J. 

Phrase: "J."
Processing 00000000.tx.405: Biol. 

Phrase: "Biol."
Processing 00000000.tx.406: Chem., 274, 3680136807.[Abstract/Free FullText] De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J.S., Schroeter, E.H., Schrijvers, V., Wolfe, M.S., Ray, W.J., Goate, A. and Kopan, R. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "3680136807."

Phrase: "[Abstract/Free FullText"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mumm,"

Phrase: "J.S.,"

Phrase: "Schroeter,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schrijvers,"

Phrase: "V.,"

Phrase: "Wolfe,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W.J.,"

Phrase: "Goate,"

Phrase: "A."

Phrase: "and"

Phrase: "Kopan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.407: (1999) A presenilin-1-dependent-secretase-like protease mediates release of notch intracellular domain. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A presenilin-1-dependent-secretase-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "release of notch intracellular domain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.408: Nature, 398, 518522.[CrossRef][ISI][Medline] Wolfe, M.S., Xia, W., Ostazewski, B.L., Diehl, T.S., Kimberly, W.T. and Selkoe, D.J. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "398,"

Phrase: "518522."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolfe,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Ostazewski,"

Phrase: "B.L., Diehl,"

Phrase: "T.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Kimberly,"

Phrase: "W.T."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.409: (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Two transmembrane aspartates in presenilin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "required for presenilin endoproteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "gamma-secretase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.410: Nature, 398, 513517.[CrossRef][ISI][Medline] Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M.G., Baumeister, R. and Haass, C. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "398,"

Phrase: "513517."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Capell,"

Phrase: "A.,"

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Keck,"

Phrase: "S."

Phrase: ","

Phrase: "Baader,"

Phrase: "M."

Phrase: ","

Phrase: "Grim,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Baumeister,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.411: (2000) Presenilin-1 differentially facilitates endoproteolysis of the -amyloid precursor protein and Notch. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Presenilin-1 differentially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "facilitates"

Phrase: "endoproteolysis of the -amyloid precursor protein"

Phrase: "and"

Phrase: "Notch."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]
Processing 00000000.tx.412: Nat. 

Phrase: "Nat."
Processing 00000000.tx.413: Cell Biol., 2, 205211.[CrossRef][ISI][Medline] Herreman, A., Serneels, L., Annaert, W., Collen, D., Schoonjans, L. and De Strooper, B. 

Phrase: "Cell Biol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "205211."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Herreman,"

Phrase: "A.,"

Phrase: "Serneels,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Collen,"

Phrase: "D."

Phrase: ","

Phrase: "Schoonjans,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.414: (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Total inactivation of gamma-secretase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in presenilin-deficient embryonic stem cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0596508:Embryonic Stem Cells [Cell]
   840   C0038250:Stem cells [Cell]
   836   C1947950:Embryonic Cell [Embryonic Structure]
   804   C0007634:Cells [Cell]
   804   C0013935:Embryonic [Embryonic Structure]
   804   C0242767:Stem [Plant]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.415: Nat. 

Phrase: "Nat."
Processing 00000000.tx.416: Cell Biol., 2, 461462.[CrossRef][ISI][Medline] Zhang, Z., Nadeau, P., Song, W., Donoviel, D., Yuan, M., Bernstein, A. and Yankner, B.A. 

Phrase: "Cell Biol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "461462."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "Z.,"

Phrase: "Nadeau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "W.,"

Phrase: "Donoviel,"

Phrase: "D."

Phrase: ","

Phrase: "Yuan,"

Phrase: "M."

Phrase: ","

Phrase: "Bernstein,"

Phrase: "A."

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.417: (2000) Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "required for gamma-secretase cleavage of beta-APP"
Meta Candidates (Total=35; Excluded=2; Pruned=0; Remaining=33)
   806   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   799   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   799   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   795 E C3538722:Amyloid Beta Precursor Protein [Laboratory Procedure]
           Amyloid Precursor Protein
           Amyloid Precursor Beta
   777   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C2825879:Amyloid, Beta [Laboratory Procedure]
   757   C0597304:Protein Cleavage [Molecular Function]
   757   C1412727:SECRETASE, BETA [Gene or Genome]
   757   C1454853:beta-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1750295:beta protein [Genetic Function]
   757   C1750297:gamma protein [Genetic Function]
   757   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   757 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0010813:cleavage [Cell Function]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0017011:Gamma [Natural Phenomenon or Process]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0330390:Beta [Plant]
   739   C0439096:Beta [Intellectual Product]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1330957:cleavage [Cell Function]
   739   C1514873:Required [Functional Concept]
   739   C1552644:Gamma [Intellectual Product]
   739   C1709634:Precursor [Idea or Concept]
   739   C2004068:Beta [Qualitative Concept]
   739   C2349976:Gamma [Quantitative Concept]

Phrase: "and"

Phrase: "transmembrane cleavage of Notch-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
Processing 00000000.tx.418: Nat. 

Phrase: "Nat."
Processing 00000000.tx.419: Cell Biol., 2, 463465.[CrossRef][ISI][Medline] Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M., Teplow, D. and Haass, C. 

Phrase: "Cell Biol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "463465."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sastre,"

Phrase: "M."

Phrase: ","

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fuchs,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Condron,"

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.420: (2001) Presenilin-dependent -secretase processing of -amyloid precursor protein at a site corresponding to the S3 cleavage of notch. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Presenilin-dependent -secretase processing of -amyloid precursor protein at a site"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   792   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   792   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0033666:protein processing [Molecular Function]
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1709634:Precursor [Idea or Concept]

Phrase: "corresponding to the S3 cleavage of notch."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C2752250:Notch S3 cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1179706:S3 [Body Location or Region]
   748   C1235660:Notch [Body Space or Junction]
   748   C1330957:cleavage [Cell Function]
   748   C1335643:S3 [Gene or Genome]
   748   C1419033:S3 [Gene or Genome]
Processing 00000000.tx.421: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.422: Rep., 2, 835841. 

Phrase: "Rep., 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413395:REP-2 [Gene or Genome]
   861   C1744664:REP [Molecular Function]

Phrase: "835841."
Processing 00000000.tx.423: Naruse, S., Thinakaran, G., Luo, J.J., Kusiak, J.W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D.D., Price, D.L., Borchelt, D.R., Wong, P.C. and Sisodia, S.S. 

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "J.J.,"

Phrase: "Kusiak,"

Phrase: "J.W., Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Qian,"

Phrase: "X.,"

Phrase: "Ginty,"

Phrase: "D.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L., Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wong,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.424: (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Effects of PS1 deficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on membrane protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0025255:Membrane [Tissue]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking in neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0599896:trafficking [Cell Function]
   706 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.425: Neuron, 21, 12131221.[ISI][Medline] Cai, D., Leem, J.Y., Greenfield, J.P., Wang, P., Kim, B.S., Wang, R., Lopes, K.O., Kim, S.H., Zheng, H., Greengard, P., Sisodia, S.S., Thinakaran, G. and Xu, H. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "21,"

Phrase: "12131221."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "Leem,"

Phrase: "J.Y.,"

Phrase: "Greenfield,"

Phrase: "J.P.,"

Phrase: "Wang,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lopes,"

Phrase: "K.O.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Xu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.426: (2003) Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "regulates"

Phrase: "intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "cell surface delivery of beta-amyloid precursor protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0011209:Delivery [Therapeutic or Preventive Procedure]
   744   C0559563:delivery [Finding]
   744   C1705822:Delivery [Activity]
Processing 00000000.tx.427: J. 

Phrase: "J."
Processing 00000000.tx.428: Biol. 

Phrase: "Biol."
Processing 00000000.tx.429: Chem., 278, 34463454.[Abstract/Free FullText] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "34463454."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W. et al."
Processing 00000000.tx.430: (1996) Secreted amyloid -protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Secreted amyloid -protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in vivo by the presenilin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "APP mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "linked to familial Alzheimer's disease."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.431: Nat. 

Phrase: "Nat."
Processing 00000000.tx.432: Med., 2, 864870.[ISI][Medline] Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D. et al. 

Phrase: "Med.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864870."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C.-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D. et al."
Processing 00000000.tx.433: (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate A1-42/1-40 ratio in vitro and in vivo. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Familial Alzheimer's disease-linked presenilin 1 variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0205419:variants [Qualitative Concept]
   701   C2931257:Alzheimer disease 1 [Disease or Syndrome]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A1-42/1-40 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.434: Neuron, 17, 10051013.[ISI][Medline] Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A. et al. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "17,"

Phrase: "10051013."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "A. et al."
Processing 00000000.tx.435: (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid -protein in both transfected cells and transgenic mice. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid -protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in both transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.436: Nat. 

Phrase: "Nat."
Processing 00000000.tx.437: Med., 3, 6772.[ISI][Medline] Tomita, T., Maruyama, K., Saido, T.C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grunberg, J., Haass, C., Iwatsubo, T. and Obata, K. 

Phrase: "Med.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6772."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Kume,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.438: (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid  protein ending at the 42nd (or 43rd) residue. 

Phrase: "(1997"

Phrase: ")"

Phrase: "The presenilin 2 mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(N141I"

Phrase: ")"

Phrase: "linked to familial Alzheimer disease"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(Volga German families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the secretion of amyloid  protein ending"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "at the 42nd"

Phrase: "("

Phrase: "or"

Phrase: "43rd"

Phrase: ")"

Phrase: "residue."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.439: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.440: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.441: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.442: USA, 94, 20252030.[Abstract/Free FullText] Lamb, B.T., Bardel, K.A., Kulnane, L.S., Anderson, J.J., Holtz, G., Wagner, S.L., Sisodia, S.S. and Hoeger, E.J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "94,"

Phrase: "20252030."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "B.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "Bardel,"

Phrase: "K.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Kulnane,"

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "J.J.,"

Phrase: "Holtz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wagner,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Hoeger,"

Phrase: "E.J."
Processing 00000000.tx.443: (1999) Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Amyloid production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "deposition in mutant amyloid precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "presenilin-1 yeast artificial chromosome transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
Processing 00000000.tx.444: Nat. 

Phrase: "Nat."
Processing 00000000.tx.445: Neurosci., 2, 695697.[CrossRef][ISI][Medline] Dewachter, I., van Dorple, J., Spittaels, K., Tesseur, I., Van den Haute, C., Moechars, D. and Van Leuven, F. 

Phrase: "Neurosci.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "695697."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "van Dorple,"

Phrase: "J.,"

Phrase: "Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moechars,"

Phrase: "D."

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.446: (2000) Modeling Alzheimer's disease in transgenic mice: effect of age and presenilin 1 on amyloid biochemistry and pathology in APP/London mice. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Modeling Alzheimer's disease in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0683033:disease model [Intellectual Product]
   767   C0684309:Disease model [Experimental Model of Disease]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: ":"

Phrase: "effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "presenilin 1 on amyloid biochemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "pathology in APP/London mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.447: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.448: Gerontol., 35, 831841.[CrossRef][ISI][Medline] Borchelt, D.R., Lee, M.K., Gonzales, V., Slunt, H.S., Ratovitski, T., Jenkins, N.A., Copeland, N.G., Price, D.L. and Sisodia, S.S. 

Phrase: "Gerontol.,"

Phrase: "35,"

Phrase: "831841."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gonzales,"

Phrase: "V.,"

Phrase: "Slunt,"

Phrase: "H.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jenkins,"

Phrase: "N.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Copeland,"

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.449: (2001) Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Accumulation of proteolytic fragments of mutant presenilin 1"

Phrase: "and"

Phrase: "accelerated amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011560:Amyloid deposition [Pathologic Function]
   901   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]

Phrase: "are"

Phrase: "co-regulated in transgenic mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0025936:Mice, Transgenic [Mammal]
   760   C0003069:Transgenic [Animal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.450: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.451: Aging, 23, 171177.[CrossRef][ISI] Duff, K. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "171177."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Duff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.452: (1997) Alzheimer transgenic mouse models come of age. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alzheimer transgenic mouse models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1519606:Transgenic Model [Experimental Model of Disease]
   844   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Models [Intellectual Product]

Phrase: "come of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]
Processing 00000000.tx.453: Trends Neurosci., 20, 279280.[CrossRef][ISI][Medline] Oyama, F., Sawamura, N., Kobayashi, K., Morishima-Kawashima, M., Kuramochi, T., Ito, M., Tomita, T., Maruyama, K., Saido, T.C., Iwatsubo, T. et al. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "279280."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oyama,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sawamura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Morishima-Kawashima,"

Phrase: "M."

Phrase: ","

Phrase: "Kuramochi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T. et al."
Processing 00000000.tx.454: (1998) Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutant presenilin 2 transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mouse, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]

Phrase: ":"

Phrase: "effect on an age-dependent increase of amyloid beta-protein 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.455: J. 

Phrase: "J."
Processing 00000000.tx.456: Neurochem., 71, 313322.[ISI][Medline] Borchelt, D.R., Ratovitski, T., Van Lare, J., Lee, M.K., Gonzales, V.B., Jenkins, N.A., Copeland, N.G., Price, D.L. and Sisodia, S.S. 

Phrase: "Neurochem.,"

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "313322."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Van Lare,"

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gonzales,"

Phrase: "V.B.,"

Phrase: "Jenkins,"

Phrase: "N.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Copeland,"

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.457: (1997) Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Accelerated amyloid deposition in the brains of transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0011560:Amyloid deposition [Pathologic Function]
   764   C1705760:Amyloid Deposition [Finding]
   742   C0333562:Deposition [Functional Concept]

Phrase: "co-expressing"

Phrase: "mutant presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "amyloid precursor proteins."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   966   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   884   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.458: Neuron, 19, 939945.[ISI][Medline] Holcomb, L., Gordon, M.N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D. et al. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "19,"

Phrase: "939945."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Holcomb,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "M."

Phrase: "N., McGowan,"

Phrase: "E.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Benkovic,"

Phrase: "S."

Phrase: ","

Phrase: "Jantzen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saad,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mueller,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "D. et al."
Processing 00000000.tx.459: (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Accelerated Alzheimer-type phenotype in transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "both mutant amyloid precursor protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "presenilin 1 transgenes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0282641:Transgenes [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]
Processing 00000000.tx.460: Nat. 

Phrase: "Nat."
Processing 00000000.tx.461: Med., 4, 97100.[CrossRef][ISI][Medline] Chen, F., Yang, D.S., Petanceska, S., Yang, A., Tandon, A., Yu, G., Rozmahel, R., Ghiso, J., Nishimura, M., Zhang, D.M. et al. 

Phrase: "Med.,"

Phrase: "4,"

Phrase: "97100."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Petanceska,"

Phrase: "S."

Phrase: ","

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "A.,"

Phrase: "Tandon,"

Phrase: "A.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rozmahel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "D."

Phrase: "M. et al."
Processing 00000000.tx.462: (2000) Carboxyl-terminal fragments of alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Carboxyl-terminal fragments of alzheimer beta-amyloid precursor protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   745   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "accumulate in restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443288:Restricted [Functional Concept]

Phrase: "and"

Phrase: "unpredicted intracellular compartments in presenilin 1-deficient cells."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C1185625:Compartments [Body Space or Junction]
   744   C1382196:Compartments [Natural Phenomenon or Process]
   734   C1948049:Cell (compartment) [Spatial Concept]
   734   C2349967:Cell compartment [Anatomical Structure]
   711 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.463: J. 

Phrase: "J."
Processing 00000000.tx.464: Biol. 

Phrase: "Biol."
Processing 00000000.tx.465: Chem., 275, 3679436802.[Abstract/Free FullText] Esler, W.P., Taylor Kimberly, W., Ostaszewski, B.L., Diehl, T.S., Moore, C.L., Tsai, J.Y., Rahmati, T., Xia, W., Selkoe, D.J. and Wolfe, M.S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3679436802."

Phrase: "[Abstract/Free FullText"

Phrase: "] Esler,"

Phrase: "W.P.,"

Phrase: "Taylor Kimberly,"

Phrase: "W.,"

Phrase: "Ostaszewski,"

Phrase: "B.L., Diehl,"

Phrase: "T.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Tsai,"

Phrase: "J.Y.,"

Phrase: "Rahmati,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Wolfe,"

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.466: (2000) Transition-state analogue inhibitors of -secretase bind directly to presenilin-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Transition-state analogue inhibitors of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "directly to presenilin-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.467: Nat. 

Phrase: "Nat."
Processing 00000000.tx.468: Cell Biol., 2, 17.[CrossRef][ISI][Medline] Xia, W., Ostaszewski, B.L., Kimberly, W.T., Rahmati, T., Moore, C.L., Wolfe, M.S. and Selkoe, D.J. 

Phrase: "Cell Biol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "17."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Ostaszewski,"

Phrase: "B.L., Kimberly,"

Phrase: "W.T.,"

Phrase: "Rahmati,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Wolfe,"

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.469: (2000) FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex. 

Phrase: "(2000"

Phrase: ")"

Phrase: "FAD mutations in presenilin-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the efficacy of a gamma-secretase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:Efficacy [Qualitative Concept]
   748   C1707887:EFFICACY [Research Activity]

Phrase: ":"

Phrase: "evidence for direct involvement of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the gamma-secretase cleavage complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C2753842:gamma-secretase complex [Cell Component]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.470: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.471: Dis., 7, 673681.[CrossRef][ISI][Medline] Xia, W., Zhang, J., Ostaszewski, B.L., Kimberly, W.T., Seubert, P., Koo, E.H., Shen, J. and Selkoe, D.J. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "7,"

Phrase: "673681."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Ostaszewski,"

Phrase: "B.L., Kimberly,"

Phrase: "W.T.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shen,"

Phrase: "J."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.472: (1998) Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "regulates"

Phrase: "the processing of beta-amyloid precursor protein C-terminal fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0033666:protein processing [Molecular Function]
   739   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "the generation of amyloid beta-protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "in endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]
Processing 00000000.tx.473: Biochemistry, 37, 1646516471.[CrossRef][ISI][Medline] Borchelt, D.R., Davis, J., Fischer, M., Lee, M.K., Slunt, H.H., Ratovitsky, T., Regard, J., Copeland, N.G., Jenkins, N.A., Sisodia, S.S. and Price, D.L. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "37,"

Phrase: "1646516471."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "J.,"

Phrase: "Fischer,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H.H.,"

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Regard,"

Phrase: "J.,"

Phrase: "Copeland,"

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.474: (1996) A vector for expressing foreign genes in the brains and hearts of transgenic mice. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A vector for expressing foreign genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "hearts of transgenic mice."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   786   C1512359:Mouse Heart [Tissue]
   770   C0018787:Hearts [Body Part, Organ, or Organ Component]
   737 E C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.475: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.476: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.477: (Biomed. Eng.), 13, 159163.[CrossRef] Perez-Tur, J., Froelich, S., Prihar, G., Crook, R., Baker, M., Duff, K., Wragg, M., Busfield, F., Lendon, C., Clark, R.F. et al. 

Phrase: "(Biomed. Eng."

Phrase: ")"

Phrase: ","

Phrase: "13,"

Phrase: "159163."

Phrase: "[CrossRef"

Phrase: "] Perez-Tur,"

Phrase: "J.,"

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "R.F. et al."
Processing 00000000.tx.478: (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A mutation in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "destroying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]

Phrase: "a splice acceptor site in the presenilin-1 gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0887918:Splice Acceptor Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0000901:acceptor [Population Group]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
Processing 00000000.tx.479: Neuroreport, 7, 297301.[ISI][Medline] Jankowsky, J.L., Slunt, H.H., Ratovitski, T., Jenkins, N.A., Copeland, N.G. and Borchelt, D.R. 

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "297301."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jankowsky,"

Phrase: "J.L., Slunt,"

Phrase: "H.H.,"

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jenkins,"

Phrase: "N.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Copeland,"

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Borchelt,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.480: (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Co-expression of multiple transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in mouse CNS"

Phrase: ":"

Phrase: "a comparison of strategies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]
Processing 00000000.tx.481: Biomol. 

Phrase: "Biomol."
Processing 00000000.tx.482: Eng., 17, 157165.[CrossRef][ISI][Medline] Lee, M.K., Borchelt, D.R., Kim, G., Thinakaran, G., Slunt, H.H., Ratovitski, T., Martin, L.J., Kittur, A., Gandy, S., Levey, A.I., Jenkins, N., Copeland, N., Price, D.L. and Sisodia, S.S. 

Phrase: "Eng.,"

Phrase: "17,"

Phrase: "157165."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H.H.,"

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Kittur,"

Phrase: "A.,"

Phrase: "Gandy,"

Phrase: "S."

Phrase: ","

Phrase: "Levey,"

Phrase: "A.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jenkins,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Copeland,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.483: (1997) Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Hyperaccumulation of FAD-linked presenilin 1 variants"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.484: Nat. 

Phrase: "Nat."
Processing 00000000.tx.485: Med., 3, 756760.[ISI][Medline] Lesuisse, C., Xu, G., Anderson, J., Wong, M., Jankowsky, J., Holtz, G., Gonzalez, V., Wong, P.C.Y., Price, D.L., Tang, F., Wagner, S. and Borchelt, D.R. 

Phrase: "Med.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "756760."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lesuisse,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Xu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "J.,"

Phrase: "Wong,"

Phrase: "M."

Phrase: ","

Phrase: "Jankowsky,"

Phrase: "J.,"

Phrase: "Holtz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gonzalez,"

Phrase: "V.,"

Phrase: "Wong,"

Phrase: "P.C.Y.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L., Tang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wagner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Borchelt,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.486: (2001) Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Hyper-expression of human apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0424295:HYPER [Finding]

Phrase: "in astroglia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astroglia [Cell]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "amyloid deposition in transgenic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.487: Hum. 

Phrase: "Hum."
Processing 00000000.tx.488: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.489: Genet., 10, 25252537.[Abstract/Free FullText] Kawarabayashi, T., Younkin, L.H., Saido, T.C., Shoji, M., Ashe, K.H. and Younkin, S.G. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "25252537."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Ashe,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.490: (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Age-dependent changes in brain,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "CSF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "plasma amyloid (beta) protein in the Tg2576 transgenic mouse model"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   782   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   760   C1750295:beta protein [Genetic Function]
   760   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   760   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   757   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1168405:protein plasma [Laboratory Procedure]
   757   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757 E C2825879:Amyloid, Beta [Laboratory Procedure]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0330390:Beta [Plant]
   739   C0439096:Beta [Intellectual Product]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C2004068:Beta [Qualitative Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.491: J. 

Phrase: "J."
Processing 00000000.tx.492: Neurosci., 21, 372381.[Abstract/Free FullText] Smith, M.J., Kwok, J.B., McLean, C.A., Kril, J.J., Broe, G.A., Nicholson, G.A., Cappai, R., Hallupp, M., Cotton, R.G., Masters, C.L., Schofield, P.R. and Brooks, W.S. 

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "372381."

Phrase: "[Abstract/Free FullText"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."

Phrase: "J.,"

Phrase: "Kwok,"

Phrase: "J.B.,"

Phrase: "McLean,"

Phrase: "C.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Kril,"

Phrase: "J.J.,"

Phrase: "Broe,"

Phrase: "G.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Nicholson,"

Phrase: "G.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Cappai,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hallupp,"

Phrase: "M."

Phrase: ","

Phrase: "Cotton,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010196:Cotton [Plant]
  1000   C0330523:cotton [Plant]
  1000   C0330524:cotton [Plant]
  1000   C1095832:Cotton [Substance]

Phrase: "R.G.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Schofield,"

Phrase: "P.R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Brooks,"

Phrase: "W.S."
Processing 00000000.tx.493: (2001) Variable phenotype of Alzheimer's disease with spastic paraparesis. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Variable phenotype of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1837514:Variable phenotype [Finding]
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "with spastic paraparesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037771:Paraparesis, Spastic [Sign or Symptom]
   861   C0221166:Paraparesis [Sign or Symptom]
Processing 00000000.tx.494: Ann. 

Phrase: "Ann."
Processing 00000000.tx.495: Neurol., 49, 125129.[CrossRef][ISI][Medline] Steiner, H., Revesz, T., Neumann, M., Romig, H., Grim, M.G., Pesold, B., Kretzschmar, H.A., Hardy, J., Holton, J.L., Baumeister, R., Houlden, H. and Haass, C. 

Phrase: "Neurol.,"

Phrase: "49,"

Phrase: "125129."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Revesz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Neumann,"

Phrase: "M."

Phrase: ","

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grim,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kretzschmar,"

Phrase: "H.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Holton,"

Phrase: "J.L., Baumeister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Houlden,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.496: (2001) A pathogenic presenilin-1 deletion causes aberrant Abeta 42 production in the absence of congophilic amyloid plaques. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A pathogenic presenilin-1 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1442161:Deletion [Cell or Molecular Dysfunction]
   804   C1511760:Deletion [Genetic Function]
   804   C1880274:Deletion [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "aberrant Abeta 42 production in the absence of congophilic amyloid plaques."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0033268:production [Occupational Activity]
Processing 00000000.tx.497: J. 

Phrase: "J."
Processing 00000000.tx.498: Biol. 

Phrase: "Biol."
Processing 00000000.tx.499: Chem., 276, 72337239.[Abstract/Free FullText] Crook, R., Chen, L.S., Bende, S.M. and LaFerla, F.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "72337239."

Phrase: "[Abstract/Free FullText"

Phrase: "] Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Bende,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "LaFerla,"

Phrase: "F.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348507:F/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.500: (1998) A variant of Alzheimer's disease wtih spastic paraparaesis and unusual plaques due to deletion of exon 9 of presenilin 1. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A variant of Alzheimer's disease wtih spastic paraparaesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "unusual plaques due to deletion of exon 9 of presenilin 1."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0333463:plaques [Acquired Abnormality]
   704 E C0011389:Plaque [Disease or Syndrome]
   704 E C0332461:Plaque [Finding]
Processing 00000000.tx.501: Nat. 

Phrase: "Nat."
Processing 00000000.tx.502: Med., 4, 14.[CrossRef][ISI][Medline] Hiltunen, M., Helisalmi, S., Mannermaa, A., Alafuzoff, I., Koivisto, A.M., Lehtovirta, M., Pirskanen, M., Sulkava, R., Verkkoniemi, A. and Soininen, H. 

Phrase: "Med.,"

Phrase: "4,"

Phrase: "14."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hiltunen,"

Phrase: "M."

Phrase: ","

Phrase: "Helisalmi,"

Phrase: "S."

Phrase: ","

Phrase: "Mannermaa,"

Phrase: "A.,"

Phrase: "Alafuzoff,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Koivisto,"

Phrase: "A."

Phrase: "M."

Phrase: ","

Phrase: "Lehtovirta,"

Phrase: "M."

Phrase: ","

Phrase: "Pirskanen,"

Phrase: "M."

Phrase: ","

Phrase: "Sulkava,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verkkoniemi,"

Phrase: "A."

Phrase: "and"

Phrase: "Soininen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.503: (2000) Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination? 

Phrase: "(2000"

Phrase: ")"

Phrase: "Identification of a novel 4.6-kb genomic deletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020792:Identification [Mental Process]
   742   C0205396:Identification [Qualitative Concept]

Phrase: "in presenilin-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "results in exclusion of exon 9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0680251:EXCLUSION [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   753   C2828389:Exclusion [Activity]

Phrase: "in a Finnish early onset Alzheimer's disease family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0344339:disease family [Finding]
   799   C0015576:Family [Family Group]
   799   C1704727:Family [Conceptual Entity]
   734   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   727 E C0241888:Familial [Functional Concept]

Phrase: ":"

Phrase: "an Alu core sequence-stimulated recombination?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.504: Eur. 

Phrase: "Eur."
Processing 00000000.tx.505: J. 

Phrase: "J."
Processing 00000000.tx.506: Hum. 

Phrase: "Hum."
Processing 00000000.tx.507: Genet., 8, 259266.[CrossRef][ISI][Medline] Mann, D.M., Takeuchi, A., Sato, S., Cairns, N.J., Lantos, P.L., Rossor, M.N., Haltia, M., Kalimo, H. and Iwatsubo, T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "259266."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mann,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Takeuchi,"

Phrase: "A.,"

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Cairns,"

Phrase: "N.J.,"

Phrase: "Lantos,"

Phrase: "P.L., Rossor,"

Phrase: "M."

Phrase: "N., Haltia,"

Phrase: "M."

Phrase: ","

Phrase: "Kalimo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.508: (2001) Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as cotton wool plaques. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Cases of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "due to deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "of exon 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the presenilin-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an unusual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700116:Unusual [Qualitative Concept]

Phrase: "but"

Phrase: "characteristic beta-amyloid pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   741 E C1521733:Pathologic [Functional Concept]

Phrase: "known as cotton wool plaques."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0440207:Cotton wool [Biomedical or Dental Material]
   760   C0010196:Cotton [Plant]
   760   C0043220:Wool [Substance]
   760   C0205309:Known [Qualitative Concept]
   760   C0330523:cotton [Plant]
   760   C0330524:cotton [Plant]
   760   C0333463:plaques [Acquired Abnormality]
   760   C1095832:Cotton [Substance]
   760   C1561494:Wool [Intellectual Product]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
Processing 00000000.tx.509: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.510: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.511: Neurobiol., 27, 189196.[CrossRef][ISI][Medline] Ishii, K., Ii, K., Hasegawa, T., Shoji, S., Doi, A. and Mori, H. 

Phrase: "Neurobiol.,"

Phrase: "27,"

Phrase: "189196."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shoji,"

Phrase: "S."

Phrase: ","

Phrase: "Doi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348291:DOI [Classification]

Phrase: "A."

Phrase: "and"

Phrase: "Mori,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.512: (1997) Increased A 42(43)-plaque depostion in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Increased A 42"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0205217:Increased [Quantitative Concept]
   827   C0442805:Increased [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(43"

Phrase: ")-"

Phrase: "plaque depostion in early-onset familial Alzheimer's disease brains"

Phrase: "with the deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "of exon 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the missense point mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0599155:Missense Mutation [Genetic Function]
   901   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutation [Genetic Function]
   827   C1552961:Point [Quantitative Concept]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   827   C2347617:point [Quantitative Concept]

Phrase: "(H163R"

Phrase: ")"

Phrase: "in the PS-1 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.513: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.514: Lett., 228, 1720.[CrossRef][ISI][Medline] Jarrett, J.T., Berger, E.P. and Lansbury, P.T. 

Phrase: "Lett.,"

Phrase: "228,"

Phrase: "1720."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jarrett,"

Phrase: "J.T.,"

Phrase: "Berger,"

Phrase: "E.P."

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.515: Jr (1993) The carboxy terminus of the  amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. 

Phrase: "Jr (1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "The carboxy terminus of the  amyloid protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596260:Carboxy [Organic Chemical]

Phrase: "is"

Phrase: "critical for the seeding of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511545:Critical [Qualitative Concept]

Phrase: ":"

Phrase: "implications for the pathogenesis of Alzheimer's disease."
Processing 00000000.tx.516: Biochemistry, 32, 46934697.[ISI][Medline] Jarrett, J.T. and Lansbury, P.T., Jr (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "32,"

Phrase: "46934697."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jarrett,"

Phrase: "J.T."

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Jr (1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Amyloid fibril formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3544412:amyloid fibril formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "requires"

Phrase: "a chemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220806:Chemically [Chemical]

Phrase: "discriminating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205235:Discriminate [Qualitative Concept]

Phrase: "nucleation event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: ":"

Phrase: "studies of an amyloidogenic sequence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "from the bacterial protein OsmB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0004627:Protein, Bacterial [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.517: Biochemistry, 31, 1234512352.[ISI][Medline] Houlden, H., Baker, M., McGowan, E., Lewis, P., Hutton, M., Crook, R., Wood, N.W., Kumar-Singh, S., Geddes, J., Swash, M. et al. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "1234512352."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "McGowan,"

Phrase: "E.,"

Phrase: "Lewis,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Kumar-Singh,"

Phrase: "S."

Phrase: ","

Phrase: "Geddes,"

Phrase: "J.,"

Phrase: "Swash,"

Phrase: "M. et al."
Processing 00000000.tx.518: (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Variant Alzheimer's disease with spastic paraparesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "and"

Phrase: "cotton wool plaques"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "is"

Phrase: "caused by PS-1 mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0026882:Mutations [Genetic Function]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to exceptionally high amyloid-beta concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0086045:Concentrations [Mental Process]
   766 E C1446561:Concentration [Quantitative Concept]
   716 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.519: Ann. 

Phrase: "Ann."
Processing 00000000.tx.520: Neurol., 48, 806808.[CrossRef][ISI][Medline] Wolfe, M.S., Citron, M., Diehl, T.S., Xia, W., Donkor, I.O. and Selkoe, D.J. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "806808."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolfe,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Diehl,"

Phrase: "T.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Donkor,"

Phrase: "I.O."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.521: (2000) A substrate-based difluoro ketone selectively inhibits Alzheimer's -secretase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A substrate-based difluoro ketone selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0022634:Ketone [Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Alzheimer's -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.522: J. 

Phrase: "J."
Processing 00000000.tx.523: Med. 

Phrase: "Med."
Processing 00000000.tx.524: Chem., 41, 69.[CrossRef] Li, Y.M., Xu, M., Lai, M.T., Huang, Q., Castro, J.L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J.G. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "41,"

Phrase: "69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y."

Phrase: "M."

Phrase: ","

Phrase: "Xu,"

Phrase: "M."

Phrase: ","

Phrase: "Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huang,"

Phrase: "Q.,"

Phrase: "Castro,"

Phrase: "J.L., DiMuzio-Mower,"

Phrase: "J.,"

Phrase: "Harrison,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lellis,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nadin,"

Phrase: "A.,"

Phrase: "Neduvelil,"

Phrase: "J.G. et al."
Processing 00000000.tx.525: (2000) Photoactivated -secretase inhibitors directed to the active site convalently label presenilin 1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Photoactivated -secretase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "directed to the active site convalently label presenilin 1."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0205681:Active Site [Functional Concept]
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0181496:Label [Manufactured Object]
   742   C0205145:Site [Spatial Concept]
   742   C0205177:Active [Functional Concept]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
   742   C2827499:Label [Governmental or Regulatory Activity]
   708   C0439851:Direct [Qualitative Concept]
   708   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.526: Nature, 405, 689693.[CrossRef][ISI][Medline] Seiffert, D., Bradley, J.D., Rominger, C.M., Rominger, D.H., Yang, F., Meredith, J.E. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "405,"

Phrase: "689693."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seiffert,"

Phrase: "D."

Phrase: ","

Phrase: "Bradley,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Rominger,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Rominger,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Meredith,"

Phrase: "J.E."
Processing 00000000.tx.527: Jr Wang, Q., Roach, A.H., Thompson, L.A., Spitz, S.M. et al. 

Phrase: "Jr Wang,"

Phrase: "Q.,"

Phrase: "Roach,"

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Thompson,"

Phrase: "L.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Spitz,"

Phrase: "S.M. et al."
Processing 00000000.tx.528: (2000) Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "are"

Phrase: "molecular targets for gamma-secretase inhibitors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C1579409:Molecular Target Inhibitors [Pharmacologic Substance]
   773   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.529: J. 

Phrase: "J."
Processing 00000000.tx.530: Biol. 

Phrase: "Biol."
Processing 00000000.tx.531: Chem., 275, 3408634091.[Abstract/Free FullText] Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S. and Malinow, R. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3408634091."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kamenetz,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hsieh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seabrook,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Malinow,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: (2003) APP processing and synaptic function. 

Phrase: "(2003"

Phrase: ")"

Phrase: "APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "synaptic function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.533: Neuron, 37, 925937.[ISI][Medline] Koo, E.H. and Squazzo, S.L. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "925937."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koo,"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Squazzo,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.534: (1994) Evidence that production and release of amyloid -protein involves the endocytic pathway. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "release of amyloid -protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "involves"

Phrase: "the endocytic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.535: J. 

Phrase: "J."
Processing 00000000.tx.536: Biol. 

Phrase: "Biol."
Processing 00000000.tx.537: Chem., 269, 1738617389.[Abstract/Free FullText] Kim, S.H., Leem, J.Y., Lah, J.J., Slunt, H.H., Levey, A.I., Thinakaran, G. and Sisodia, S.S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "1738617389."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leem,"

Phrase: "J.Y.,"

Phrase: "Lah,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0238705:LAH [Anatomical Abnormality,Disease or Syndrome]
  1000   C1427484:LAH [Gene or Genome]
  1000   C1842839:LAH [Disease or Syndrome]

Phrase: "J.J.,"

Phrase: "Slunt,"

Phrase: "H.H.,"

Phrase: "Levey,"

Phrase: "A.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.538: (2001) Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Multiple effects of aspartate mutant presenilin 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "trafficking of amyloid precursor protein."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0599895:Protein Trafficking [Cell Function]
   797   C1159772:Protein Trafficking [Cell Function]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0599896:trafficking [Cell Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.539: J. 

Phrase: "J."
Processing 00000000.tx.540: Biol. 

Phrase: "Biol."
Processing 00000000.tx.541: Chem., 276, 4334343350.[Abstract/Free FullText] Kaether, C., Lammich, S., Edbauer, D., Ertl, M., Rietdorf, J., Capell, A., Steiner, H. and Haass, C. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "4334343350."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kaether,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Ertl,"

Phrase: "M."

Phrase: ","

Phrase: "Rietdorf,"

Phrase: "J.,"

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.542: (2002) Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "processing of betaAPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "is"

Phrase: "targeted in a complex"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439855:Complex [Qualitative Concept]
   770   C1521840:Targeted [Functional Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "with nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "to the plasma membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.543: J. 

Phrase: "J."
Processing 00000000.tx.544: Cell Biol., 158, 551561.[Abstract/Free FullText] Leem, J.Y., Saura, C.A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L.T., Veselits, M.L., Tomita, T., Gasparini, L. and Iwatsubo, T. 

Phrase: "Cell Biol.,"

Phrase: "158,"

Phrase: "551561."

Phrase: "[Abstract/Free FullText"

Phrase: "] Leem,"

Phrase: "J.Y.,"

Phrase: "Saura,"

Phrase: "C.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Pietrzik,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Christianson,"

Phrase: "J.,"

Phrase: "Wanamaker,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "King,"

Phrase: "L.T.,"

Phrase: "Veselits,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gasparini,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.545: (2002) A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. 

Phrase: "(2002"

Phrase: ")"

Phrase: "A role for presenilin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating"

Phrase: "the delivery of amyloid precursor protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011209:Delivery [Therapeutic or Preventive Procedure]
   753   C0559563:delivery [Finding]
   753   C1705822:Delivery [Activity]

Phrase: "to the cell surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.546: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.547: Dis., 11, 6482.[CrossRef][ISI][Medline] Gravina, S.A., Ho, L., Eckman, C.B., Long, K.E., Otvos, L., Jr Younkin, L.H., Suzuki, N. and Younkin, S.G. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "11,"

Phrase: "6482."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gravina,"

Phrase: "S."

Phrase: "A.,"

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Long,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "K.E.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr Younkin,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: (1995) Amyloid  protein (A) in Alzheimer's disease brain. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Amyloid  protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "in Alzheimer's disease brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.549: J. 

Phrase: "J."
Processing 00000000.tx.550: Biol. 

Phrase: "Biol."
Processing 00000000.tx.551: Chem., 270, 70137016.[Abstract/Free FullText] Yamamoto, T. and Hirano, A. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "70137016."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hirano,"

Phrase: "A."
Processing 00000000.tx.552: (1986) A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. 

Phrase: "(1986"

Phrase: ")"

Phrase: "A comparative study of modified Bielschowsky,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0009491:Comparative Study [Intellectual Product]
   790   C1579762:comparative study [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "Bodian"

Phrase: "and"

Phrase: "thioflavin S stains on Alzheimer's neurofibrillary tangles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.553: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.554: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.555: Neurobiol., 12, 39.[ISI][Medline] Hirano, A. and Zimmerman, H.M. 

Phrase: "Neurobiol.,"

Phrase: "12,"

Phrase: "39."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirano,"

Phrase: "A."

Phrase: "and"

Phrase: "Zimmerman,"

Phrase: "H.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348952:H/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.556: (1962) Alzheimer's neurofibrillary changes. 

Phrase: "(1962"

Phrase: ")"

Phrase: "Alzheimer's neurofibrillary changes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   988   C0085400:Alzheimer's neurofibrillary change [Acquired Abnormality]
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.557: A topographic study. 

Phrase: "A topographic study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.558: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.559: Neurol., 7, 227242.[ISI][Medline] Reaume, A.G., Howland, D.S., Trusko, S.P., Savage, M.J., Lang, D.M., Greenberg, B.D., Siman, R. and Scott, R.W. 

Phrase: "Neurol.,"

Phrase: "7,"

Phrase: "227242."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reaume,"

Phrase: "A.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Howland,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Trusko,"

Phrase: "S.P.,"

Phrase: "Savage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331893:Savage [Health Care Related Organization]

Phrase: "M."

Phrase: "J.,"

Phrase: "Lang,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Siman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Scott,"

Phrase: "R.W."
Processing 00000000.tx.560: (1996) Enhanced amyloidogenic processing of the -amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" A sequence. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "amyloidogenic processing of the -amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "in gene-targeted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the Swedish familial Alzheimer's disease mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "and"

Phrase: "a """

Phrase: "humanized"

Phrase: """ A sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.561: J. 

Phrase: "J."
Processing 00000000.tx.562: Biol. 

Phrase: "Biol."
Processing 00000000.tx.563: Chem., 271, 2338023388.[Abstract/Free FullText] Slunt, H.H., Thinakaran, G., von Koch, C., Lo, A.C.Y., Tanzi, R.E. and Sisodia, S.S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "2338023388."

Phrase: "[Abstract/Free FullText"

Phrase: "] Slunt,"

Phrase: "H.H.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "von Koch,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lo,"

Phrase: "A.C.Y.,"

Phrase: "Tanzi,"

Phrase: "R.E."

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.564: (1994) Expression of a ubiquitous, cross-reactive homologue of the mouse -amyloid precursor protein (APP). 

Phrase: "(1994"

Phrase: ")"

Phrase: "Expression of a ubiquitous, cross-reactive homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the mouse -amyloid precursor protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.565: J. 

Phrase: "J."
Processing 00000000.tx.566: Biol. 

Phrase: "Biol."
Processing 00000000.tx.567: Chem., 269, 26372644.[Abstract/Free FullText]

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "26372644."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

